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Transcriptome analysis is of great importance in the field of genomic research. 
Genome-wide analysis of expressed transcripts in a given cell or tissue can reveal 
significant information about gene expression and regulation under different condi-
tions such as developmental and disease processes. Recent studies have provided 
novel insights into the complexity of transcriptomes and the regulation of gene ex-
pression. The regulatory role for small non-coding RNAs is one of the key discover-
ies that have given a new dimension to the understanding of gene expression control. 
The latest developments in technologies for transcriptome profiling include the ap-
plication of next generation sequencing systems that have made an enormous impact 
on biology. Here we applied these new genomics approaches to study infectious dis-
eases and cancer using zebrafish as a model system.
Transcriptomics 
The transcriptome comprises all expressed RNA transcripts in a cell or an or-
ganism. Transcriptomics measures all transcript species in a given cell, including 
protein-coding mRNAs and small non-coding RNAs, and gives insight into how 
the expression levels of these transcripts are regulated under different conditions. 
Analyzing the transcriptome helps to characterize the complexity of the genome. 
Transcriptional profiling, besides cataloging the known transcripts, can lead to the 
identification of novel gene models by discovering novel gene boundaries, splic-
ing variants, additional promoters, alternative exons, 5’and 3’ untranslated regions 
(UTRs), non-coding transcripts and antisense transcripts (Cloonan et al., 2008; 
Morin et al., 2008; Mortazavi et al., 2008; Pan et al., 2008; Rosenkranz et al., 2008; 
Sultan et al., 2008; Wang et al., 2009). Quantifying expression levels of transcripts 
also facilitates our understanding of the molecular background of specific devel-
opmental processes and pathological conditions (Brentani et al., 2005; Mardis and 
Wilson, 2009).
In the last decade several high-throughput methods have been developed for 
large-scale studies of gene expression levels. Basically, all these methods can be di-
vided into two categories: microarray-based and sequencing-based approaches. 
Since the mid-1990s, microarray-based methods have become generally used to 
analyze large-scale datasets. Using microarrays, scientists are able to detect the ex-
pression of thousands of genes simultaneously. The common basics of these methods 
are the hybridization of fluorescently labeled cDNA or amplified RNA to comple-
mentary oligonucleotide probes on the microarray platforms and detection of the 
hybridization intensity relative to the abundance of the particular mRNA species 
(Schena et al., 1995). They have been widely applied in molecular profiling of dif-
ferent developmental processes, diseases, pharmacogenomic responses, or whole 
genome association studies (Bertone et al., 2004; Brentani et al., 2005; Douglas 
and Ehlting, 2005; Scherf et al., 2000; White, 2001)). The microarray technique al-
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lows to detect and measure gene expression at the mRNA level, to describe genetic 
variations (SNPs, copy-number variations, chromosomal changes), and to profile 
DNA-protein interactions. Lately, more specific types of arrays have been developed 
like tiling (Bertone et al., 2004), all-exon (Gardina et al., 2006) or exon-junction 
(Clark et al., 2002) arrays, which are used to analyze specific regions of the genome. 
Furthermore, such array platforms as kinome or phosphatome chips have also been 
developed recently to determine the phosphorylation status of expressed gene prod-
ucts (Arena et al., 2005; Diks et al., 2004; Hestvik et al., 2003; Parikh et al., 2009). 
Although microarray technology is high-throughput and relatively inexpensive it has 
some limitations, including the necessity of existing knowledge of the genome se-
quence for designing arrays or cross-hybridization problems between highly related 
sequences (Okoniewski and Miller, 2006; Royce et al., 2007). Additionally, issues 
such as poor sensitivity for low abundance-species, difficulties in comparing expres-
sion levels across different experiments, requirement for complicated normalization 
methods, and the measurement of relative rather than absolute expression levels, 
add to the limitations of microarrays (Irizarry et al., 2005; Okoniewski and Miller, 
2006; Royce et al., 2007).
Another approach to quantify and annotate transcriptomes is the sequencing-
based approach which overcomes some limitations of array-based methods (Irizarry 
et al., 2005; Pedotti et al., 2008; t Hoen et al., 2008; Wilhelm and Landry, 2009). 
Sequencing-based transcriptome profiling methods directly determine cDNA se-
quences. The first type of sequence-based approach was the cataloging of expressed 
sequence tags (ESTs) using the Sanger sequencing method. In the EST method sin-
gle sequencing reads are made of the 5’or 3’ends of all cDNA clones in a cDNA li-
brary. The resulting sequences, typically 500 to 800 bp in length, give an overview 
of the mRNAs represented in the cDNA library. Sanger sequencing has been used 
for decades for deciphering complete genes and later whole genomes and it is still 
the most commonly used technique to date because of the long read length and low 
error rate. However, the Sanger-based EST method has its weaknesses namely being 
non-quantitative, and relatively low-throughput with high costs (Boguski et al., 1994; 
Gerhard et al., 2004).
The shortcomings of the EST method triggered the generation of ‘clone-and-
count’ (Tyagi, 2000) tag-based approaches such as serial analysis of gene expression 
(SAGE) (Carninci et al., 2005; Harbers and Carninci, 2005; Velculescu et al., 1995). 
In this profiling technique short sequence fragments representative for each cDNA 
are produced and concatenated to form large clones that are subsequently sequenced 
by the Sanger method. The sequencing step is followed by counting the number of 
times a short signature sequence (tag) has been observed (Morozova and Marra, 
2008). Many technologies have been developed improving the basics of SAGE such 
as massively parallel signature sequencing (MPSS) (Brenner et al., 2000), polony 
multiplex analysis of gene expression (PMAGE) (Kim et al., 2007), cap analysis 
of gene expression (CAGE) (Carninci et al., 2005), LongSAGE (Wahl et al., 2005), 
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DeepSAGE (Nielsen et al., 2006) and SuperSAGE (Matsumura et al., 2005) tech-
niques. These are medium to high throughput methods providing qualitative and 
quantitative data with accurate, digital output of gene expression levels compared 
to the analog nature of the signals generated by microarray technology. The results 
illustrate absolute abundances of transcripts instead of the relativity of array-based 
techniques and there is no requirement for prior knowledge of sequences and no 
bias due to a predefined array content (Harbers and Carninci, 2005). SAGE-derived 
sequencing methods have been applied for studying several human genetic diseases 
such as acute myeloid leukemia, neurodegenerative diseases, and cancer (Horan, 
2009). While these methods have been used in several transcriptome analyses, the 
high cost, the low throughput level of sequencing and difficulties of cloning steps has 
limited their application. 
The very recently developed next generation sequencing methods by Illumina/
Solexa, ABI/SOLiD, 454/Roche, and Helicos are ultra high-throughput deep sequenc-
ing technologies that have substantially reduced the cost of sequencing. Transcriptome 
profiling methods based on next generation sequencing technology include the so-
called RNA sequencing (RNA-Seq) and Digital Gene Expression (Fig. 1A) (DGE or 
Tag-Seq) that allow the simultaneous determination of millions of short sequences 
(Hegedus et al., 2009; Morrissy et al., 2009; Mortazavi et al., 2008; Nagalakshmi 
et al., 2008; Shendure, 2008; t Hoen et al., 2008; Wang et al., 2009; Wilhelm and 
Landry, 2009). In these methods the cloning step is eliminated and the advantages 
of these sequencing-based transcriptome profiling approaches over the microarray 
technique include the absence of background signals and large dynamic range, the 
improved ability to distinguish between homologous sequences, and the high accu-
racy, resolution and sensitivity (Shendure, 2008). In RNA-Seq methods RNA is first 
sheared and then converted to cDNA, or cDNA is produced first and then sheared 
into short fragments. Subsequently, adaptors are attached to one or both ends of the 
cDNA fragments, and, with or without an amplification step, these cDNA fragments 
Figure 1. Next generation sequencing technologies. A) Schematic representation of RNA se-
quencing (RNA-Seq) and Digital Gene Expression (DGE or Tag-Seq) methods. During RNA-Seq ei-
ther the mRNA is first converted to cDNA, then randomly sheared to short fragments and attached 
by linkers, or first mRNA is randomly sheared and then converted to cDNA and attached by linkers. 
An alternate option is that the fragmented mRNAs are attached by linker molecules before conver-
sion to cDNA. During DGE the isolated mRNA is converted to DNA and through enzymatic diges-
tions 17 bp long transcript-specific tags are generated and linked to adaptors. In both methods 
after amplification steps, sequencing and bioinformatic analysis are performed. Figure modified 
from Graveley BR (2008) Power sequencing. Nature 453: 1197. B) Schematic representation of Tag-
Seq. After cDNA synthesis and capture on magnetic beads fragments are digested with an anchor-
ing enzyme NlaIII, ligated to MmeI, a tagging enzyme cutting 21 nt downstream of the recognition 
sequence creating 17 bp transcript-specific tags. These tags are then ligated to adapters, amplified, 





are then sequenced to obtain short reads from one end (single-end sequencing) or 
both ends (pair-end sequencing). The reads, which are typically 30–400 bp, depend-
ing on the sequencing platform, are aligned to a reference genome or reference tran-
script database, or assembled de novo without the genomic sequence to produce a 
genome-scale transcription map (Wang et al., 2009). As an alternative to RNA-Seq 
methods, DGE or Tag-Seq involves the high-throughput sequencing of transcript-
specific sequence tags similar as in conventional SAGE but without the need for tags 
concatenation and cloning (Fig. 1B) (Hegedus et al., 2009; Morrissy et al., 2009; t 
Hoen et al., 2008). While RNA-Seq methods provide more detailed information of 
the transcriptome complexity, DGE or Tag-Seq is more suitable for quantification 
and more affordable for the comparison of larger numbers of samples. In addition to 
the usefulness for mRNA expression profiling, next generation sequencing techology 
has advanced the analysis of small noncoding RNAs (Friedlander and Little, 2009; 
Hackenberg et al., 2009; Morin et al., 2008; Wyman et al., 2009). Furthermore, next 
generation sequencing technologies make an enormous contribution to the whole-
genome sequencing of microbial, plant and animal genomes (Engstrand, 2009; Qi 
et al., 2009). Several other applications include targeted resequencing, cancer ge-
nome sequencing, HLA genotyping for immune-mediated conditions, and studies 
of epigenetic modifications (Bentley et al., 2009; Cloonan et al., 2008; Gabriel et 
al., 2009; Gargiulo and Minucci, 2009; Hurd and Nelson, 2009; Lister et al., 2008; 
Mardis and Wilson, 2009; Mortazavi et al., 2008; Nagalakshmi et al., 2008; Sultan et 
al., 2008; Wilhelm and Landry, 2009). The application of next generation technology 
to the analysis of transcriptomes has shown that both in prokaryotic and eukaryotic 
species much more of the genome is transcribed than previously known. Several re-
cent studies revealed novel transcribed regions, the use of additional promoters, and 
extensive variation in splicing isoforms, gene boundaries, and 3’UTRs. In addition, 
there is increasing evidence for the abudant presence of antisense transcripts and 
other non-coding transcripts. (Cloonan and Grimmond, 2008; Morin et al., 2008; 
Mortazavi et al., 2008; Pan et al., 2008; Sultan et al., 2008).
Despite many advantages, sequence-based trancriptome profiling is more 
complex and currently still more costly than microarray analysis. Comparison of 
sequence-based and array-based transcriptome data has revealed overlaps as well 
as technology-dependent differences (Hegedus et al., 2009; t Hoen et al., 2008). 
Therefore, using both methods can be considered complementary to each other.
Regulation of gene expression
Transfer of biological information from DNA through RNA to proteins is the 
central dogma of molecular biology that was first determined by Francis Crick and 
his team more than 50 years ago. Transfer of the information is called gene expres-
sion. In the first step of gene expression the sequence information is transferred from 
DNA to messenger RNA (mRNA) by the mechanism called transcription. Followed 
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by several maturation steps mRNA is translated into proteins. These processes are 
strictly regulated, which is essential to ensure the correct macromolecular machin-
ery of the living organism. 
Gene expression is regulated on different levels, from transcription, through post-
transcriptional regulation to post-translational modification of the protein. These 
mechanisms together tune the appropriate level of the gene product. In eukaryotes, 
transcription depends on the chromatin structure of the DNA, which is a complex 
of DNA and its binding proteins, mostly histones. Modification of this structure 
by methylation and acetylation of histones, and DNA-binding proteins, decreases 
the binding affinity of RNA polymerase and can result in gene silencing. On the 
transcriptional level, several proteins and complexes can regulate gene expression, 
acting as transcription factors (activators or repressors) or transcriptional cofac-
tors that can modulate the activity of transcription factors or the function of RNA 
polymerase. After mRNA is transcribed, posttranscriptional modifications can alter 
the level of gene expression as well. If RNA molecules are stabilized by a 5’ cap and 
polyadenylated tail they are protected from degradation and transported to the site 
of translation. The translation process provides another level of regulation either by 
ribosome recruitment at the initiation step of translation or by modulation of the 
elongation and termination steps of the protein synthesis. Secondary structure of the 
mRNA is also an important factor in regulation.
According to the central dogma, transcripts coding for proteins are transcribed 
from the protein-coding strand of the DNA that is called the sense strand. However, 
numerous antisense transcripts have been detected in prokaryotes and viruses lately. 
Antisense transcripts are molecules that are transcribed from the opposite strand to 
the protein-coding strand. These transcripts were found to regulate gene expression 
by affecting mRNA transcription, processing and translation (Wagner and Simons, 
1994). Recent studies provide evidence that the majority of genes are transcribed in 
a bidirectional manner in eukaryotes as well (Carninci et al., 2005; Katayama et al., 
2005; Yelin et al., 2003). Although the mechanism by which antisense RNAs act on 
sense strand expression is largely unknown, antisense transcripts have been ascribed 
to play roles in gene regulation, including degradation of the corresponding sense 
transcript (RNA interference) and in gene silencing at the chromatin level (Beiter et 
al., 2009; Carninci et al., 2005; Katayama et al., 2005).  As an example of the antisense 
phenomenon, the proper dosage of the expression of PU.1, a human and murine 
hematopoietic transcription factor gene critical for suppression of leukemia, was 
shown to rely on antisense RNA modulators (Ebralidze et al., 2008).
Recently, it has become evident that small non-coding RNAs play major roles in 
the regulation of gene expression by binding to complementary sequences of mR-
NAs and destabilizing and sequestering them for degradation. Small non-coding 
RNAs (ncRNA) are 19-31 nucleotide long functional RNAs that are not translated 
into protein. There are several groups of them, such as transfer RNA (tRNA), ribos-
omal RNA (rRNA), small nuclear (snRNA), small nucleolar RNA (snoRNA), trans-
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acting (tasiRNAs), small-scan RNAs (scnRNAs), repeat-associated siRNAs (rasiR-
NA), Piwi-interacting RNAs (piRNAs), microRNA (miRNA) and small interfering 
RNA (siRNA) (Chu and Rana, 2007). They are involved in many cellular processes 
both in plants and animals. Small RNAs can be conserved or specific for different 
species. Although there are numerous classes and sizes of ncRNAs, they all share a 
common function in cellular physiology: epigenetic regulation of gene expression. 
They behave as sequence-specific triggers for mRNA degradation, translation repres-
sion, heterochromatin formation, and transposon control. In the recent years, both 
microarray-based and next generation sequencing methods have been applied for 
profiling of non-coding transcripts and many novel small ncRNAs have been discov-
ered using these high-throughput techniques (Morozova and Marra, 2008).
In the last decade, miRNAs have become one of the major focuses of research 
in molecular biology and they have one of the best understood and described roles 
in gene regulation among the small ncRNA molecules. MicroRNAs are involved in 
the post-transcriptional regulation of gene expression by regulating mRNA transla-
tion or stability (Filipowicz et al., 2008; Jackson and Standart, 2007; Nilsen, 2007). 
Although a large number of studies have been performed on miRNAs and many miR-
NAs have already been discovered, our knowledge about miRNA-directed regulation 
is still not complete and a large number of miRNAs have not yet been identified. It 
can be expected that in the coming years the application of the above-mentioned 
high-throughput methods and further technology developments for transcriptomic 
analysis will lead to the identification of additional miRNAs and will make a large 
contribution to the analysis of their function.
MicroRNAs
MicroRNAs (miRNAs) are small non-coding single-stranded RNAs with a length 
of 19-25/21-25 nucleotides (nt). They regulate gene expression by binding to their tar-
get mRNAs, and they are key negative regulators of stability and translation (Schmidt 
et al., 2009).
The first miRNA was detected in C. elegans in 1993. Lin-4, a 22 nucleotide long 
small RNA was shown to be a post-transcriptional regulator of lin-14 and essential 
in post-embryonic developmental events. This phenomenon was thought to be spe-
cific, but a few years later another small RNA let-7 was also found to be important 
in the development of C. elegans and to be conserved in many other animal species 
(Pasquinelli et al., 2000). This finding also led to the discovery of hundreds of miR-
NAs in plants and animals using bioinformatic approaches and molecular cloning. 
MiRNAs have been demonstrated to show high conservation between different eu-
karyotic species (Griffiths-Jones et al., 2005; Lim et al., 2003; Rodriguez et al., 2004). 
The miRNAs show high diversity of function as they are involved in a wide variety 
of biological processes such as proliferation, differentiation, cell fate determination, 
apoptosis, signal transduction, development and disease pathogenesis (Sonkoly and 
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Pivarcsi, 2009). Their importance in development has been proved by blocking the 
production of all miRNAs in mouse and zebrafish, which resulted in developmental 
arrest during embryogenesis (Kloosterman et al., 2004). Regarding their involve-
ment in diseases, numerous miRNAs have been detected to play important roles in 
tumorigenesis (Bellon et al., 2009). Nevertheless, the biological relevance of most 
miRNAs and their targets still remains to be determined.
Genes coding for miRNAs are located both in protein-coding and non-coding 
regions of the genome. MiRNA genes are either organized in clusters or encoded in 
single loci. MiRNAs in clusters are first transcribed as polycistronic primary tran-
scripts and later processed to single miRNAs (Medina and Slack, 2008). The majority 
of all known mammalian miRNAs are mapped to intronic regions of either coding 
or non-coding transcriptional units, whereas ~10% are detected at exonic regions of 
non-coding transcripts. 
MiRNAs are produced through a series of maturation steps (Fig. 2) (reviewed 
in Carissimi et al., 2009; Medina and Slack, 2008; Williams et al., 2008). They first 
are transcribed as a several kilobases long 5’ capped and 3’ polyadenylated primary 
transcript (pri-miRNA) from miRNA genes, mostly by RNA polymerase II. This 
double-stranded pri-miRNA is recognized and cleaved in the nucleus by the RNAase 
III enzyme Drosha /DGCR8 complex into one or more precursor miRNAs (pre-
miRNA). The pre-miRNA is a 60-80 nt long stemloop structure with a 2-nucleotide 
3’ overhang, which is recognized and transported to the cytoplasm by exportin-5 via 
a Ran-GTP-dependent mechanism. In the cytoplasm, an RNase III enzyme called 
Dicer cleaves the loop from the stem, thus producing a mature 20-23 nt double-
stranded miRNA. Dicer cleavage requires association with the transactivating re-
sponse RNA-binding protein (TRBP) and Argonaut 2 (Ago2) completing the RNA 
Induced Silencing Complex (RISC)/ribonuclear particle (RNP) complex. Only the 
strand with the higher stability of the duplex in the 5’ half, the guide strand, is sub-
sequently loaded into a RISC. The other strand (passenger strand or star strand) is 
degraded. However, in some cases both strands of the pre-miRNA are detected as 
mature miRNAs. These mature miRNAs are now able to bind to their targets by rec-
ognizing sequence complementarity.
Binding by perfect complementarity commonly occurs in plants and only oc-
casionally in animals (Tang et al., 2003). In this case the mRNA is deadenylated 
and subsequently degraded. In animals, the miRNAs bind more frequently to the 
3’ untranslated region (3’ UTR) of their targets with imperfect complementary. The 
sequence complementarity in the so-called seed sequence of the miRNA (nucle-
otide 2-8 from the 5’ end) seems to determine the specificity of miRNA–target RNA. 
Binding of the 3’ end of the miRNA to the target may facilitate the regulation and can 
even compensate for the improper complementarity of the seed sequence (Brennecke 
et al., 2005; Didiano and Hobert, 2006). This results in translational inhibition, fol-
lowed by a variable degree of mRNA degradation. The mechanisms by which miR-
NAs regulate translational silencing are either the blocking of translational initiation 
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or elongation steps, or the sequestering of their targets in the cytoplasmic P-bodies, 
where mRNA storage and decay takes place (Medina and Slack, 2008). It has recently 
been shown that translational repression occurs prior to deadenylation and destabi-
lization (Cannell et al., 2008). 
In animals the expression of 30% or more of the genes is predicted to be regulated 
by miRNAs (Kapsimali et al., 2007). While some genes involved in basic cellular 
processes avoid miRNA regulation due to short 3’UTRs that are specifically deplet-
ed of miRNA binding sites, others are regulated by a set of miRNAs. On the other 
Figure 2. MicroRNA biogenesis. In the nucleus miRNA genes are first transcribed as primary 
miRNA (pri-miRNA) transcripts with 5’ cap and 3’ poly(A) tail by RNA polymerase II (pol II) which are 
recognized and cleaved by Drosha/DGRC8. The generated hairpin precursor miRNA (pre-miRNA) 
transcript is exported to the cytoplasm by exportin-5 and processed by Dicer RNase enzyme pro-
ducing 20-23 nt double-stranded miRNA. After cleavage, only the guide strand, the mature miRNA 
strand is loaded into RNA Induced Silencing Complex (RISC)/ribonuclear particle (RNP) complex 
leading to mRNA cleavage or induction of translational repression. In some cases, also the other 
strand (miRNA star sequence) can be incorporated into the RISC complex with similar efficiency, 
and therefore can also be functional.
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hand, the effects of a miRNA can be pleotropic. It has been estimated that a single 
miRNA family can regulate as many as 200 or even more different genes (Medina 
and Slack, 2008). One miRNA may have several target sites in the 3’UTR of a single 
mRNA (Saetrom et al., 2007). Spatial and temporal expression patterns of miRNAs 
have been shown to be related to their conserved functions (Kapsimali et al., 2007; 
Lagos-Quintana et al., 2002; Sempere et al., 2004). It has also been demonstrated that 
changes in the level of specific miRNAs correlate with abnormal conditions of a cell, 
tissue or organism (Kloosterman et al., 2006). 
MiRNAs in diseases
Since miRNAs play important roles in different cellular mechanisms responsible 
for maintaining the cell’s homeostasis, it is conceivable that their aberrant expres-
sion may contribute to a wide variety of diseases. It was discovered that miRNAs are 
associated with neurodegenerative disorders like Alzheimer’s disease (significantly 
decreased level of miR-107) and Parkinson’s disease (very low level or absence of 
miR-133b in the midbrain tissue); hepatic disorders (involvement of miR-196 and 
miR-448); primary muscle disorders like Duchenne muscular dystrophy, Miyoshi 
myopathy and dermatomyositis (consistently up-regulated levels of miR-146b, miR-
21, miR-155, miR-214, miR-222); or cardiovascular diseases like cardiac hypertro-
phy and coronary artery disease (miR-133, miR-1 over-expression) (Garofalo et al., 
2008). 
MiRNAs are also involved in the pathogenesis of infectious diseases and cancer 
as they play a role in the mechanisms of apoptosis, proliferation, stress resistance, 
metabolism, defense against pathogenic infections, and importantly tumorigenesis 
and metastasis (Medina and Slack, 2008). 
There is increasing evidence that a complex network of miRNAs works within 
the immune system and that miRNAs themselves may also represent an ancient anti-
viral immune system (Lu and Liston, 2009). Complex regulatory mechanisms have 
been revealed where miRNAs fine-tune development and function of haematopoi-
etic lineages, B and T cell homeostasis and response, and T cell selection in the thy-
mus. MiR-181a has an essential role in the development of both B and T lymphocytes, 
miR-150 plays a critical role in B cell differentiation, miR-142 is involved in T cell 
development, and miR-223 is important in granulocytic and T cell differentiation 
(Carissimi et al., 2009; Sonkoly and Pivarcsi, 2009).
During infection, the first defense line of the organism is the innate immune 
response. As part of this response monocytes and macrophages recognize micro-
bial ligands by pattern recognition receptors on their membranes, such as Toll-like 
receptors (TLRs) (Mogensen, 2009). During this first immune response hundreds 
of genes are induced to defeat the pathogen. Recently, several studies have suggest-
ed that miRNAs play an important role in the regulation of this complex response. 
Several miRNAs are differentially regulated by bacterial and viral infections ensur-
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ing regulation of macrophage inflammatory responses. While miR-146 and miR-155 
were up-regulated by bacterial ligands, miR-132 and miR-125b showed decreased 
expression level during LPS-treatment (Sonkoly et al., 2008). Beside these in vitro 
studies, in vivo experiments showed a rapid increase in the numerous miRNAs such 
as miR-21, miR-25, miR-27b, miR-100, miR-140, miR-142-3p, miR-181c, miR-187, 
miR-194, miR- 214, miR-223 and miR-224. During antiviral defense several miRNAs 
were over-expressed (such as miR-196, miR-296, miR-351, miR-431 and miR-448) 
having sequence-predicted targets within the hepatitis C virus (HCV) genomic RNA 
(Sonkoly and Pivarcsi, 2009). 
In the past few years miRNA expression profiling has also come into focus in 
the field of molecular oncology. Several studies have demonstrated differentially ex-
pressed miRNAs in cancer. One class of these miRNAs, called oncomirs, act on on-
cogenes (oncogenic oncomirs) and/or tumor suppressor genes (tumor-suppressing 
oncomirs) and are direct causative agents of tumorigenesis. Other cancer-associated 
miRNAs appear to be indirectly involved in genomic, epigenomic or physiologi-
cal changes relevant to the different types of cancer (Esquela-Kerscher and Slack, 
2006; Lu et al., 2005; Medina and Slack, 2008). MiR-15 and miR-16 have decreased 
levels or show total absence in most patients with chronic lymphocytic leukemia, 
consistent with a tumor-suppressive function of these miRNAs (Calin and Croce, 
2006). MiRNAs of the let-7 family also act as tumor suppressors in vivo, regulating 
RAS oncogenes commonly down-regulated in solid tumors (Garofalo et al., 2008). 
Increased levels of a particular miRNA, for example due to gene amplification or 
transcriptional disregulation, can also be a cause of cancer. Up-regulation of miR-
155 in B cells is associated with high grade lymphoma pre-B leukemia (Costinean et 
al., 2006). Similarly, over-expression of the miR-106b-25 cluster was shown to play 
critical role in gastric cancer (Petrocca et al., 2008). Cancer pathogenesis may also 
be affected by mutations that disrupt or create new miRNA binding sites in target 
mRNAs (Costinean et al., 2006; Garofalo et al., 2008; Sonkoly and Pivarcsi, 2009). 
Differences in miRNA expression levels were found not only between normal and 
tumor tissues, but also between primary tumors and metastatic tissues. For example, 
miR-10b was shown to induce invasion and metastasis, whereas miR-335 and miR-
126 are metastasis suppressors in human breast cancer (Garofalo et al., 2008).
Revealing groups of differentially expressed miRNAs under different disease 
conditions and demonstrating their biological functions is of great importance in 
understanding of pathogenesis and the development of novel strategies for disease 
treatment. These efforts are assisted by disease modeling using in vitro and in vivo 
systems.
Modeling of diseases
To study pathogenesis of different human diseases researchers use in vitro and 
animal models. In vitro cell-based assays are used to simplify experiments on patho-
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genesis of human diseases and because of methodological and ethical issues regard-
ing the use of mammals in experiments. Although cell culture systems are highly 
useful to unravel specific steps in complex physiological processes and signaling 
mechanisms, they cannot provide information about disease pathogenesis in vivo 
(Lieschke and Currie, 2007).
When choosing an animal model system researchers take into account the simi-
larities and differences between the animal and human. There are practical as well as 
molecular and cell biological aspects to consider in selecting an animal as a model 
organism. Some of these are; husbandry infrastructure, cost of keeping animals, 
anatomical, molecular, genetic or pathological similarities, and possibility, feasibil-
ity and affordability of forward and reverse genetics (Lieschke and Currie, 2007). 
Several animal models have been developed to better understand different disorders 
including blood diseases, diabetes, muscular dystrophy, neurodegenerative disease, 
syndromes of angiogenesis and lipid metabolism, and also for infectious diseases 
and cancer.
Invertebrate animal models like Caenorhabditis elegans and Drosophila mela-
nogaster are commonly applied, especially in the field of developmental biology 
based on their molecular and genetic similarities to vertebrates. However, by lacking 
many structures and organ systems involved in human diseases, these organisms are 
not very useful for studying pathogenesis. Although both C. elegans and D. mela-
nogaster have an innate immune system – which is very primitive in the former but 
more complex and similar to that of vertebrates in the latter one – neither of them 
have an adaptive immune system, which limits their application in immunological 
studies (Ewbank, 2002; Hoffmann, 2003).
The closer evolutionary proximity and genomic, anatomical, cell biological and 
physiological homologies between human and other vertebrates makes these higher 
animals commonly used for disease modeling. For example, mouse and rat are ex-
cellent models in biomedical research because of the similarities they share with hu-
man and also the genetics approaches that are possible in these organisms. However, 
rodent and other mammalian animal models have some limitations, for example in 
utero development limits embryological studies. Furthermore, infrastructure sup-
port and high cost of experiments make large-scale screens challenging to perform. 
Some of the limitations of mammalian models seem to be resolved by using ze-
brafish (Danio rerio) as a model organism. Recognizing their high developmental 
and cellular physiological similarities with mammals and advantages for experimen-
tal manipulation, George Streisinger pioneered the use of zebrafish as a vertebrate 
model system for developmental biology and embryogenesis (Kari et al., 2007). 
Working with zebrafish has several advantages, including that animals can be kept 
easier and at minimal cost compared to higher vertebrates. The zebrafish genome 
has been sequenced by the Sanger Center and is available to the research community. 
The zebrafish has many orthologous genes, and even conserved synteny with mam-
mals (Barbazuk et al., 2000). Direct observation and manipulation of embryogenesis 
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is possible because of the external fertilization and development. Detecting func-
tional and morphological changes is also facilitated by the optical transparency of 
the embryos and early adults. Small size, high fecundity (100-300 embryos per week) 
and short generation times (embryogenesis is complete by 5 days post fertilization) 
also make the zebrafish model suitable for experimental screens. The organs are 
permeable to small molecules during organogenesis, facilitating protein visualiza-
tion with dye stainings and analyzing therapeutic compounds. These characteristics 
make zebrafish one of the major subjects of high-throughput screenings. Large scale 
forward and reverse genetic screens have made use of all these features of zebrafish 
and gained success in understanding vertebrate-specific mechanisms of develop-
ment (Meeker and Trede, 2008). 
From the 1980s zebrafish has become an excellent experimental model for study-
ing pathogenic mechanisms of human diseases (Lieschke and Currie, 2007). Many 
zebrafish models of human diseases have been created through forward and reverse 
genetics approaches. With forward genetics approaches a set of point mutations 
are generated by random mutagenesis using the mutagen ethylnitrosourea (ENU) 
or by non-targeted retroviral- and transposon-mediated insertional mutagenesis. 
Phenotype-based screening of such mutant populations is a powerful approach to 
discover new genes or new functions for known genes. The main reverse genetics 
approaches include the generation of knock-outs by targeting induced local lesions 
in genomes (TILLING), transient gene knock-down with antisense morpholino oli-
gonucleotides, transient gene over-expression with mRNA, and transgenesis. With 
the generation of specific zebrafish disease models, investigation of the molecular 
and cellular background of human diseases is facilitated. Zebrafish models have been 
generated for congenital and hereditary diseases, metabolic, endocrine, nutritional 
disorders, psychological and behavioral abnormalities, immunological diseases, in-
fectious diseases, as well as carcinogenesis (Kari et al., 2007; Lieschke and Currie, 
2007; Meeker and Trede, 2008).
Zebrafish as a model of infectious diseases and cancer 
In the last decade, zebrafish has been developed as an in vivo model system for 
immunological research due to the remarkable similarities of its immune system to 
that of human (Traver et al., 2003; van der Sar et al., 2004). Similarly to mammals, 
zebrafish has both an innate and an adaptive immune system which developed evo-
lutionary from the jawed fish (Kasahara et al., 2004). Zebrafish has the counterparts 
of most if not all determinants involved in the human immune system, for example 
macrophages and neutrophils, homologues of T and B lymphocytes, cytokines and 
signaling molecules, as well as a well-developed complement system and inflamma-
tory proteins (Lesley and Ramakrishnan, 2008; Lieschke and Currie, 2007; Meeker 
and Trede, 2008). However, there are differences between the sites of maturation. 
One of the most important features of the zebrafish immune system is that the adap-
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tive immunity develops only after embryogenesis during the first several weeks of 
larval development, while the innate immune system is present from the first day 
of embryogenesis onwards. Combined with the transparency of the embryos, this 
characteristic allows for the real-time and intravital analysis of the role of the innate 
immune system in host-pathogen interactions, in separation from the role of adap-
tive immunity (Lesley and Ramakrishnan, 2008).
To better understand bacterial and viral pathological mechanisms several ex-
perimental infections have been developed in embryonal and adult zebrafish us-
ing Gram-negative bacteria (Salmonella typhimurium, Salmonella arizonae, Vibrio 
anguillarum, Aeromonas salmonicida, Edwardsiella tarda), Gram-positive bacteria 
(Mycobacterium marinum, Bacillus subtilis, Listeria monocytogenes, Staphylococcus 
aureus, Streptococcus iniae, Streptococcus pyogenes) and viruses (Spring viraemia of 
carp virus, Infectious haematopoietic necrosis virus (IHNV), Infectious pancreatic 
necrosis virus, Viral hemorrhagic septicemia virus) (Fig. 3) (Meeker and Trede, 2008; 
van der Sar et al., 2004).
Zebrafish has also been recognized as a powerful model for tumor biology and 
cancer drug development (Feitsma and Cuppen, 2008). It spontaneously develops 
almost any type of tumor with morphology similar to human tumors, most com-
monly in testis, gut, thyroid, liver, peripheral nerve, connective tissue, and ultimo-
branchial gland. Several experimental approaches to generate zebrafish cancer mod-
els have been applied, namely treatment with mutagens, forward genetic screening 
for mutants showing enhanced proliferation or genomic instability, the generation of 
knock-outs in known tumor suppressor genes, and the generation of transgenic s to 
express (human) oncogenes (Feitsma and Cuppen, 2008). In addition, xeno-trans-
Figure 3. Real-time visualization of bacterial infection in the zebrafish embryo. The embryo 
was injected at 27 hours post fertilization with approximately 250 colony forming units of DsRed-
labelled Salmonella typhimurium bacteria into the caudal vein and imaged at 2 hours post infec-
tion. An overlay picture of the bright field and DsRed fluorescent images is shown. Bacteria are 
trapped inside macrophages that are mainly observed in the bloodstream over the yolk sac (white 
arrow) and in the blood island posterior of the yolk sac extension (black arrow). The embryo is 
oriented with the anterior side to the left and dorsal side to the top.
Chapter 1
22
plantation models of mammalian or human cancer cells into zebrafish have been 
developed (Haldi et al., 2006; Nicoli et al., 2007). 
Although the above-mentioned advantages make zebrafish a very practical model 
organism, it also has some disadvantages. One issue is that compared to mammals, 
zebrafish lacks certain organs like lungs and mammary glands, or shows differ-
ences in organ functions (e.g. in zebrafish the kidney marrow replaces the function 
of the mammalian bone marrow). In addition, there are difficulties in establishing 
inbred lines, cell lines and tissue cultures, there is a lack of antibody reagents, and 
the technology for targeted gene modification and knock-out generation is less ad-
vanced than for rodent models (Lieschke and Currie, 2007). A weakness of zebrafish 
as an infection model is that zebrafish is generally maintained between 26oC and 
29oC, while optimal growth and expression of virulence factors of human patho-
gens typically occurs at 37oC. However, some models, for example the zebrafish – 
Mycobacterium marinum model for tuberculosis, use natural fish pathogens with 
lower permissive temperature ranges that are closely related to human pathogens 
(Lesley and Ramakrishnan, 2008; Meeker and Trede, 2008). 
Outline of the thesis
In this study zebrafish models for infection and cancer are used to analyze the 
transcriptome complexity during these disease processes and to gain insight into 
regulatory functions of microRNAs by using array-based and sequencing-based 
large-scale genomics tools. 
Chapter 1 is a general introduction reviewing the following topics: (i) the aim 
of transcriptomics and high-throughput approaches of genome-wide scale gene ex-
pression profiling, (ii) mechanisms of gene regulation, (iii) discovery of microRNAs, 
their biogenesis and mode of action, (iv) the role of microRNAs in diseases, (v) in 
vitro and animal modeling of diseases focusing on zebrafish as a novel model organ-
ism, and (vi) recent advances in the use of zebrafish as a model system for studying 
the immune system response to infectious diseases and cancer.
In Chapter 2 the functional complexity of the adult zebrafish transcriptome in 
response to Mycobacterium infection is characterized using Solexa/Illumina’s digital 
gene expression (DGE/Tag-Seq) system, a novel tag-based transcriptome sequencing 
method. DGE/Tag-seq data is compared with a previous multi-platform microarray 
analysis and qPCR results, and infection-induced new gene products are discovered 
and validated.
Chapter 3 describes deep sequencing of the transcriptome of zebrafish embryos 
in response to Salmonella infection. Data from tag-based sequencing (DGE/Tag-
Seq) are compared with full RNA sequencing (RNA-Seq) data and previous microar-
ray results. Additionally, the Salmonella-induced transcriptome alterations are com-
pared with the Mycobacterium infection data from chapter 2.
Chapter 4 describes microRNA expression profiling analyses of infectious dis-
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eases in zebrafish. Different bacterial infections are evaluated and common micro-
RNA induction profiles are assessed. The dataset is used to compare human and ze-
brafish microRNA regulation, with a specific focus on the miR-146 family and their 
predicted target genes in the Toll-like receptor pathway. Furthermore, microRNA 
expression is compared with expression of predicted target genes.
In Chapter 5 results of microRNA expression profiling using a zebrafish liver 
cancer model are reported. Differentially expressed microRNA in liver tumor tissue 
versus healthy liver tissue are categorized and, compared to microRNAs detected in 
human hepatocellular carcinoma and other types of cancer. Target predictions of mi-
croRNAs associated with liver cancer in zebrafish and human are made. In addition, 
the set of microRNAs from the liver cancer study is compared to the dataset from 
the infection study of chapter 4 to deduce common microRNA regulators of cancer 
and the immune response.
Finally, Chapter 6 gives a summary and general discussion of the technologies 
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Novel high-throughput deep sequencing technology has dramatically changed the 
way that the functional complexity of transcriptomes can be studied. Here we report 
on the first use of this technology to gain insight into the wide range of transcrip-
tional responses that are associated with an infectious disease process. Using Solexa/
Illumina’s digital gene expression (DGE) system, a tag-based transcriptome sequenc-
ing method, we investigated mycobacterium-induced transcriptome changes in a 
model vertebrate species, the zebrafish. We obtained a sequencing depth of over 5 
million tags per sample with strong correlation between replicates. Tag mapping 
indicated that healthy and infected adult zebrafish express over 70% of all genes 
represented in transcript databases. Comparison of the data with a previous mul-
ti-platform microarray analysis showed that both types of technologies identified 
regulation of similar functional groups of genes. However, the unbiased nature of 
DGE analysis provided insights that microarray analysis could not have achieved. 
In particular, we show that DGE data sets are instrumental for verification of pre-
dicted gene models and allowed us to detect mycobacterium-regulated switching 
between different transcript isoforms. Moreover, genomic mapping of infection-in-
duced DGE tags revealed novel transcript forms for which any previous EST-based 
evidence of expression was lacking. In conclusion, our deep sequencing analysis re-
vealed in depth the high degree of transcriptional complexity of the host response 
to mycobacterial infection and resulted in the discovery and validation of new gene 
products with induced expression in infected individuals.
Introduction
Cellular identity and function is determined by the transcriptome: the complete 
repertoire of expressed RNA transcripts. Development and disease processes in mul-
ticellular organisms are governed by complex variations in transcriptional activities. 
Deciphering the functional complexity of transcriptomes is extremely challenging, 
especially since recent studies indicate that much more of the genome is transcribed 
than previously thought and that the majority of genes is transcribed in a bidirec-
tional manner (Carninci et al., 2005; Katayama et al., 2005; Yelin et al., 2003). Recent 
advances in the development of ultra high-throughput deep sequencing technologies 
are making a huge impact on genomic research. These next generation sequencing 
systems, such as the Solexa/Illumina Genome Analyzer and the ABI/SOLiD Gene 
Sequencer, can sequence in parallel millions of DNA molecules derived directly from 
mRNA, without the need to use bacterial clones (Cloonan and Grimmond, 2008; 
Morozova and Marra, 2008; Wang et al., 2009). The direct sequencing yields libraries 
of short sequences (25–50 nucleotides), referred to as RNA-Seq data or Digital Gene 
Expression (DGE) data. Sequencing-based methods generate absolute rather than 
relative gene expression measurements and avoid many of the inherent limitations 
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of microarray analysis (Irizarry et al., 2005; Pedotti et al., 2008; t Hoen et al., 2008; 
Wilhelm and Landry, 2009), which has been the most commonly used technology 
for transcriptome profiling over the last decade. 
The first results of transcriptome profiling using next generation sequencing 
technology have recently been published (Cloonan et al., 2008; Lister et al., 2008; 
Mortazavi et al., 2008; Nagalakshmi et al., 2008; Sultan et al., 2008; Wilhelm et al., 
2008). These RNA-Seq studies were based on different procedures starting either 
with mRNA fragmentation or with cDNA synthesis that is followed by fragmentation. 
Dependent on the protocol used, information on transcript directionality, which is 
useful for annotation and detection of antisense transcription, was retained or not 
(Shendure, 2008). RNA-Seq studies of yeasts detected transcription of 92–99% of all 
known genes and demonstrated that most of the genome sequence is transcribed 
(75% in Saccharomyces cerevisiae and >90% in Saccharomyces pombe) (Nagalakshmi 
et al., 2008; Wilhelm et al., 2008). Evidence of transcript heterogeneity and of novel 
transcribed regions, including non-coding and antisense transcripts, was obtained. 
Furthermore, a genome-wide regulation of splicing was revealed (Wilhelm et al., 
2008). Bioinformatical analysis of RNA-Seq data needs to deal with mapping of 
short reads to the genome, issues of multi-mapping, and mapping of splice-crossing 
reads. The analysis becomes even more challenging when dealing with the more 
complex genomes of vertebrate species. Nevertheless, the first applications of RNA-
Seq methodology to mouse and human have now already provided rich information 
for new or revised gene models. By indicating the presence of additional promoters, 
alternative exons, alternative 3’UTRs, non-coding transcripts and bidirectional tran-
scripts, these studies have made it clear that genome annotation is far from complete 
(Cloonan et al., 2008; Morin et al., 2008; Mortazavi et al., 2008; Pan et al., 2008; 
Rosenkranz et al., 2008; Sultan et al., 2008;Wang et al., 2008). 
An alternative to RNA-Seq is the use of tag-based transcriptome sequencing 
methods, such as serial analysis of gene expression (SAGE), which generates short 
signature sequences (tags) for the 3’-end regions of mRNA transcripts (Harbers and 
Carninci, 2005; Velculescu et al., 1995). SAGE-derived technologies include MPSS 
(massive parallel signature sequencing) and PMAGE (polony multiplex analysis 
of gene expression) that rely on amplification of 3’ tag sequences on microbeads 
(Brenner et al., 2000; Kim et al., 2007). Other useful tag-based sequencing technolo-
gies include the 5’-SAGE or CAGE (cap analysis of gene expression) methods that 
determine the 5’-ends of mRNAs by oligo-capping or cap-trapping (Harbers and 
Carninci, 2005; Hashimoto et al., 2009). The classical LongSAGE technique is based 
on the cleavage of cDNA with two restriction enzymes, an anchoring enzyme (com-
monly NlaIII, which cuts at CATG sites) and a tagging enzyme (MmeI) cutting 17 bp 
downstream of the anchoring enzyme’s recognition site. Although SAGE, LongSAGE 
and similar SuperSAGE methods have greatly contributed to transcriptome analy-
sis, their application has previously been limited by laborious ditag formation and 
concatemer cloning procedures and by the costs and throughput level of sequencing 
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steps. However, SAGE-derived methods, which are particularly suitable for quanti-
tative expression analysis, are back into view with next generation sequencing tech-
nology that entirely eliminates the need for tag cloning and provides a much greater 
sequencing depth.
Here, we used the second Illumina Genome Analyzer platform (GA II) to perform 
a SAGE-derived Digital Gene Expression (DGE) analysis of the zebrafish transcrip-
tome response to mycobacterium infection. The zebrafish-mycobacterium model 
recapitulates hallmark features of human tuberculosis (Lesley and Ramakrishnan, 
2008; Swaim et al., 2006). We have previously performed a multiplatform microar-
ray study showing that mycobacterium-infected zebrafish express many homologs 
of human immune response genes and genes that have previously been implicated 
in the response to mycobacterial infection (Meijer et al., 2005). We also observed 
induction of genes with previously unknown relationship to the immune response, 
indicating that the use of the zebrafish mycobacterium model can assist functional 
annotation of genes and provide new leads in the investigation of mycobacterial 
pathogenesis. The previous study was limited by contents of commercially available 
microarray designs, whereas the DGE analysis reported here provides wide unbiased 
coverage of the entire transcriptome. Comparison of DGE and microarray data re-
vealed a substantial degree of overlap in differentially expressed transcripts as well 
as technology-dependent differences, indicating the value of using two complemen-
tary transcriptome analysis methods. Furthermore, by mapping our DGE tag data 
onto transcript databases and onto the genomic sequence we could show that many 
alternative transcript forms and novel transcripts are disease-specifically regulated, 
information that could not have been obtained by microarray analysis.
Results
Basic quantitative parameters and reproducibility of DGE library 
sequencing
In previous microarray studies we have show that mycobacterium infection of 
zebrafish results in a highly reproducible host response at the transcriptome level 
(Meijer et al., 2005; van der Sar et al., 2009). Here we have pooled biological repli-
cates from these previous studies to make representative samples for deep sequenc-
ing analysis. We sequenced two DGE libraries (technical duplicates) of a pool of four 
control fish (cont-a, cont-b) and two DGE libraries of a pool of four mycobacterium-
infected fish (inf-a, inf-b). The total count number of tags per library ranged from 
5.3 to 8.4 million and the number of tag entities with unique nucleotide sequences 
ranged from 0.8 to 1.1 million (Supplementary Table 2). As shown in Fig. 1, the dis-
tribution of tag entities and total tag counts over different tag abundance categories 
showed very similar tendencies for all four DGE libraries. The lowest abundant tags 
that were still consistently detected in all four libraries occurred at a frequency of 
below 1 count per million. To further investigate the reproducibility of DGE library 
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sequencing we performed correlation analyses of all four possible sample combina-
tions (cont-a vs. cont-b, inf-a vs. inf-b, cont-a vs. inf-a, and cont-b vs. inf-b) (Fig. 2). 
Pearson correlations for the parallel libraries (cont-a vs. cont-b and inf-a vs. inf-b) 
were 0.99 and 0.95, indicating the high technical reproducibility of the DGE method. 
In contrast, Pearson correlations for control vs. infected library pairs were much 
lower (0.77 and 0.81), consistent with a large effect of mycobacterium infection on 
the host transcriptome as previously observed in microarray experiments (Meijer et 
al., 2005; van der Sar et al., 2009).
Efficiency of tag mapping to transcript databases
Mapping the tags to known transcripts is the most efficient way to reveal the mo-
lecular events behind DGE profiles. In our study the tag sequences of the four DGE 
libraries were mapped to the zebrafish transcript datasets of the UniGene, RefSeq 
and Ensembl databases and found to match with over 70% of all sequence entries 
in these databases (Table 1). The mapping efficiency increased significantly as the 
count number of tags increased. Specifically, a 50% mapping efficiency was observed 
for tags with around 10 copies and the mapping efficiency increased to about 80% 
Figure 1. Distribution of tag entities and total tag counts over different tag abundance cate-
gories. Categories of tag abundance were assigned by setting the lower limit of the count number 
that includes a tag as a category member. The percentages of total tag counts (filled squares) and 
number of different tag entities (open squares) per category are plotted on a logarithmic scale.
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for tags with an abundance of over 200 copies (Fig. 3). This means that the most 
abundant tags correspond to the most highly expressed transcripts, which in turn 
are most likely to be found in the existing zebrafish transcript collections. Tags map-
ping to a unique sequence position form the most important subset of the DGE 
libraries as they can unambiguously identify a transcript. Up to 54% of the sequence 
records in the different transcript databases could be unequivocally identified by 
unique tag mapping (Supplementary Table 3). Examples of the most abundantly ex-
pressed genes in all libraries that could be unequivocally identified by tag mapping 
comprised more than ten different ribosomal subunit genes, translation initiation 
and elongation factor genes (eif5a and ef1a), creatine kinase genes (muscles a and 
b) and several cytoskeletal protein genes, including those encoding alpha and beta 
actin, keratin and skeletal muscle myosin proteins.
Figure 2. Correlation analysis of DGE libraries. Correlation charts are shown of the tag entity 
counts of the four possible combinations of DGE libraries from control fish (cont-a and cont-b) and 
from mycobacterium-infected fish (inf-a and inf-b). Dots in the charts indicate individual tag enti-
ties. Pearson correlation coefficients are shown in the upper left corner of each plot.
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Changes in tag profile induced by mycobacterium infection
In order to identify the tags showing a significant change in expression between 
the two control vs. infected library pairs we used the Bayesian approach described 
by Lash et al. that takes into account differences in library size (Lash et al., 2000). 
The cont-b vs. inf-b library pair showed the highest number of significant tag enti-
ties (Supplementary Fig. 1), which can be explained by the greater sequencing depth 
of inf-b library compared with the inf-a library (Supplementary Table 2). A total of 
5049 significantly changed tag entities were detected in the intersection of the cont-a 
vs. inf-a and the cont-b vs. inf-b library pairs (Supplementary Fig. 1; Supplementary 
Table 4). Efficiencies of tag mapping to the UniGene, RefSeq and Ensembl tran-
script databases were very similar for the two parallel library pairs (Supplementary 
Table 5). In both cases the highest percentage of significant tags (ca. 40%) could 
be mapped to the UniGene database, which is the largest in size (Supplementary 
Table 5). The intersection of the two library pairs contained a total of 1051 different 
UniGene transcripts, constituting 2% of the total number of transcripts in this data-
base (Supplementary Fig. 1). Mapping to a unique UniGene transcript was observed 
for 27% of the significant tags. Approximately 2-fold more significant tag entities 
mapped to the sense strand of the transcripts than to the antisense strand in any of 
the three investigated transcript databases (Supplementary Table 5). By comparison, 
the ratio of sense to antisense mapping of the total number of tags (significant and 
non-significant) was approximately 1:1 for all libraries. This suggests that in spite of 
the high number of antisense mapping events detected, the transcriptional regu-
lation in the mycobacterium-induced immune response acts most strongly on the 
sense strand. The possibility that the host response to mycobacterium infection may 
also depend on the regulation of antisense expression is of great interest and will 
require further investigations. In the present study, we focused on the regulation of 
sense strand transcripts.
Comparison of DGE tag data with a reference set of mycobacterium-
regulated genes
Previously we analyzed the zebrafish transcriptome response to mycobacterium 
infection using three different microarray platforms (Sigma-Compugen spotted 
oligonucleotide library, MWG spotted oligonucleotide library and Affymetrix). In 
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that study we identified a set of genes whose differential expression was detected 
irrespective of the type of microarray used and that could therefore serve as a multi-
platform reference for future transcriptome profiling studies in the mycobacterium—
zebrafish model (Meijer et al., 2005). For the present study we took the exact same 
samples as used for DGE tag profiling and hybridized these to a fourth microarray 
platform (Agilent 44k). Next, a new reference set was defined consisting of 121 my-
cobacterium-regulated genes (55 up-regulated and 66 down-regulated) confirmed in 
two separate studies and by in total four microarray platforms (Supplementary Table 
6). This reference set was used for comparison with our DGE tag data. As shown in 
Supplementary Table 6, 120 genes out of the 121 genes in the reference set were rep-
resented by transcript tags in our DGE libraries. The only gene not represented lacks 
the NlaIII restriction site that is required for detection by DGE. For 100 out of the 
120 genes detected (83%) the DGE experiments identified significantly different tag 
counts between control and infected libraries, whereas the significance threshold was 
not met for 20 genes. 79 out of 100 significantly changing genes were unambiguously 
identified by the DGE tags. In 97% of these cases (77 out of 79) the direction of change 
positively correlated between DGE and microarray analysis (Fig. 4A; Supplementary 
Table 6). Identification of the remaining 21 genes was ambiguous because the tags 
mapped to multiple UniGene transcripts. However, in nearly all cases (20 out of 21) 
multiple mapping occurred to highly related transcripts, encoding a fragment or 
isoform of the same protein or a near-identical protein. Furthermore, the direction 
of change positively correlated between DGE and microarray data in 90% of the 
cases where multiple mapping occurred (19 out of 21) (Fig. 4A; Supplementary Table 
6). Therefore, we conclude that in most cases even the multi-mapped tags, which 
are usually discarded in SAGE-based experimental systems, can also reveal useful 
information. Finally, when we extended the comparison of the direction of change 
between DGE and microarray analysis to include also the non-significant tags (map-
ping to 20 UniGenes in the reference set), we found a positive correlation in 93% of 
the cases (112 out of the 120 detected genes, Fig. 4B). In conclusion, comparison of 
our DGE tag data with the reference set of mycobacterium-regulated genes indicates 
a strong agreement between data obtained by different transcriptome profiling tech-
nologies.
Comparison of DGE tag data with Agilent microarray data and qPCR
The flexibility of the Agilent platform is a major advantage for microarray anal-
yses of zebrafish since it allows continuous upgrading of custom designed probes. 
Agilent is also a preferred platform because previously used platforms (Meijer et al., 
Figure 3. Efficiency of tag mapping to the UniGene transcript database. Bars indicate the 
percentages of successful (green) and non-successful (blue) tag mapping events for the different 
categories of tag abundance as assigned in Fig. 1. The numbers of tag entities per category are 
indicated below the graph.
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2005) are no longer available (MWG, Sigma-Compugen) or several years outdated 
(Affymetrix). In order to compare our DGE tag data to Agilent microarray data we 
used the subset of UniGene transcripts that were identified in both control-infected 
library pairs by unambiguous mapping of significant tags to the sense strand. A total 
of 815 different UniGene identifiers met these criteria but only 580 of these UniGenes 
Figure 4. Correlation between DGE and microarray analysis. (A) Comparison of DGE results 
with a reference set of mycobacterium-regulated genes based on four microarray platforms. DGE 
results were evaluated by P-value with the significance threshold at 0.05. (B) The same compari-
son as in (A), but based on the direction of change of all the tags (significant and non-significant) 
mapped on the same transcript. This approach gives a raw estimation of concordance even in 
those cases where DGE detected non-significant mappings. (C) Comparison of DGE and Agilent 
microarray results.
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were represented in the Agilent probe set. Agilent microarray analysis showed a sig-
nificant change in the same direction as determined by DGE analysis for 348 of these 
genes (60%) (Fig. 4C; Supplementary Table 7). Only 14 genes showed a conflicting 
significant change in the opposite direction, and no significant change was detected 
for 218 genes (Fig. 4C; Supplementary Table 7). These results indicate a substantial 
overlap between DGE and Agilent microarray results in addition to technology-de-
pendent differences.
Figure 5. qPCR validation of DGE tag data. (A) Genes showing a significant change by DGE analy-
sis and for which Agilent microarray analysis showed a significant change in the opposite direc-
tion (jak1, slc2a7, zgc:110304, zgc:153647, zgc:158405) or no change (stc1). (B) Genes showing a signifi-
cant change in the same direction by DGE and Agilent microarray analysis. (C) Genes showing a 
significant change by DGE analysis and not represented on the Agilent microarray platform. Up-
regulation of gene expression by mycobacterium infection is indicated by a positive fold change 
and down-regulation by a negative fold change. Bars touching the chart border indicate infinite 
fold changes (zero tags in either the control or infected libraries). The following selection of genes 
was tested with their gene description, UniGene ID and Entrez Gene ID indicated between brack-
ets: jak1 (janus kinase 1, Dr.74470, 30280), slc2a7 (slc2a7 solute carrier family 2 (facilitated glucose 
transporter), member 7, Dr.77040, 100006415), stc1 (stanniocalcin 1, Dr.88421, 393511), zgc:110304 
(predicted tumor-associated calcium signal transducer 1 homolog, Dr.39071, 550255), zgc:153647 
(predicted cytochrome P450, family 2, subfamily J, polypeptide 2 homolog, Dr.79897, 768288), 
zgc:158405 (predicted neutrophil cytosolic factor 2 homolog, Dr.66415, 562473), cebpd (CCAAT/
enhancer binding protein (C/EBP), delta, Dr.1280, 140817), slc5a1 (solute carrier family 5 (sodium/
glucose cotransporter), member 1, Dr.87868, 93654), crfb7 (cytokine receptor family member b7, 
Dr.91624, 777651), nos2b (nitric oxide synthase 2b, inducible, Dr.118320, 563654) snx10 (sorting nexin 
10a, Dr.13606, 403027), wt1b (wilms tumor 1b, Dr.91799, 568416), LOC556194 (hypothetical LOC556194, 




In order to verify a subset of the DGE tag data by a third independent technol-
ogy we used quantitative reverse transcriptase PCR (qPCR) analysis. The selection 
of genes tested included 6 genes that showed a conflict between DGE and Agilent 
microarray data (Fig. 5A), 3 genes that behaved similarly between the two technolo-
gies (Fig. 5B), and 5 genes whose differential expression was detected only by DGE 
analysis because they were not represented on the Agilent microarray (Fig. 5C). For 
almost all genes tested, with the exception of jak1 only (Fig. 5A), qPCR analysis con-
firmed the direction of change detected by DGE analysis.
Functional annotation and human disease relationships
To achieve an unbiased functional annotation of the infection-responsive genes 
that were identified by DGE analysis we tested for significant enrichment of Gene 
Ontology (GO) groups (Supplementary Table 8). Among the up-regulated UniGene 
transcripts we observed specific enrichment of gene groups including immune re-
sponse related transcription factors, proinflammatory cytokines and MHC class II 
proteins (with enriched GO-terms ‘immune system process’, ‘response to stimulus’, 
‘extracellular region’, ‘catalytic activity’). Gene groups encoding proteolytic enzymes 
(such as matrix metalloproteinases, cathepsins and proteasome subunits) and lys-
osomal proton transporting ATPases were also enriched among the up-regulated 
transcripts. Statistical testing of the down-regulated UniGene transcripts revealed 
significant enrichment of gene groups encoding enzymes involved in carbohydrate, 
alcohol, steroid, amino acid and lipid metabolism (with enriched GO-terms ‘meta-
bolic process’ and ‘catalytic activity’). Additionally down-regulated were genes en-
coding cytoskeletal proteins (among which skeletal muscle actin and myosin), tight 
junction proteins, solute carriers and fatty acid binding proteins (with enriched GO 
terms ‘structural molecule activity’, ‘transporter activity’, ‘binding’, ‘envelope’). The 
up- and down-regulated gene groups corresponded well with those identified in our 
previous microarray analysis of the zebrafish host response to mycobacterium infec-
tion (Meijer et al., 2005), indicating that DGE and microarray analysis identified 
similar functional groups of genes. 
Gene ontology analysis allowed identification of only 41% of the significantly up- 
or down-regulated transcripts. In order to extend and improve the annotation of 
the DGE data set we retrieved the putative human orthologs of the zebrafish genes 
by using the g:Orth function of the g:Profiler web server (http://biit.cs.ut.ee/gpro-
filer) and by searching the NCBI HomoloGene database. In addition, we compiled 
information on protein similarities from the UniGene database. As a result, we were 
able to annotate 73% of the up-regulated and 83% of the down-regulated transcripts, 
whereas the remaining transcripts lacked any similarity to genes with known func-
tion (Fig. 6; Supplementary Table 9). 
Since M. marinum infection of zebrafish is considered as an animal model of hu-
man tuberculosis, next we analyzed how the whole set of mycobacterium-regulated 
genes may associate with a known human pathological condition. A search using 
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GeneALaCart, provided by GeneCards (www.genecards.org), linked our data set to 
397 OMIM (Online Mendelian Inheritance in Man) disorders, of which 132 were 
additionally represented by UniProt disorders that are associated with monogenic 
human genetic diseases (Supplementary Table 9). This is a substantial proportion 
(16%) of the mycobacterium-regulated UniGene clusters identified by DGE analysis.
Genomic mapping of DGE tag sequences
Disease-related genes may be underrepresented in the zebrafish transcript da-
tabases that are mostly based on sequencing of cDNA libraries from healthy fish. 
Therefore, additional mycobacterium-regulated transcripts can be revealed by ge-
nomic mapping of the DGE tag sequences (Supplementary tables 2 and 5). Genomic 
mapping of the significant tags had a success rate of 59% (of which 84% unique map-
ping events), which was approximately 1.5-fold more efficient than mapping to the 
UniGene transcript database (Supplementary Table 5). The fact that we did not allow 
mismatches and that the zebrafish genome is highly polymorphic may explain that 
still a substantial proportion of the significant tags could not be mapped. In addition, 
tags extending over intron boundaries would not be picked up in genomic mapping 
and gaps in the zebrafish genome sequence still exist. The chromosomal distribu-
tion of the complete collection of tag entities (significant and non-significant) was 
roughly proportional to the chromosome length (Fig. 7A). However, the chromo-
somal distribution of the significant tags was less flat (Fig. 7B) and specific regions 
could be identified within the individual chromosomes where a number of tags clus-
tered together, suggestive of potential genomic hotspots linked with the physiologi-
cal processes induced by mycobacterium infection. In Fig. 7C, we show an example 
of such a region on chromosome 3 where 10 mycobacterium-regulated genes were 
identified. These included grb2 and ras family genes (zgc:112091, rac2, arl6ip1) linked 
with immune response and hematopoietic signaling (e.g. Diebold and Bokoch, 2001; 
Martin et al., 2005; Pettersson et al., 2000), several genes involved in inflammation 
and defense (encoding granulin a, ferritin-like, nucleobindin-1 and actinoporin pro-
teins (Aroian and van der Goot, 2007; He and Bateman, 2003; Leclerc et al., 2008; 
Recalcati et al., 2008), and the zebrafish homolog of the human CORO1A gene, which 
encodes the actin-binding protein coronin that has long been implicated in myco-
bacterial pathogenesis (Jayachandran et al., 2007; Kaul, 2008).
Verification of predicted gene models based on DGE tag information
Since DGE is a SAGE-based transcript profiling method, theoretically all the ob-
served tags in the DGE libraries should be mapped to the so called canonical site, a 
sequence region located following the last NlaIII cutting site on the sense strand at 
the 3’-end of the transcript. In our experiments only about 40% of the sense strand 
mappings fell to the canonical site. Furthermore, approximately 70% of the detected 
transcripts were represented by more than one tag. These observations are consist-
ent with similar results in DGE analysis of the mouse transcriptome (t Hoen et al., 
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2008) and may be explained partly by incomplete NlaIII digestion during library 
preparation as well as by frequent use of alternative polyadenylation and/or alter-
native splicing sites (Pan et al., 2008; Wang et al., 2008). The existence of multiple 
tags per transcript can be conveniently utilized for the experimental verification 
of ab initio gene predictions from the Ensembl database. Many of these predicted 
transcripts gather more than one tag hit and many of them have count numbers 
over several hundred up to thousands. Detection of multiple tags with high count 
numbers specific for a predicted transcript indicates the reliability of the transcript 
sequence and the biological importance of the given gene. In a specific example 
(Ensembl: GENSCAN00000043834, encoding a homolog of the human olfactome-
din 4 (OLFM4) gene induced by mycobacterium infection in our DGE study) we 
show how tag mapping over different Genscan exons can support predicted gene 
models (Fig. 8A).
Infection-induced transcript isoform switching
Next we have tried to identify transcripts where the infection triggered unbal-
anced alterations in tag expression pattern that may be caused by the selective induc-
tion or repression of particular transcript isoforms generated by alternative splicing, 
alternative polyadenylation or alternative transcription initiation. To this extent we 
Figure 6. Distribution of transcripts over different annotation categories. (A) Transcripts up-
regulated by mycobacterium infection. (B) Transcripts down-regulated by mycobacterium infec-
tion.
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Figure 7. Distribution of genomic DGE tag mapping sites over the different chromosomes. 
(A) Normalized chromosomal distribution of DGE tags (significant and non-significant) per mega-
base. Mapping results of one DGE library (cont-a) are shown as a representative example. The total 
number of mapping sites and the number of mapping sites with unique sequence were deter-
mined using the unmasked and masked versions of the Zv7 zebrafish genome sequence. Both 
the upper and lower strand of genomic DNA was equally populated by the tags of the DGE librar-
ies (Supplementary Table 3). (B) Normalized chromosomal distribution of the DGE tags that were 
significantly changed by mycobacterium infection. (C) Distribution of the unique and significant 
tags mapping to chromosome 3. A region between 27.2 and 29.9Mb where 29 significant tags map 
closely together, assigning an active chromosomal region during mycobacterium infection, is in-
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selected transcripts with at least two mapped tags, and we investigated how their tag 
expression patterns changed within the transcripts upon mycobacterium infection. 
Among the mycobacterium-regulated gene set we identified over 30 cases where part 
of the detected tag repertoire changed to a much greater extent than other tags, or 
where different tags for the same transcript were changed in the opposing direction. 
An example of a case where only part of the tag repertoire was changed is stannio-
calcin 1 (stc1), a gene for a calcium-regulating glycoprotein hormone. Up-regulation 
of this gene upon mycobacterium infection was confirmed by qPCR analysis (Fig. 
5A). Five tags at the 3’-end of the transcript showed a significant change with 4–10 
times increase in count number in the two control vs. infected library pairs (Fig. 8B). 
However, the most 3’ tag of this transcript was unchanged in both library pairs. Since 
the last four tags are located in the 3’ UTR of this transcript, this observation most 
probably reflects a selectively induced alternative polyadenylation event, where the 
infection results in the expression of a transcript variant having a shorter 3’ UTR 
region. This hypothesis is also supported by the finding that the 3’ UTR contains 
two polyadenylation signals, one at the very end of the sequence after the last weakly 
changing tag and another in a more upstream position. Alternative polyadenylation 
might be a mechanism for regulation of stc1 mRNA stability, which was previously 
shown to be affected by external stimuli (Ellis and Wagner, 1995). An example of a 
case where tags for the same transcript changed in opposite directions is cathepsin D 
(ctsd). The tag expression pattern for this gene indicates selective down-regulation 
of a longer transcript form with concomitant up-regulation of a transcript with a 
shorter 3’ UTR (Fig. 8C).
Identification of novel transcript forms induced by mycobacterium 
infection
Finally, we attempted to find novel mycobacterium-regulated transcript forms 
(splice variants) without any previous indications from different prediction methods. 
As above, we took advantage of the observation that the majority of known tran-
scripts were represented by more than one tag. We anticipated that the same would 
dicated in red with the genomic structure shown below. Genes that are hit on the sense strand by 
the significant tags are shown in yellow and other genes in blue. Annotations of encoded proteins 
on the two strands of the genomic sequence are indicated by rectangles above and below the rul-
er. The coronin 1a gene (coro1a; coronin, actin binding protein, 1A) that is hit by 2 up-regulated tags 
has a direct link with tuberculosis infection (Jayachandran et al., 2007; Kaul, 2008). The proteins 
encoded by other genes that were hit by up-regulated tags are indicated in grey boxes. All these 
proteins have previously been linked with responses to inflammation or infection (e.g. Aroian and 
van der Goot, 2007; Diebold and Bokoch, 2001; He and Bateman, 2003; Leclerc et al., 2008; Martin 
et al., 2005; Pettersson et al., 2000; Recalcati et al., 2008). Proteins encoded by genes hit by down-
regulated tags are shown in white boxes.
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Figure 8. Genome data mining using DGE tag information. Arrows pointing up indicate the 
mapping positions of tags with significantly increased expression under mycobacterium-infection 
conditions. Arrows pointing down indicate tags significantly down-regulated by mycobacterium 
infection. Lines indicate non-significant tags. Bold arrows correspond to tag counts above 100 in 
the DGE libraries of mycobacterium-infected fish. (A) Verification of an ab initio gene prediction 
from Ensembl. Three exons of the predicted GENSCAN00000043834 gene, a homolog of the human 
olfactomedin 4 gene, are supported by DGE tag information. The tag distribution further supports 
the existence of at least two alternative splice forms, represented by ENSDAREST00000036260 and 
ENSDAREST00000036258. (B) Infection-dependent isoform switching. Arrowheads below the gene 
indicate the positions of the last two polyadenylation signals in the stc1 transcript. The unchanged 
expression of the most 3’ tag vs. the significant induction of more upstream tags suggest alterna-
tive polyadenylation induced by mycobacterium infection leading to a transcript with a shorter 
3’ UTR. (C) Infection-dependent up- and down-regulation of two transcript isoforms of the ctsd 
gene. (D) Infection-dependent alternative splicing leading to a novel gene product. A cluster of 5 
significant tags was detected downstream of the known zgc:112143 gene, encoding the zebrafish 
homolog of the tumor-necrosis factor alpha-induced protein 9. Horizontal arrows indicate the po-
sition of RT-PCR primers used to verify the expression of an alternative transcript form that com-
prises the tag cluster region. From sequence analysis of the amplified product we could derive 
alternative splicing of the 5th exon to a new exon 6, encoding a different C-terminal domain of the 
protein. The 3’-end of exon 6 was not determined (open rectangle).
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likely be true for currently unknown transcript forms and therefore searched for tag 
clusters with significant tags that could not be mapped to any of the three transcript 
databases used in this work, but having genomic localizations close to each other. 
Next, we examined the neighboring genomic environment of these tag clusters, and 
inspected the gene annotations in that region for the presence of potential immune 
relevant functions. Out of 98 investigated clusters 29 proved to be located close to a 
gene that might have a function in immune defense (Supplementary Table 10). As 
an example, we experimentally confirmed the expression of a novel splice form of 
the zgc:112143 gene, which is homologous to the human tumor necrosis factor alpha-
induced protein 9 gene (TNFAIP9, also known as STEAP4), encoding a six trans-
membrane putative channel or transporter protein (Moldes et al., 2001). To this ex-
tent we performed RT-PCR on RNA samples from control and infected fish, taking a 
forward primer in one of the known exons of the gene (exon 3) and a reverse primer 
overlapping with one of the mycobacterium-induced tags located downstream of 
the known 3’ transcript end in a region without any predicted or EST-based indica-
tions of transcription. An RT-PCR product could be amplified from infected but 
not from control RNA samples, in agreement with the much higher tag counts in 
the DGE libraries from infected fish (total count numbers: cont-a/cont-b: 3/2; inf-a/
inf-b: 86/369). Sequence analysis of the resulting product revealed alternative splic-
ing in the known exon 5 resulting in a novel transcript form comprising a 6th exon 
that is the source of the significant DGE tags that we identified in our study (Fig. 
8D). Alternative splicing changes the C-terminal domain of the TNFAIP9 homolog, 
downstream of the six predicted transmembrane domains of this protein.
Discussion
Major advances in transcriptomics have become possible as a result of novel tech-
nology developments in deep sequencing (Cloonan and Grimmond, 2008; Morozova 
and Marra, 2008; Wang et al., 2009; Wilhelm and Landry, 2009). Here we report on 
the first deep sequencing study of the vertebrate host response to infectious disease. 
We chose the mycobacterium-zebrafish infection model as a case study because of 
its relevance to human tuberculosis, a disease that is characterized by an intricate 
interaction between host and pathogen (Lesley and Ramakrishnan, 2008; Pieters, 
2008). Furthermore, multi-platform microarray data sets of infection in this model 
were available for validation purposes (Meijer et al., 2005). Transcriptome alterations 
underlying a complex process like infectious disease are characterized not only by 
massive gene induction and repression responses, but also by subtle changes in tran-
script levels and presumably in the expression of alternative transcript forms (Vos 
et al., 2007). Our results demonstrate that deep sequencing is a major improvement 
over microarray analysis for detection of transcriptional changes over such a wide 
range. Moreover, the unbiased nature of deep sequencing data gives a fundamental 
advantage for gene discovery and genome annotation. 
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In this study we used Solexa/Illumina’s Digital Gene Expression (DGE) system, 
which is essentially a SAGE-based tag profiling approach. We could reach a sequenc-
ing depth of 5–8 million tags per library and confirmed the reproducibility of repli-
cate DGE library constructions by correlation analysis. Using a Bayesian method for 
statistical evaluation of our DGE tag data from control and mycobacterium-infected 
animals, we found over 5000 sequence tags to be differentially expressed. Count 
numbers of the significant tags spanned a dynamic range of three orders of mag-
nitude. An example of one of the most abundant tag sequences represented skel-
etal muscle actin alpha 1, which was detected by over 40,000 copies in the controls 
and down-regulated to around 10,000 copies upon mycobacterium infection. As an 
example of the sensitivity of the method, a tag sequence specific for the transcript 
encoding peptidoglycan recognition protein 1 was undetectable in the DGE libraries 
from control fish and was significantly up-regulated to around 20 copies in the DGE 
libraries from infected fish. The sensitivity of DGE profiling is further demonstrated 
by the fact that our analysis of a single developmental stage of the zebrafish (adult 
stage) could detect over 70% of all transcripts in the UniGene, RefSeq and Ensembl 
databases. The significantly changed tag sequences mapped to approximately 2% of 
the transcripts in these databases.
Since only one other Illumina-based DGE study has presently been reported (t 
Hoen et al., 2008), it was important to validate our DGE results by independent 
transcriptome profiling technologies. Our DGE data showed strong correlation (over 
90%) with a reference set of mycobacterium-regulated genes that had previously been 
confirmed in a multi-platform microarray study. Comparison with microarray data 
obtained from a single microarray platform (Agilent) also showed a substantial level 
of correlation (60%). Furthermore, gene ontology analysis showed significant enrich-
ment of similar functional groups of genes in DGE and Agilent microarray data sets. 
In most of the investigated cases where DGE and microarray analysis gave conflict-
ing results, qPCR analysis supported the DGE results. Conflicts between DGE and 
microarray results may occur for technical reasons, but may also result from the fact 
that microarray probes will often detect a mixture of different transcript isoforms, 
whereas DGE analysis can discriminate between specific transcript isoforms (t Hoen 
et al., 2008). Both methods have their intrinsic limitations, as discussed extensively 
by t Hoen et al. (2008). In short, important drawbacks of microarray analysis con-
cern limited sensitivity, cross-hybridization problems and inadequate probe design. 
On the other hand, DGE will fail to identify some transcripts that lack a unique 
tag sequence or cutting site for the DGE anchoring enzyme (NlaIII in this study). 
Therefore, microarray analysis and DGE can be considered complementary to each 
other. DGE compares favorably to microarray analysis in standardization between 
laboratories (Irizarry et al., 2005; Marioni et al., 2008; Pedotti et al., 2008; t Hoen et 
al., 2008). The most important advantage of DGE analysis is that the method is not 
limited by predefined array content. In our study, we detected differential expression 
of many transcripts that were not represented on the available microarray platforms. 
Chapter 2
48
By qPCR analysis we confirmed the differential expression of a subset of these tran-
scripts, with tag abundances in the range of 20–400 copies. 
Classical SAGE studies (Velculescu et al., 1995), based on conventional sequenc-
ing of cloned tags, have focused on analysis of the canonical tags, which are the tags 
resulting from the most 3’ located NlaIII restriction site on the sense strand of the 
transcript. The drawback of mapping only the canonical tags is that any information 
on alternative polyadenylation or alternative splicing is lost. In addition to biological 
mechanisms, partial digestion may also contribute to non-canonical mappings. As 
long as partial digestion is carefully controlled for by simultaneous preparation of 
parallel libraries with the same batch of reagents it does not present a problem. Rather, 
as a result of the enormous sequencing depth achieved in DGE analysis, the more 
5’ located non-canonical tags can provide a useful source of additional information. 
Furthermore, valuable insights can be obtained from genomic mapping of those tags 
that fail to hit the transcript databases. Here we have shown that the information 
obtained from genomic mapping of the entire set of DGE tags can be used (i) to 
investigate genomic clustering of co-regulated transcriptome responses, (ii) to verify 
the expression of ab initio predicted genes, (iii) to detect switching between alterna-
tive transcript forms induced by mycobacterial infection, and (iv) to detect and map 
novel mycobacterium-regulated transcript forms for which any previous EST-based 
evidence of expression was lacking. Altogether, we found a 50% higher efficiency for 
genomic mapping of the significant tag entities than for mapping to the UniGene 
transcript database. This shows the limitations of the use of cDNA sequence data for 
disease studies, a problem that is solved by deep sequencing strategies.
Contrary to tag-based DGE analysis, full RNA sequencing procedures (RNA-
Seq), in which mRNA or cDNA is fragmented mechanically, result in overlapping 
short fragments that cover the entire transcriptome. Clearly this approach is even 
more powerful for unraveling transcriptome complexity. However, tag sampling 
methods, which produce a less complex data mass, are currently more suitable and 
affordable for comparative expression studies of larger numbers of samples. For the 
mouse it has been estimated that 40 million RNA-Seq reads are required to achieve 
coverage of most transcripts and to allow accurate analysis of expression differences 
between samples (Mortazavi et al., 2008). In contrast, approximately 2 million tran-
script-specific DGE tags from mouse were shown to be sufficient to reliably detect 
low abundant genes (t Hoen et al., 2008). Whereas the quantification of RNA-Seq 
results may be complicated by unequal coverage of transcripts by sequence reads, the 
quantitative comparison of DGE tag libraries can build directly on the vast knowl-
edge of statistical evaluation of conventional SAGE experiments (Lash et al., 2000; t 
Hoen et al., 2008; Zhu et al., 2008). 
Unlike some of the RNA-Seq protocols, SAGE-derived DGE analysis provides 
information on transcript directionality. In our study approximately 40% of the map-
ping events were detected on the antisense strand of UniGene, RefSeq or Ensembl 
database transcripts. This is comparable to data reported for mouse DGE analysis, 
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where evidence for bidirectional transcription was found for 51% of all detectable 
UniGene clusters (t Hoen et al., 2008). Similar as in their study, we found no correla-
tion between the abundance of sense and antisense tags for the same transcript. To 
what extent antisense transcripts might result from transcriptional noise is currently 
unknown. However, there is accumulating evidence for the widespread occurrence 
of antisense transcription and its biological relevance (Beiter et al., 2009; Carninci 
et al., 2005; Katayama et al., 2005). For example, the proper dosage of expression of 
the human and murine hematopoietic transcription factor PU.1, critical for suppres-
sion of leukemia, was shown to rely on antisense RNA modulators (Ebralidze et al., 
2008).We found that mycobacterium infection significantly induced both sense and 
antisense DGE tags of the zebrafish homolog of the PU.1 gene (spi1), suggesting that 
antisense regulation of the expression of this gene may be an ancient evolutionary 
mechanism.
The mycobacterium-infected zebrafish analyzed in this study were at the late 
stage of chronic tuberculosis. As previously observed in microarray analysis, our 
DGE study showed massive changes in the expression levels of known immune re-
sponse genes and of genes that have been implicated in human tuberculosis (Meijer 
et al., 2005). Many of the mycobacterium-regulated genes that we could functionally 
annotate were homologous to human genes that have been linked with genetic dis-
eases. These included inflammatory and hematologic disorders, for example, anemia, 
which is commonly associated with tuberculosis (Lee et al., 2006). We also identified 
many interesting genes that had not been linked to tuberculosis in previous studies. 
For example, we demonstrated infection-dependent up-regulation of an ab initio 
predicted homolog of olfactomedin 4 (OLFM4), also known as granulocyte colony 
stimulating factor stimulated clone-1 (hGC-1). This gene encodes a glycoprotein of 
unknown function, suggested to be involved in cell adhesion, cancer progression 
and myeloid development (Chin et al., 2008; Liu et al., 2008). We also observed 
induction of a specific transcript variant of the zebrafish homolog of stanniocalcin 
1 (stc1), a gene suggested to be involved in macrophage chemotaxis and transend-
othelial migration of inflammatory cells (Chakraborty et al., 2007; Kanellis et al., 
2004). Furthermore, by genomic tag mapping we demonstrated induction of a novel 
alternative splice form of a gene homologous to the human tumor necrosis factor 
alpha-induced protein 9 gene (TNFAIP9, also known as STEAP4). This gene en-
codes a six transmembrane putative channel or transporter protein implicated in 
inflammatory responses and cancer progression (Korkmaz et al., 2005; Wellen et al., 
2007). The above mentioned genes are merely given as examples to illustrate how our 
deep sequencing-based systems approach can quickly lead from mapping of total 
transcriptome responses to detailed functional annotation. More importantly, the 
entire description of all mycobacterial regulated genes provides an unbiased basis 
for subsequent candidate gene approaches that was not possible with prior micro-
array-based transcriptome profiling. In future studies we will use deep sequencing 
technology to compare the present data set of the late stage of tuberculosis with 
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earlier stages of disease progression, including granuloma formation in the zebrafish 
embryo model that is more amenable to experimental manipulation (Lesley and 
Ramakrishnan, 2008).
Conclusions
We have demonstrated here that deep sequencing analysis, using Solexa/Illumina’s 
digital gene expression (DGE) system, provides a robust, sensitive and unbiased al-
ternative to microarray analysis with major advantages for detection of the broad 
range of transcriptional responses that occur during the process of an infectious 
disease, as exemplified in this study using the zebrafish mycobacterium model. First, 
by mapping of DGE sequence tags to transcript databases we showed that mycobac-
terium infection induced quantitative changes in the expression levels of many genes, 
including those previously implicated in human tuberculosis. These data showed 
over 90% concordance with a reference set of mycobacterium-regulated genes that 
had previously been confirmed in a multi-platform microarray study. Second, by ge-
nomic mapping of the DGE sequence tags we could reveal transcriptional responses 
that microarray analysis would have failed to detect, such as the switching between 
alternative transcript isoforms, the expression of novel splice products not present in 
the current transcript and EST databases, and a high level of antisense transcription. 
Our DGE study substantiates recent RNA sequencing results in other model species 
indicating a much larger extent of genome transcription than previously thought. 
Furthermore, it demonstrates the advantages of a deep sequencing approach for gene 
discovery and genome annotation and provides new leads for functional studies of 
candidate genes involved in host–pathogen interaction.
Materials and methods
Zebrafish husbandry and infection experiments
Zebrafish were handled in compliance with the local animal welfare regulations 
and maintained according to standard protocols (http://ZFIN.org). The infection ex-
periment was approved by the animal welfare committee (DEC) of Leiden University. 
Adult male zebrafish were infected by intraperitoneal inoculation with approximately 
1×103 Mycobacterium marinum bacteria as previously described (Meijer et al., 2005). 
Four of the RNA samples used for this study were identical to those from our previ-
ously published chronic infection study (control fishes c1, c2 and infected fishes i1, 
i2) (Meijer et al., 2005). Four additional RNA samples (control fishes c3, c4 and in-
fected fishes i3, i4) were from an independent M. marinum E11 infection experiment 
performed under similar conditions. All four infected fish were sacrificed when they 
showed overt signs of fish tuberculosis, including lethargy, skin ulcers and extensive 
granuloma formation in organs, such as liver and kidney. Histological examination 
of fish from the same experiments confirmed that the pathology of infected fish cor-
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responded to fish tuberculosis (Swaim et al., 2006; van der Sar et al., 2004) and that 
no characteristics of the disease were present in the control fish.
RNA isolation
Fish were snap frozen in liquid nitrogen, stored at −80 °C, and homogenized in 
liquid nitrogen using amortar and pestle. Portions of 50–100µg of powdered tissue 
were used for extraction of total RNA with 1ml of TRIZOL® Reagent (Invitrogen) 
according to the manufacturer’s instructions. The RNA samples were incubated for 
20min at 37°C with 10 units of DNaseI (Roche Applied Science) to remove residual 
genomic DNA prior to clean up using RNeasy columns (Qiagen). The integrity of 
the RNA was confirmed by Lab-on-chip analysis using the 2100 Bioanalyzer (Agilent 
Technologies). The samples used had an average RIN value of 9.5 and a minimum 
RIN value of 8.9.
Digital gene expression-tag profiling (DGE)
For DGE analysis RNA samples from the four control fish (c1, c2, c3, c4) were 
pooled, and RNA samples from the four infected fish (i1, i2, i3, i4) were pooled. 
Before pooling the individual RNA samples had been checked by microarray analy-
sis for correlation between biological replicates. From each pool duplicate libraries 
for tag sequencing were prepared in order to assess technical reproducibility. Tag 
library preparation was performed using the DGE: Tag Profiling for NlaIII Sample 
Prep kit from Illumina according to the manufacturer’s instructions. In brief, 1 µg of 
total RNA was used for mRNA capture using magnetic oligo(dT)beads. First- and 
second-strand cDNA was synthesized and bead-bound cDNA was subsequent-
ly digested with NlaIII. Fragments other than the 3’ cDNA fragments attached to 
oligo(dT) beads were washed away and a GEX NlaIII adapter was ligated to the free 
5’-end of the digested bead-bound cDNA fragments. The GEX NlaIII adapter con-
tains a restriction site for MmeI which cuts 17–18 bp downstream from the NlaIII 
site, thereby releasing 21–22 bp tags starting with the NlaIII recognition sequence, 
CATG. A second adapter (GEX adapter 2) was ligated at the site of MmeI cleavage, 
and the adapter-ligated cDNA tags were enriched using PCR-primers that anneal 
to the adaptor ends. The resulting 85 bp fragments were purified from a 6% acry-
lamide gel. Purity and yield were checked by Lab-on-chip analysis using the 2100 
Bioanalyzer (Agilent Technologies). A total of 6 pmol of cDNA per tag library was 
used for cluster generation on individual lanes of Illumina’s 1.4 mm channel flow cell, 
and sequencing by synthesis was performed using the Illumina Genome Analyzer II 
system (ServiceXS, Leiden, the Netherlands) according to the manufacturer’s proto-
cols. Image analysis, base calling, extraction of 17 bp tags and tag counting were per-
formed using the Illumina pipeline. The raw data (tag sequences and counts) were 
deposited in the GEO database under submission number GSE14782.
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Statistical evaluation of DGE libraries
The tag entities and count numbers of DGE libraries from control and infected 
fish were collected and summarized by custom perl and PHP scripts. Statistical com-
parison was performed using the Bayesian method described by Lash et al. (2000) 
with the software tool available from the SAGEmap resource. We accepted the change 
of a tag expression as significant if the chance of a false positive hit was less than 5% 
(P < 0.05). The correlation of the detected count numbers between parallel libraries 
was statistically assessed by calculation of Pearson correlation coefficient using the 
built-in function of Microsoft Excel.
Mapping of DGE tags
For mapping of DGE tags to different transcript databases or to the zebrafish ge-
nome we created virtual libraries containing all the possible 17 bases length sequenc-
es of these resources located next to an NlaIII restriction site. For transcript map-
ping we used the UniGene (Danio rerio build 105), Refseq (2007_07) and Ensembl 
(ZFISH7.49) transcript databases. For genomic mapping we used the native and the 
masked form of the zebrafish genome version Zv7, which were downloaded from 
the FTP server of the Ensembl database. For mapping against UniGene transcripts 
we used the file containing the sequence with the longest region of high-quality se-
quence data from each UniGene cluster. For monitoring the mapping events on both 
strands, both the sense and the complementary antisense sequences were included 
in the data collection. Information on the position of polyadenylation signals and 
the length of polyadenylation tails was also collected from the transcript databases. 
Virtual tag libraries and the DGE libraries were uploaded into an in house developed 
data warehouse using a relational database engine for mapping of DGE tags onto 
virtual libraries. Only perfect matches over the entire 21 bp length of the 17 bp tag 
plus the 4 bp NlaIII recognition site were allowed. During the mapping process the 
system tracked the so-called multiple mapping events where tags detected in the 
experiments could be assigned to more than one transcript or to more than one 
position in the genome.
Microarray analysis
Agilent microarray analysis was performed using a custom designed platform 
(GEO submission number GPL7735) with previously described conditions for la-
beling, hybridization, scanning and feature extraction (Stockhammer et al., 2009). 
Samples from control fish (c1–c4) were labeled with Cy3 dye and samples from in-
fected fish (i1–i4) with Cy5 dye. After feature extraction, data were imported into 
Rosetta Resolver 7.1 (Rosetta Biosoftware, Seattle, Washington) and subjected to de-
fault ratio error modeling. Ratio results from four control fish vs. four infected fish 
(c1 vs. i1, c2 vs. i2, c3 vs. i3, c4 vs. i4) were combined using the default ratio experi-
ment builder. Data were analyzed at the level of UniGene clusters (UniGene build 
#105). Microarray data were submitted to the GEO database under series GSE14782.
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RT-PCR
Real-time quantitative RT-PCR (qPCR) was performed as previously described 
(Stockhammer et al., 2009). All reactions were done in duplicate. For normaliza-
tion ppial (peptidylprolyl isomerase A like), which was unaffected by mycobacte-
rium infection, was taken as reference. Sequences of forward and reverse primers 
are shown in Supplementary Table 1. RT-PCR verification of the mycobacterium-
induced novel transcript variant of the zgc:112143 gene was performed using the 
SuperScript III One-Step RT-PCR System with Platinum Taq DNA Polymerase 
(Invitrogen). A primer overlapping with one of the significant tags located down-
stream of the known 3’ transcript end was used for the reverse transcription reac-
tion (CCAGACACTCAAACAGACATG). The same primer was subsequently used 
in the PCR amplification step, in combination with a forward primer in exon 3 of the 
known transcript (ATGAGCGAGTTACCAACGGA). The resulting PCR product 
was sequenced using the sequencing service of ServiceXS (Leiden, The Netherlands) 
and submitted to GenBank under accession number FJ754358.
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Salmonella enterica serovar Typhimurium (S. typhimurium) bacteria cause an in-
flammatory and lethal infection in zebrafish embryos. To characterize the embryonic 
innate host response at the transcriptome level, we have extended and validated pre-
vious microarray data by Illumina next-generation sequencing analysis. Comparison 
of tag-based sequencing (DGE or Tag-Seq) with full transcript sequencing (RNA-
Seq) showed a strong correlation of sequence read counts per transcript and an 
overlap of 241 transcripts differentially expressed in response to infection. A slightly 
lower overlap of 165 transcripts was observed with previous microarray data. Based 
on the combined sequencing-based and microarray-based transcriptome data we 
compiled an annotated reference set of infection-responsive genes in zebrafish em-
bryos, encoding transcription factors, signal transduction proteins, cytokines and 
chemokines, complement factors, proteins involved in apoptosis and proteolysis, 
proteins with anti-microbial activities, as well as many known or novel proteins not 
previously linked to the immune response. Furthermore, by comparison of the deep 
sequencing data of S. typhimurium infection in zebrafish embryos with previous 
deep sequencing data of Mycobacterium marinum infection in adult zebrafish we 
derived a common set of innate host defense genes that are expressed both in the 
absence and presence of a fully developed adaptive immune system and that provide 
a valuable reference for future studies of host-pathogen interactions using zebrafish 
infection models.
Introduction
In the recent years zebrafish has become widely used as a model for in vivo stud-
ies of host-pathogen interactions. Zebrafish develop both an innate and adaptive 
immune system with notable similarities to that of mammals (Traver et al., 2003; 
Trede et al., 2004). Zebrafish embryos can be exploited to study innate immunity 
separately from adaptive immune functions, since components of the innate im-
mune system are functional already at the first day of embryogenesis contrary to the 
adaptive immune system that is not active during the first weeks of zebrafish devel-
opment (Davidson and Zon, 2004; Herbomel et al., 1999; Lam et al., 2004; Willett et 
al., 1999). Furthermore, the externally developing and transparent zebrafish embryos 
are highly suited for real-time analysis of host-pathogen interactions, which can be 
combined with efficient gene knock-down analysis using antisense morpholino oli-
gonucleotides. It has been demonstrated that the components of the main innate im-
mune signaling pathways are strongly conserved between zebrafish and mammals 
(Meijer et al., 2004; Stein et al., 2007) and several infection models for studying in-
nate immune response mechanisms in zebrafish embryos have now been developed 
(Meeker and Trede, 2008). Salmonella infections, causing salmonellosis and typhoid 
fever, are studied in several animal models, of which the best studied is the mouse 
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model of S. enterica serovar Typhimurium infection (hereafter referred to as S. typh-
imurium) (Santos et al., 2001). The opportunity of real time analysis led to the de-
velopment of a S. typhimurium infection model in zebrafish embryos (van der Sar et 
al., 2003). Intravenous infection of 1 day old zebrafish embryos with S. typhimurium 
strain SL1027 resulted in a lethal infection with bacteria showing intracellular repli-
cation in macrophage-like cells as well as extracellular replication in micro-colonies 
at the epithelium of blood vessels. In contrast, lipopolysaccharide (LPS) mutants of S. 
typhimurium (Ra) were non-pathogenic in zebrafish embryos, similar as in mamma-
lian hosts (van der Sar et al., 2003). Components of the S. typhimurium cell wall and 
motility apparatus trigger innate host defense pathways, including Toll-like recep-
tor (TLR) signaling (Salazar-Gonzalez and McSorley, 2005). A morpholino knock-
down analysis of the common TLR-adaptor protein, MyD88, showed that zebrafish 
embryos lacking MyD88 function lost the ability to clear an infection with the at-
tenuated S. typhimurium Ra mutant strain, demonstrating that the innate immune 
response of the zebrafish embryos involved MyD88-dependent signaling (van der 
Sar et al., 2006). To characterize the zebrafish embryonic host immune response to S. 
typhimurium wild-type and Ra mutant infection a time-course microarray analysis 
was performed, showing the induction of genes encoding cell surface receptors, sig-
naling intermediates, transcription factors, and inflammatory mediators, with strong 
similarity to host responses detected in other vertebrate models and human cells 
(Stockhammer et al., 2009). A conserved role of zebrafish Toll-like receptor 5 (TLR5) 
homologs in recognition of Salmonella flagellin was demonstrated (Stockhammer 
et al., 2009). Furthermore, similar as mammals, zebrafish embryos were shown to 
employ both MyD88-dependent and MyD88-independent signaling pathways dur-
ing infection (Stockhammer et al., 2009).
As demonstrated by our previous microarray analysis, the S. typhimurium-ze-
brafish model presents a useful case study for the embryonic innate host response 
to an inflammatory bacterial infection (Stockhammer et al., 2009). Here we have 
extended this microarray study by a deep sequencing analysis using the previously 
described tag-based sequencing method known as digital gene expression (DGE) 
(Hegedus et al., 2009; t Hoen et al., 2008) also named Tag-Seq (Morrissy et al., 2009). 
We determined the overlap between deep sequencing and microarray data and re-
port a detailed annotation of the S. typhimurium-responsive gene set validated by 
both analysis methods. Furthermore, we compared the tag-based sequencing ap-
proach with full transcript sequencing (RNA-Seq), and based on the overlap be-
tween the data sets demonstrate the usefulness of both deep sequencing approaches 
for transcriptome quantitation during infection. We compared the data with our 
previous deep sequencing analysis of Mycobacterium marinum infection in adult 
zebrafish and annotated the gene set commonly induced in both infection models. 





Identification of Salmonella-responsive genes by tag sequencing 
Previously we have performed a microarray analysis of the innate immune re-
sponse of one day old zebrafish embryos to Salmonella typhimurium infection 
(Stockhammer et al., 2009). Over the first 8 hours of the infection we observed in-
duction of an increasing number of specific gene groups including transcription fac-
tors, signaling molecules, and inflammatory mediators. Here we took the 8 hours 
post infection (hpi) time point for a deep sequencing analysis. Using the digital gene 
expression (DGE) procedure previously described (Hegedus et al., 2009), hereafter 
referred to as Tag-Seq (Morrissy et al., 2009), we obtained around 10 million se-
quence-specific tags from control and infected embryos each. A total of 2471 tag enti-
ties showed significantly different expression between the libraries from control and 
infected fish. Of all significant tags 66% (1630 tags) could be mapped to the UniGene 
database. The majority of these tags (95%) showed up-regulated expression during 
infection, while only 5% was down-regulated. Mapping of the significantly changed 
tags identified a total of 959 different UniGene transcripts when the tags mapping to 
multiple transcripts were excluded (and 2049 including the tags with multiple map-
ping). A total of 815 of these transcripts were identified only by tags mapping to the 
sense strand, 121 transcripts by tags mapping only to the antisense strands, and 23 
transcripts collected significant tags mapping to both the sense and antisense strands. 
Gene ontology (GO) analysis of the up-regulated transcripts with tags mapping to 
the sense strand showed enrichment of the GO-term response to stimulus (P<0.01), 
consistent with earlier microarray results (Stockhammer et al., 2009). 
Validation of Salmonella-responsive genes by comparative analysis of tag 
sequencing and microarray data
Approximately 60% of the UniGene transcripts that were identified by up- or 
down-regulated tags in the Tag-Seq analysis (sense strand mapping) were present on 
the custom Agilent microarray platform used in our previous study (Stockhammer 
et al., 2009). From those UniGene transcripts, 111 were changed in the same direc-
tion (108 up-regulated and 3 down-regulated), 1008 were not significantly changed 
in the microarray study, and 10 showed a change in the opposite direction between 
deep sequencing and microarray data (Fig. 1A). Conversely, in the microarray analy-
sis 1254 genes in total were significantly changed (929 up-regulated and 325 down-
regulated with fold change >1.5), of which 1133 were not significantly changed in the 
Tag-Seq analysis. The limited overlap between microarray and deep sequencing data 
can be explained by differences in methodology, experimental design (e.g. number 
of parallels), and data processing workflows that are based on different statistical 
methods to select significant hits. From a biological point of view, the statistical 
method used to accept expression changes in Tag-Seq analysis as significant (Lash et 
al., 2000) appeared to be more stringent, as it relied on fold changes of at least a fac-
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tor 2 for the more abundant tags and over 5 fold change for the lower abundant tags. 
As an alternative to this statistical method we developed the Cumulative Transcript 
Detection Index (CTDI) as a means to evaluate differential expression in Tag-Seq 
datasets. As previously noted (Hegedus et al., 2009), in Tag-Seq analysis the majority 
of transcripts are represented by more than one tag in the sequence data. The CTDI 
value reflects the accumulated information from all tags that map to the same tran-
script, giving increased weight to tags with higher significance in statistical testing 
(Lash et al., 2000) and giving lower weight to those transcripts where tags are present 
that change in the opposite direction. We separately calculated the CTDI values for 
tags mapping to the sense strands (sCTDI) and antisense strands (asCTDI) of the 
UniGene database transcripts (Fig. 2) and used the sCTDI data for comparison with 
our microarray data (Fig. 1B). We found that 165 of the transcripts that were differen-
tially expressed according to sCTDI calculation were changed in the same direction 
in our microarray analysis (161 up-regulated and 4 down-regulated; Supplementary 
Table 1). Therefore, the responsiveness of these transcripts to Salmonella infection in 
embryos has been confirmed by two independent transcriptome analysis methods.
Validation of Salmonella-responsive genes by comparative analysis of Tag-
Seq and RNA-Seq data
Validation of the Tag-Seq data by comparison with microarray data was limited 
Figure 1. Comparison of Tag-Seq and microarray data of Salmonella infection of zebrafish 
embryos. The microarray data set of 1-day-old zebrafish embryos at 8 hours after infection with 
Salmonella typhimurium is taken from Stockhammer et al. (2009) and compared here with Tag-
Seq data of the same samples. (A) Venn diagram showing the overlap of the microarray data set 
with the Tag-Seq dataset based on statistical evaluation according to Lash et al., (2000). (B) Venn 
diagram showing the overlap of the microarray data set with the Tag-Seq dataset based on sCTDI 
calculation. For the transcripts changed only in Tag-Seq analysis (left part of the Venn-diagrams) 
the numbers in brackets indicate presence on the microarray platform. In the overlapping sectors 
of the Venn-diagrams the numbers of up-regulated transcripts are indicated in green, numbers of 
down-regulated transcripts in blue, and numbers of transcripts changed in opposite direction in 
Tag-Seq and microarray analysis are indicated in grey. 
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Figure 2. Evaluation of Tag-Seq data by Cumulative Transcript Detection Index (CTDI) calcu-
lation. The distribution of the number of transcripts over the range of CTDI values is plotted on 
a logarithmic scale. Data for tags mapping to the sense (sCTDI) and antisense (asCTDI) strands of 
the UniGene transcript database are plotted separately. Transcripts represented by at least one tag 
with a significant expression change based on statistical evaluation according to Lash et al. (2000) 
have an absolute CTDI value larger than 0.95. For details of CTDI calculation see the Materials 
and Methods section. (A) CTDI plot of Salmonella infection of zebrafish embryos. sCTDI values 
ranged between -2 and +15 and asCTDI values ranged between -2 and +7 and were in similar range 
when tags were mapped to the RefSeq (-4<sCDTI<11, -2<asCTDI<4) or Ensembl (-5<sCDTI<10, 
-3<asCTDI<4) databases. (B) CTDI plot of Tag-Seq data from Mycobacterium infection of adult ze-
brafish (Hegedus et al., 2009). 
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by the fact that only about one third of all transcripts in the UniGene database were 
represented on the microarray platform. To extend the validation of our Tag-Seq 
dataset we therefore performed a comparison with RNA-Seq, in which whole cDNA 
transcripts are fragmented and deep sequenced. For RNA-Seq analysis, control and 
Salmonella-infected embryo samples from an independent experiment were used. 
Approximately 15 million reads were obtained for both samples subjected to RNA-
Seq. For comparison between RNA-Seq and Tag-Seq the reads were mapped to the 
Ensembl transcript database based on the Zv8 genome sequence. In both cases ap-
proximately half of the sequence reads could be mapped to Ensembl transcripts if no 
mismatches were allowed. When we allowed 1 mismatch for mapping of the longer 
RNA-Seq reads (51 nucleotides in RNA-Seq as compared to 17 nucleotides in Tag-
Seq) the mapping efficiency could be increased to approximately two-thirds of the 
total reads. Mapping of RNA-Seq reads identified 85-86% of the known Ensembl 
transcripts, while 63-69% of transcripts were identified by mapping of Tag-Seq reads 
(Fig. 3A). Pearson correlations for RNA-Seq versus Tag-Seq libraries of control and 
infected embryos were 0.84 and 0.81 respectively, which is relatively high especially 
considering that RNA-Seq and Tag-Seq libraries were constructed from different 
biological samples (Fig. 3B). As can be observed in the correlation plots, the agree-
ment between RNA-Seq and Tag-Seq data was better for the moderate to highly ex-
pressed transcripts than for the low abundant transcripts (Fig. 3B). Statistical evalu-
ation showed that 1244 transcripts were differentially expressed in Tag-Seq analysis 
and 976 transcripts in RNA-Seq analysis. In both cases more transcripts were up-
regulated than down-regulated (Fig. 3C, 3D). However, detection of down-regulated 
transcripts appeared more efficient with RNA-Seq, where 17% of all differentially 
expressed transcript were down-regulated, than with Tag-Seq, where the down-reg-
ulated transcripts comprised only 3% of all differentially expressed transcripts. Gene 
ontology (GO) analysis of the up-regulated transcripts of both Tag-Seq and RNA-
Seq analysis showed enrichment of the GO-term response to stimulus (P<0.05). In 
total 160 up-regulated and 7 down-regulated transcripts were overlapping between 
Tag-Seq and RNA-Seq analysis, while 23 transcripts showed changes in opposite di-
rections between the two methods (up in Tag-Seq and down in RNA-Seq) (Fig. 3D). 
When the Tag-Seq data were evaluated using the above described CTDI algorithm 
for cumulative detection of tags mapping to the same transcript, the overlap between 
Tag-Seq and RNA-Seq increased to 233 up-regulated and 8 down-regulated tran-
scripts (Fig. 3E, Supplementary Table 1). In conclusion, Tag-Seq and RNA-Seq were 
similarly suitable to derive quantitative information on infection-responsive gene 
expression and the overlap of differentially expressed transcripts between these two 
deep sequencing methods was slightly better than the overlap between Tag-Seq and 
microarray analysis (compare Fig.1A,B, Fig.3D,E) .
Annotation of the validated Salmonella-responsive gene set
After collapsing UniGene and Ensembl transcript IDs to single genes, the total set 
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of Salmonella-responsive genes confirmed by two transcriptome analysis methods 
consisted of 317 genes, of which 163 were overlapping between Tag-Seq and microar-
ray analysis, 230 between Tag-Seq and RNA-Seq, and 76 by all three methods of gene 
expression profiling. This set of 317 genes (309 up-regulated and 8 down-regulated) 
was taken for a detailed annotation (Supplementary Table 1, Fig. 4). We categorized 
the differentially expressed genes into 5 categories: 1A - annotated genes previously 
implicated in the vertebrate immune response (82 up + 4 down), 1B -  novel/hypo-
thetical genes with similarity to genes previously implicated in the vertebrate im-
mune response (31 up), 2A - annotated genes not previously linked to the immune 
response (100 up + 2 down), 2B - novel/hypothetical genes with similarity to genes 
not previously linked to the immune response (50 up + 2 down), and 3 - genes with 
unknown function and for which we could not derive any functional prediction (46 
up). The genes in the 1A/B and 2A/B categories were ordered by (predicted) func-
tions based on literature and gene ontology data (Supplementary Table 1, Fig. 4). The 
annotated or novel/hypothetical genes with homology to human immune-related 
genes (categories 1A/B) together comprised 22 infection-induced genes with func-
tions in transcription activation or repression, including transcription factors of 
the ATF, AP-1(JUN/FOS), CEBP, ETS, IRF, MYB, MYC, NFκB, and STAT families. 
Categories 1A/B also contained 21 up-regulated genes involved in immune-related 
signal transduction pathways, including MAP kinase (MAPK), ERBB2, interleukin 
Figure 3. RNA-Seq analysis of Salmonella infection of zebrafish embryos. (A) Efficiency of 
transcript detection by Tag-Seq and RNA-Seq. The Venn-diagrams show the overlap between 
all Ensembl transcripts and the transcript identified by mapping of reads from Tag-Seq or RNA-
Seq analysis of control and infected embryos. One mismatch was allowed for mapping of the 51 
nucleotides long RNA-Seq reads and no mismatches were allowed for mapping of the 17 nucle-
otides long tag entities in Tag-Seq. (B) Correlation between Tag-Seq and RNA-Seq data. Scatter 
plots show the counts per Ensembl transcript for both methods. Only reads mapping to a single 
transcript were included in the analysis. (C) Tag-Seq and RNA-Seq detection of differential expres-
sion between control and infected embryos. Scatter plots show the counts per Ensembl transcript 
(RNA-Seq) or counts per tag (Tag-Seq) for libraries of control versus infected embryos. Transcripts 
(RNA-Seq) or tags (Tag-Seq) with significantly different expression between control and infected 
libraries are indicated in red. In RNA-Seq the reads were first mapped to Ensembl transcripts and 
subsequently differential expression was statistically evaluated according to Lash et al. (2000). The 
RNA-Seq scatter plot shows RPKM values, which are the total read counts per kilobase per million 
mapped reads (Mortazavi et al., 2008). In Tag-Seq differential expression was statistically evaluated 
at the level of the individual tags. (D) Venn diagram showing the overlap of the Tag-Seq and RNA-
Seq data sets based on statistical evaluation according to Lash et al. (2000). (E) Venn diagram show-
ing the overlap of the Tag-Seq and RNA-Seq data sets, based on sCTDI calculation for the Tag-Seq 
data. Tag-Seq reads mapping to the antisense strands of Ensembl transcripts were excluded from 
all analyses. In RNA-Seq, information on transcript directionality is not obtained and therefore all 
read mapping data are included in the analyses.
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1 receptor (IL1R) and Toll-like receptor (TLR) signaling. The genes involved in TLR 
signaling included several negative regulators of the pathway, including irak3, socs3a 
and socs3b, and the NFκB inhibitor genes nfkbiaa and nfkbiab, as previously noted in 
Stockhammer et al. (2009). The signal transduction group also contained 4 members 
of the membrane-spanning 4-domains subfamily. The up-regulated genes in catego-
ries 1A/B further comprised 9 genes with (predicted) cytokine or chemokine activity, 
13 genes related to complement activation and the acute phase response, 12 genes 
Figure 4. Annotation of the gene set responsive to Salmonella infection in zebrafish embryos. 
Differential expression of genes in the diagram was confirmed by Tag-Seq and microarray analy-
sis, or by Tag-Seq and RNA-Seq analysis, or by all three transcriptome profiling methods as indi-
cated in Supplementary Table 1. Genes were grouped into five categories: category 1A - annotated 
genes previously implicated in the vertebrate immune response based on GO annotations of the 
zebrafish genes and their human homologues, on PubMed abstracts and on overlap with the com-
mon host response defined by Jenner and Young (2005), 1B - novel/hypothetical genes with similar-
ity to genes previously implicated in the vertebrate immune response, 2A - annotated genes not 
previously linked to the immune response, 2B - novel/hypothetical genes with similarity to genes 
not previously linked to the immune response, 3 - genes with unknown function. The number of 
genes in each category is indicated in the pie diagram and the corresponding genes are ordered 
by functional groups. Genes up-regulated by Salmonella infection (309 genes) are indicated in 
black, and genes down-regulated (8 genes) are indicated in blue. Gene descriptions and accession 
numbers are given in Supplementary Table 1.
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involved in apoptosis and 11 genes with proteolytic functions, including proteasome 
activator subunit genes, cathepsins, serpins and matrix metalloproteinases (mmp9, 
mmp13 and mmp14b). Furthermore, categories 1A/B contained smaller groups of 
up-regulated genes encoding MHC complex proteins, coagulation factors, enzymes 
(e.g. the prostaglandin biosynthetic gene ptgs1) and several genes that we classified 
under defense response, such as the antimicrobial hepcidin (hamp1/2) gene, the pep-
tidoglycan recognition (plyrp5) gene, the immediate early response gene, ier2. The 
categories 1A/B contained only four down-regulated genes of which two, mpx (my-
eloperoxidase) and lyz (lysozyme C), are also clearly linked to the defense response. 
The down-regulation of these genes might suggest a Salmonella-specific mechanism 
to counteract host defense. The down-regulated genes further included a cathepsin 
gene (ctssb.1) and the macrophage expressed gene 1 (mpeg1), which encodes a per-
forin-like protein whose precise function is unknown. In contrast, two other cathep-
sins (ctsc, ctsk) and an mpeg1-like gene (zgc:110354) were present in the up-regulated 
gene set. The 150 up-regulated and 4 down-regulated genes of the 2A/B categories 
that have not previously been directly linked to immune response were associated to 
GO terms such as cytoskeletal structure and organization, enzyme activity (includ-
ing several metabolic genes), translation, and transporter activity (including several 
solute carriers). The 2A/B categories also contained up-regulated genes associated 
with proteolysis, signal transduction and transcription factor or cofactor functions, 
which were not previously linked specifically to host defense.
Comparison of different infection studies 
Previously we have used Tag-Seq analysis to investigate the host response of adult 
zebrafish at the end stage of Mycobacterium marinum infection ((Hegedus et al., 
2009); chapter 2). The end stage of Mycobacterium infection in adult fish is associated 
with a strong inflammatory response, similar to what we observed during Salmonella 
infection of zebrafish embryos. Therefore, we decided to compare the specific gene 
groups regulated in both infection studies. To this extent we re-examined our previ-
ous Tag-Seq data set from Mycobacterium infection by CTDI calculation (Fig. 2B). 
The CTDI values for tags mapping to the sense strands (sCTDI) of the UniGene 
database transcripts ranged between –7 and +12, whereas these values ranged be-
tween -2 and +15 in the Salmonella Tag-Seq data set, indicating that more transcripts 
were down-regulated in the Mycobacterium infection study. This is consistent with 
our previous analyses that showed a large number of genes encoding metabolic en-
zymes and muscle proteins to be down-regulated during Mycobacterium infection 
when the fish become strongly emaciated (Hegedus et al., 2009; Meijer et al., 2005). 
Next, we determined the overlap between the up- and down-regulated transcripts of 
the Salmonella and Mycobacterium infection studies (Fig. 5A, Supplementary Table 
2). We found 228 and 3 commonly up- or down-regulated transcripts that corre-
sponded to 206 and 2 up- or down-regulated genes. These genes were functionally 
annotated and grouped into the 5 categories described above, showing that the com-
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Figure 5. Comparison of infection responses in adult and embryonic zebrafish. The Tag-Seq 
data of Salmonella infection of zebrafish embryos reported here were compared with previously 
published DGE data of the end stage of Mycobacterium infection in adult zebrafish (Hegedus et al., 
2009). (A) Venn diagram showing the overlap between DGE data of the different infection studies 
based on sCTDI calculation. In the overlapping sector of the Venn-diagram the numbers of up-
regulated transcripts are indicated in green, numbers of down-regulated transcripts in blue, and 
the numbers of transcripts changed in opposite direction in the two different infection studies is 
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monly up-regulated genes included 94 annotated or novel/hypothetical genes with 
homology to human immune-related genes (categories 1A/B), 77 annotated or novel/
hypothetical genes that have not been directly implicated in host defense in previous 
studies (categories 2A/B), and 35 genes for which we could make no functional pre-
diction (category 3). Only two genes were identified as commonly down-regulated 
between the different infection studies, encoding a predicted intermediate filament 
protein and a ribosomal protein. Commonly up-regulated genes with previous links 
to host defense (categories 1A/B) were mainly associated with apoptosis, coagulation, 
complement activation and acute phase response, cytokine and chemokine activity, 
defense response, proteolysis, signal transduction, transcriptional activation and re-
pression, and transporter activity. Commonly up-regulated genes in categories 2A/B 
were mainly associated with cytoskeletal structure and organization, enzyme activity, 
proteolysis, signal transduction, transcriptional activation and repression, transla-
tion and transporter activity. 
Discussion
In this study we used the S. typhimurium-zebrafish infection model for a deep 
sequencing analysis of the embryonic innate host response to an inflammatory infec-
tion. Using both tag-based (Tag-Seq) and full transcript (RNA-Seq) sequencing ap-
proaches we extended and validated previous microarray data of this infection model 
(Stockhammer et al., 2009). The combined sequencing-based and microarray-based 
transcriptome data resulted in an annotated reference set of Salmonella-responsive 
genes in zebrafish embryos, including those homologous to human immune-related 
genes as well as many known or novel genes not previously linked to the immune 
response. Furthermore, comparison of the deep sequencing data of Salmonella in-
fection in zebrafish embryos with previous deep sequencing data of Mycobacterium 
infection in adult zebrafish (Hegedus et al., 2009), defined a common set of innate 
host defense genes that are expressed both in the absence and presence of a fully 
developed adaptive immune system.
For deep sequencing analysis we chose S. typhimurium infected 1-day-old 
zebrafish embryos at 8 hpi, which time point was based on the strong induc-
tion of inflammatory genes that we detected in our previous microarray analysis 
(Stockhammer et al., 2009). Furthermore, we previously showed that induction of 
inflammatory genes such as il1b and mmp9 relied on MyD88-dependent signaling 
indicated in grey. (B) Annotation of the overlap group of up-regulated genes in the different infec-
tion studies. Genes were grouped into 5 categories as in Figure 4. The number of genes in each 
category is indicated in the pie diagram and the corresponding genes are ordered by functional 
groups. Genes up-regulated by Salmonella and Mycobacterium infection (206 genes) are indicated 
in black, and genes down-regulated by both infections (2 genes) are indicated in blue. Gene de-
scriptions and accession numbers are given in Supplementary Table 2.
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at this time point (Stockhammer et al., 2009). Consistent with the microarray re-
sults, more up-regulated than down-regulated transcripts were detected by Tag-Seq 
and RNA-Seq deep sequencing. However, for reasons currently unknown, the per-
centage of down-regulated transcripts was lower in Tag-Seq (3%) than in RNA-Seq 
(17%) and microarray analysis (26 %). Gene ontology analysis of the up-regulated 
gene sets of all three transcriptome analysis methods showed enrichment of the GO-
term response to stimulus. Although less than 20% of the genes previously found to 
be up-regulated in microarray analysis could be confirmed by deep sequencing, a 
commonly responsive set of 165 transcripts could be defined encoding transcription 
factors, signal transduction proteins, cytokines and chemokines, complement fac-
tors, proteins involved in apoptosis and proteolysis, and proteins with anti-microbial 
activities. The overlap between Tag-Seq and RNA-Seq was slightly higher (241 tran-
scripts) and confirmed the differential expression of these gene groups. The total 
overlap between the different transcriptome profiling methods might seem limited. 
As previously discussed (Hegedus et al., 2009; t Hoen et al., 2008), this can be at-
tributed not only to technical differences, but also to differences in data processing 
and statistical evaluation, or to differences between the methods in discriminating 
between expression of different transcript isoforms. Importantly, the Tag-Seq and 
RNA-Seq data sets contained many differentially expressed transcripts that were not 
included in the microarray platform, and these data sets are therefore highly useful 
to extend and improve the microarray design. 
In this study we only analyzed sequence reads mapping to UniGene, RefSeq or 
Ensembl transcript databases. However, about one third of the significant Tag-Seq 
reads did not map to transcript databases. Similarly, transcript mapping failed for 
one third of the RNA-Seq reads, even when one mismatch was allowed. While poly-
morphisms and reads extending over intron boundaries may at least partly account 
for mapping failures, these observations suggests that a large set of infection-respon-
sive genes is still unknown, which can be of great interest for further studies.
We have previously shown that Tag-Seq data can be used to detect selective in-
duction or repression of different transcript isoforms generated by alternative splic-
ing, alternative polyadenylation or alternative transcription initiation (Hegedus et al., 
2009). Such events may be detected when different tags for the same transcript show 
significant changes in opposite directions. In the present study we did not exploit 
this aspect of the deep sequencing technique, since our main objective was to define 
a robust marker set of inflammatory genes as a reference for infection studies in the 
zebrafish embryo model. For this reason, we focused specifically on those transcripts 
whose corresponding tags consistently changed in the same direction and developed 
the Cumulative Transcript Detection Index (CTDI). This index reflects the accu-
mulated information from all tags that map to the same transcript, giving increased 
weight to tags with higher significance in statistical testing. The CTDI calculation 
proved useful for the comparison of Tag-Seq with microarray and RNA-Seq and 
increased the overlap between the data sets by approximately 30% in both cases as 
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compared to the use of the conventional Bayesian statistical evaluation method for 
the analysis of tag sequence data (Lash et al., 2000). 
Previous studies (Mortazavi et al., 2008; t Hoen et al., 2008) have estimated that 
RNA-Seq analysis requires in the order of 10-fold more sequence reads for accurate 
quantification of expression differences between samples. Here, for the first time, a 
comparative Tag-Seq and RNA-Seq analysis of the host response to infection was 
performed. We found that 10 million Tag-Seq reads and 15 million RNA-Seq reads 
were both sufficient to detect around 1000 differentially expressed Ensembl tran-
scripts during infection based on Bayesian statistical evaluation (Lash et al., 2000). 
Furthermore, Pearson correlation coefficients (>0.8) showed a linear relationship 
between the sequence read counts per Ensembl transcript in Tag-Seq and RNA-Seq, 
indicating the comparable performance of both methods in quantifying the tran-
scriptome response to infection. Clearly RNA-Seq data have proved superior to Tag-
Seq data for unraveling transcriptional landscapes (Wang et al., 2009). An advantage 
of Tag-Seq as compared to the RNA-Seq method used here, is that it allows discrimi-
nation between the expression of sense and antisense transcripts, which is of interest 
in view of the increasing evidence for the widespread occurrence and biological rel-
evance of antisense transcription (Beiter et al., 2009; Carninci et al., 2005; Katayama 
et al., 2005). A substantial proportion of the differentially expressed sequence tags 
(10%) mapped to the antisense strands of known or predicted transcripts; however, 
this was much lower than previously observed in Tag-Seq analysis of M. marinum 
infection in adult zebrafish (40%; Hegedus et al., 2009).
Similar to S. typhimurium infection of zebrafish embryos, the end stage of M. 
marinum infection of adult zebrafish is also associated with a strong inflammatory 
response (Meijer et al., 2005; van der Sar et al., 2009). The similarity between these 
inflammatory responses at the level of gene expression was demonstrated here by an 
overlap of 206 up-regulated genes between the Tag-Seq data of S. typhimurium in-
fection and the previously reported Tag-Seq data of M. marinum infection (Hegedus 
et al., 2009). This common set of infection-responsive genes included transcription 
factors and signaling components involved in the innate host defense, as well as 
genes not previously linked to the immune response of interest for further study in 
zebrafish models. The transcriptome data of both infection models provide a valu-
able reference for future studies of host-pathogen interactions in zebrafish.
Materials and methods
DGE (Tag-Seq) library construction and sequencing
The RNA samples for DGE analysis were identical to those used in Stockhammer 
et al., 2009. In brief, zebrafish embryos were infected with Salmonella typhimurium 
(strain SL1027) by microinjection of DsRED-labeled bacteria into the caudal vein 
close to the urogenital opening after the onset of blood circulation (27 hpf). An equal 
volume of PBS was injected in the control group. RNA samples were collected at 8 
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hours post infection (hpi) and samples from triplicate infection experiments were 
pooled. DGE libraries from the RNA pools (1 μg) of Salmonella-infected and con-
trol embryos were prepared using the DGE:Tag Profiling for NlaIII Sample Prep kit 
from Illumina as previously described (Hegedus et al., 2009). The libraries were se-
quenced in duplicate using 2 and 3 pmol of cDNA. Sequencing was performed using 
the Illumina Genome Analyzer II System (BaseClear B.V., Leiden, The Netherlands) 
according to the manufacturer’s protocols. Image analysis, base calling, extraction of 
17 bp tags and tag counting were performed using the Illumina pipeline. Tag counts 
from duplicate libraries were merged in silico.
RNA-Seq library construction and sequencing
Samples used for full RNA sequencing were the infected and uninfected con-
trol groups from a morpholino knock-down study to be reported elsewhere 
(Stockhammer et al., unpublished results). The procedure of S. typhimurium infec-
tion and the time-point of analysis (8 hpi) were identical as for the DGE analysis and 
previous microarray study (Stockhammer et al., 2009). Total RNA was isolated using 
the Qiagen miRNeasy kit according to the manufacturer’s instructions (QIAGEN 
GmbH, Hilden). RNA-Seq libraries were made from 4 µg of each sample, using the 
Illumina mRNA-Seq Sample Preparation Kit according to the manufacturer’s in-
structions (Illumina, Inc. San Diego). An amount of 4 pmol of each library was se-
quenced in one lane with a read length of 51 nt using the Illumina Genome Analyzer 
II System (BaseClear B.V., Leiden, the Netherlands). 
DGE (Tag-Seq) data analysis
Mapping of tag sequences to transcript databases or to the zebrafish genome was 
performed as previously described (Hegedus et al., 2009). For transcript mapping 
we used the Ensembl Danio rerio Zv8.55 database, the RefSeq database (2009-09-14), 
and the Danio rerio UniGene build 105 and 117 databases. For comparison of Tag-Seq 
and RNA-Seq data the Ensembl transcript database derived from the latest version 
of the zebrafish genome was used. For comparison of Tag-Seq and microarray data 
we used the UniGene build 105 database, since this database was used in previous 
microarray analysis (Stockhammer et al., 2009). For genomic mapping the native 
and masked form of the zebrafish genome version Zv8 were downloaded from the 
FTP server of the Ensembl database. Statistical comparison of DGE/Tag-Seq data 
from Salmonella-infected and control embryos was performed using the Bayesian 
method described by Lash et al. (2000) with the software tool available from the 
SAGEmap resource (Lash et al., 2000). Briefly, the method performs a key-by-key 
comparison of two key-count distributions by generating a probability that the fre-
quency of any key in the distribution differs by more than a given fold factor from the 
other distribution. For two Tag-Seq libraries, the algorithm performs a differential, 
tag-by-tag count comparison, with correction for the total size of the library. In our 
analysis we used a 2-fold factor difference of transcript expression level as the subject 
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of the Bayesian statistical evaluation. The algorithm returns a probability value (P) 
for each tag describing the chance that the detected count numbers represent a fold 
difference of the tag concentration between the investigated samples greater than or 
equal to 2. The change of a tag expression was accepted as significant if P was above 
0.95. As an alternative means to evaluate differential expression in Tag-Seq datasets 
we developed the Cumulative Transcript Detection Index (CTDI), which accumu-
lates data from all tags that map to the same transcript: 
where:  n is the number of the detected tag entities in a transcript
 P is the significance of tags (Lash et al., 2000)
 D is the coefficient for the direction of change (1 for increase or -1 for de 
 crease).
In the CTDI calculation P2 is used for giving increased weight for tags with higher 
significance, while the formula gives lower weight to those transcripts where tags 
are present that show changes in the opposite direction. In other words, the CTDI 
measure reflects the extent of experimental confidence regarding the direction of the 
transcript expression change after infection. CTDI values were calculated separately 
for tags mapping to the sense strand (sCTDI) and the antisense strands (asCTDI) of 
transcripts in the database. All transcripts represented by minimally one tag with a 
significant expression change based on statistical evaluation according to Lash et al. 
(2000) have an absolute CTDI value larger than 0.95. For comparison with microar-
ray data we considered all transcripts with an absolute sCTDI value larger than 0.95 
and P larger than 0.8 for at least one of the tags in the CTDI calculation.
RNA-Seq data analysis
Sequence reads were mapped to Ensembl transcripts (Zv8.55) using the CLCbio 
Genomics Workbench version 3.6.5 (www.clcbio.com). RPKM values (read counts 
corrected for library size and transcript length) were calculated according to 
Mortazavi et al. (2008). Differential expression between control and infected samples 
was calculated based on total read counts per transcript using the method of Lash et 
al. (2000) as described above under Tag-Seq analysis.
Gene annotation
Gene Ontology (GO) analysis of significantly expressed Salmonella-responsive 
genes was performed using the GeneTools eGOn v2.0 web-based gene ontology 
analysis software (www.genetools.microarray.ntnu.no) at the level of the UniGene 














of Tag-Seq, microarray and RNA-Seq datasets were functionally annotated using the 
National Center for Biotechnology Information (NCBI) Gene Ontology Annotation 
(GOA), Entrez Gene, and HomoloGene databases and the AmiGO (http://amigo.ge-
neontology.org/cgi-bin/amigo/go.cgi) gene ontology database. Human homologues 
of zebrafish genes were identified by Ensembl’s BioMart data mining tool (http://
www.ensembl.org/biomart/martview/) and using the NCBI HomoloGene database. 
The previous implication of genes in the vertebrate immune response was based on 
the GO data of the zebrafish genes and their human homologues supplemented by 
PubMed abstract searches and on overlap with the common host response gene list 
defined by Jenner and Young (Jenner and Young, 2005).
Supplementary data 
Supplementary data associated with this chapter can be found at http://apo.
szbk.u-szeged.hu/transfer/A_ORDAS/.
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MicroRNAs (miRNAs) are a class of small non-coding RNAs that play important 
roles in controlling mRNA stability and translation. Several miRNAs have been im-
plicated in development and function of the immune system and their aberrant ex-
pression has been linked to pathogenesis of human diseases. Recently, zebrafish infec-
tion models have been developed to study the vertebrate immune system. Signaling 
pathways of the immune response were found to be conserved between human and 
zebrafish, but the interaction between miRNAs and the zebrafish immune system 
has not yet been addressed. Here, we used a custom-designed microarray platform 
to evaluate miRNA expression in zebrafish infection models. By infection studies 
with two pathogens, Mycobacterium marinum and Salmonella typhimurium, mod-
eling human tuberculosis and salmonellosis, respectively, we identified a set of com-
mon infection-responsive miRNAs, including members of the miR-21, miR-146 and 
miR-181 families, previously linked to immunity and cancer in human and mamma-
lian models. The context of innate immunity was sufficient for the infection response 
of these miRNAs, as their differential expression occurred not only in adult fish but 
also in embryos prior to development of adaptive immunity. We also determined 
that predicted target genes of the strongly infection-inducible miR-146 family are 
conserved between human and zebrafish. These include key signaling intermediates 
of the TLR pathway that is pivotal for pathogen recognition and activation of the 
innate immune response, suggesting a miR-146-mediated feed back mechanism to 
properly control the inflammatory response. Together, our results uncovered overlap 
in human and zebrafish immune-related miRNAs as well as miRNA target genes, 
indicating the usefulness of zebrafish infection models to increase our knowledge of 
miRNA functions in the vertebrate immune system. 
Introduction
The discovery of microRNAs (miRNA) has added a new level of complexity to 
how biological processes are controlled. MicroRNAs are small non-coding single 
stranded RNAs with a length of 19-25/21-25 nucleotides (nt) that control gene expres-
sion by regulating mRNA stability and translation in a unique tissue-specific, de-
velopmental stage-specific and disease-specific manner (Schmidt et al., 2009). They 
are involved in the regulation of variety of biological processes, including cell cycle, 
differentiation, development, metabolism and disease pathogenesis (Sonkoly and 
Pivarcsi, 2009). MiRNA genes are evolutionarily conserved and located in introns 
and exons of protein-coding genes and non-coding regions of the genome. They 
are transcribed mostly by RNA polymerase II into several kilobases long, double-
stranded primary transcripts (pri-miRNA). Pri-miRNA is subsequently cleaved in 
the nucleus by the Drosha /DGCR8 complex into one or more ~ 70 nt-long pre-
cursor miRNA strands (pre-miRNA). Pre-miRNA is exported to the cytoplasm by 
MicroRNA expression during bacterial infections in zebrafish
79
exportin-5, where it is bound to RNase Dicer and to the RNA-induced silencing 
complex (RISC) and processed into a mature miRNA molecule. Only the active or 
mature strand is retained in the RISC complex, the passenger strand is removed and 
degraded. However, in some cases both strands of the miRNA duplex (the primary 
miRNA and its star sequence) are incorporated in the RISC complex with similar ef-
ficiency. In animals, the mature miRNAs usually bind to complementary sequences 
in the 3’ untranslated region of target mRNAs, particularly with their seed sequences 
(nucleotide 2-8 from the 5’ end). This results in repression of gene expression by 
translational inhibition and mRNA degradation. Under certain conditions miRNAs 
can also induce the translation of target mRNAs (Vasudevan et al., 2007) or tran-
scriptionally silence gene expression (Kim et al., 2008). The physiological impact of 
this is still unknown. MiRNA biogenesis is controlled by extensive transcriptional 
and post-transcriptional regulation.
Proteins in miRNA biogenesis as well as several miRNAs have been implicated 
in the immune system, both in the process of haematopoiesis and in the function of 
haematopoietic cell lineages. The miR-17~92 cluster has been shown to be a ubiqui-
tous regulator of B-cell, T-cell and monocyte development. MiR-142 was shown to 
be a regulator of T cell development, miR-150 has been implicated in B cell differ-
entiation, miR-155 was shown to be involved in T- and B-cell maturation, miR-181a 
in B-cell differentiation and CD4+ T-cell selection, activation and sensitivity, and 
miR-223 is specifically expressed cells of the granulocytic lineage (Baltimore et al., 
2008; Carissimi et al., 2009; Lindsay, 2008; Lu and Liston, 2009; Sonkoly et al., 2008; 
Taganov et al., 2006; Xiao et al., 2007).
MiRNAs have not only been linked to development of immune cells but also to 
the process of infection or inflammation. There is increasing evidence that they have 
important roles in regulating innate immune responses, the first line of defence to 
bacteria, viruses, and other pathogens. As part of the first immune response, mono-
cytes and macrophages recognize microbial ligands with their pattern recognition 
receptors, of which the Toll-like receptors (TLRs) form one of the major families. 
Due to activation of the downstream signaling pathways hundreds of genes are in-
duced to defeat the pathogen. Several miRNAs are induced or repressed during bac-
terial and viral infections. After exposure of (human or mouse) monocytes to bacte-
rial lipopolysaccharide (LPS) miR-132, miR-146, and miR-155 showed significant up-
regulation (O’Connell et al., 2007; Taganov et al., 2006; Tili et al., 2007). In addition, 
miR-146 is also induced by proinflammatory stimuli, including interleukin-1 (IL-1) 
and tumor necrosis factor (TNF), in a NF-κB-dependent manner, and miR-155 was 
found to be stimulated by interferon (IFN) or TNF (O’Connell et al., 2007; Taganov 
et al., 2006). MiR-146 and miR-155 might be components of negative feedback loops 
attenuating TLR signaling pathways, where miR-146 limits IL-1 receptor-associated 
kinase 1 (IRAK1) and TNF receptor-associated factor 6 (TRAF6) expression, and 
miR-155 suppresses FADD, RIP and IKK (Pedersen and David, 2008). In contrast, 
miR-125b, which targets TNF mRNA, is down-regulated following LPS-induced TLR 
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signaling, thereby stimulating the production of TNF (Pedersen and David, 2008; 
Tili et al., 2007). There is also evidence that miRNAs play role in viral infections 
either by contributing to the antiviral defence or facilitating the replication of the 
pathogen. 
As miRNAs regulate the normal development and function of the immune sys-
tem, their aberrant expression have been suggested to be involved in pathogenesis 
of diseases. A large number of recent studies demonstrated deregulated miRNAs 
in immune-related disorders like inflammatory or autoimmune diseases. In inflam-
matory diseases such as psoriasis and atopic eczema, miR-146 and miR-125b were 
found to be deregulated (Carissimi et al., 2009). In rheumatoid arthritis miR-146 
and miR-155 are commonly up-regulated. (Nakasa et al., 2008; Stanczyk et al., 2008). 
Many other miRNAs (miR-17~92, miR-21, miR-129, miR-203, miR-451 etc) have 
been detected in other types of immune-related disorders supporting the fact that 
these miRNAs play critical role in inflammation (Carissimi et al., 2009; Sonkoly and 
Pivarcsi, 2009). Since the immune system is tightly connected with cancer, not sur-
prisingly the expression of many of the immunity-related miRNAs is also changed in 
a variety of tumors (Bhaumik et al., 2008; Costinean et al., 2006; Esquela-Kerscher 
and Slack, 2006; Garzon et al., 2009; Hurst et al., 2009; Lu et al., 2005; Medina and 
Slack, 2008).
Although many recent studies have contributed to the discovery of novel miR-
NAs and have aimed to shed light on their role in gene expression, only a limited 
number of the mRNA targets of miRNAs have been experimentally validated and 
the contribution of miRNA regulation to the pathogenesis of human diseases is far 
from understood. As miRNAs are highly evolutionary conserved across vertebrates, 
studies using different model organisms can provide valuable information about 
their functions in development of human diseases. In the last decade, zebrafish, 
which has an innate and adaptive immune system similar to that of mammals, has 
been commonly applied as model system for immunological research (Traver et al., 
2003; van der Sar et al., 2004). Zebrafish models have been developed for different 
infections, including Mycobacterium marinum infection as a model for tuberculo-
sis and Salmonella typhimurium infection as a model for food poisoning (Davis et 
al., 2002; Meijer et al., 2004; Meijer et al., 2005; Stockhammer et al., 2009; van der 
Sar et al., 2003; van der Sar et al., 2009). Zebrafish is also a convenient model to 
study miRNA function and its miRNA family has been well described (Davis et al., 
2002; Kloosterman et al., 2007; Kloosterman et al., 2006; Schier and Giraldez, 2006; 
Wienholds et al., 2005). However, the functions of miRNAs in the immune system of 
zebrafish have not yet been addressed. 
Here, we have used a custom-designed microarray platform to evaluate miRNA 
expression in adult zebrafish and zebrafish larvae infected with different bacterial 
pathogens. Common microRNA induction profiles from different bacterial infec-
tions are assessed and compared to human miRNA expression profiles in the lit-
erature. We have focused on miR-146 family and their predicted target genes in the 
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TLR pathway, and have compared microRNA expression with previously published 
expression data of predicted target genes (Stockhammer et al., 2009; van der Sar 
et al., 2009). Our results show that there are infection-responsive miRNAs highly 
conserved between human and zebrafish and also that there is considerable overlap 
in miRNA target genes, indicating that the zebrafish can be a useful model to dissect 
functions of miRNAs in the vertebrate immune system. 
Results
Microarray analysis of microRNA profiles in response to infection
In order to study the effects of bacterial infection on microRNA (miRNA) expres-
sion profiles we used RNA samples from different infection experiments in adult 
and embryonal zebrafish that we had previously analyzed for gene expression differ-
ences (Stockhammer et al., 2009; van der Sar et al., 2009). Bacteria tested included 
Salmonella typhimurium, which causes a lethal infection in 1-day-old zebrafish em-
bryos (van der Sar et al., 2003) and Mycobacterium marinum strains Mma20 and 
E11, which respectively cause acute disease or chronic granulomatous tuberculosis 
in zebrafish adults (van der Sar et al., 2004) and also induce granuloma formation 
in zebrafish larvae (Davis et al., 2002). We analyzed samples from embryos injected 
into the blood at 27 hpf with S. typhimurium bacteria (Stockhammer et al., 2009). 
In addition, embryos at 48 hpf were infected with M. marinum E11 using a novel 
infection system, in which bacterial suspensions with polyvinylpyrrolidone (PVP) 
as a carrier are injected into the yolk sac (Spaink et al., unpublished results). For 
comparison a non-pathogenic bacterium Lactobacillus casei Shirota was used in the 
yolk infection system and the effect of PVP carrier was determined as a control. In 
adult infection experiments, M. marinum strains Mma20 and E11 were injected into 
the intraperitoneal cavity. Details of the experimental set-up of the embryonic and 
adult infection studies are shown in Fig. 1.
To quantify microRNA gene expression profiles we used a custom-designed 8x15k 
Agilent zebrafish array. In the infection experiments with embryos, the total number 
of probes that showed more than 1.5-fold induction or repression of the expression 
level (P < 1.00E−4) was highest for the M. marinum E11 yolk-infected embryos (Fig. 
2A). The number of differentially expressed probes was 8 times lower when similar 
doses of non-pathogenic L. casei Shirota were injected into the yolk and 18 times 
lower in control injections with PVP carrier. Similarly, the number of differentially 
expressed probes was 10 times lower in S. typhimurium caudal vein infections than 
in M. marinum E11 yolk-infected embryos. The numbers of differentially expressed 
probes in adult infection experiments with M. marinum were in a similar range as in 
the M. marinum E11 yolk-infected embryos (Fig.2A). Comparing the two M. mari-
num strains, a higher number of probes were differently expressed in infections with 
the Mma20 strain that causes acute disease than in the case of the E11 strain that 
causes chronic disease. For both strains, at 1 dpi 1.5 to 2-fold more probes were up-
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regulated than down-regulated, while at 6dpi experiments 3 to 4 times more probes 
were down-regulated than up-regulated. 
Annotation of differentially expressed microRNAs
The custom-designed microarray platform contained probes for both known 
and predicted miRNAs, the latter classified into three categories: C1 - novel confi-
dent miRNAs for which there is compelling experimental evidence, C2 - candidate 
miRNAs with clear hairpin structure but less experimental evidence, and C3 - ad-
ditional hairpins identified in the zebrafish genome sequence that are less likely to 
be miRNAs. The distribution of differentially expressed probes over the known and 
predicted miRNA categories in the different embryonal and adult infection experi-
ments is shown in Fig. 2B. The total number of known miRNAs regulated during 
infection was highest for the M. marinum yolk infections in embryos (181 out of a 
total of 496 probes), much lower for the other embryonal infections (13-20 probes), 
Figure 1. Overview of the infection experiments. (A) For infection of embryos with S. typhimu-
rium, bacteria were microinjected into the caudal vein close to the urogenital opening after the 
onset of blood circulation (27 hpf ). An equal volume of PBS was likewise injected for the control 
group (Stockhammer et al., 2009). RNA samples for transcriptome analysis were collected at 8 hours 
post infection (hpi). For yolk infection experiments, embryos were staged at 48 hpf and M. mari-
num E11 bacteria were injected in PVP suspension. For comparison a non-pathogenic bacterium 
Lactobacillus casei Shirota was injected in PVP suspension at similar concentrations as used for M. 
marinum. As controls PVP-injected and uninjected embryos were employed. For gene expression 
analysis we extracted RNA samples at 3 days post infection (dpi). (B) In adult infection experiments, 
M. marinum strains Mma20 and E11 were injected into the intraperitoneal cavity of male zebrafish 
and PBS-injected males were used as a control. For microarray analysis we collected RNA samples 
from two time points, 1 and 6 days post infection (dpi).
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and intermediate for the adult M. marinum infections (39-82 probes). Furthermore, 
in the M. marinum yolk-infected embryos a particularly high number of known 
miRNAs fell into the down-regulated category (158) compared with the other infec-
tions. In comparison with the known miRNAs, the number of predicted miRNAs 
Figure 2. Differentially expressed miRNA probes in adult and embryonal infections. (A) Total 
number of up-regulated and down-regulated probes. (B) Number of up-regulated and down-re-
gulated probes in four annotation categories: known miRNAs, and predicted miRNAs, C1, C2, and 
C3, with decreasing level of confidence as further detailed in the text. The total number of probes 
on the array per category is: 546 probes in known, 62 probes in C1, 54 probes in C2 and 6942 probes 
in C3 category. Embryonal infections were performed by injection of S. typhimurium (St) into the 
caudal vein at 27 hpf or by yolk injection of M. marinum (E11) or L. casei Shirota (LcS) at 48 hpf. PVP is 
the carrier control for yolk injections. Adult infections were performed with M. marinum strains E11 
(E11 1dpi, E11 6dpi) and Mma20 (Mma20 1dpi, Mma20 6dpi). For further details of the experimental 
set-up of the infection studies see Figure1.
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(total of the C1-C3 categories) that showed differential expression in the infection 
experiments was between 3 and 20-fold higher. In particular, in all M. marinum 
embryo or adult infections the number of differentially expressed probes in the C3 
category was very high (ranging between 388 and 913 out of a total of 5912 probes). In 
the much smaller C1 and C2 categories (consisting of 24 and 18 probes, respectively), 
the highest number of changes was observed in the M. marinum embryo infection 
(C1 12 probes, C2 6 probes). In the adult infection experiments with the M. marinum 
E11 and Mma20 strains, C3 probes were mostly up-regulated at 1dpi, and down-regu-
lated at 6dpi. In contrast, the known miRNAs were more frequently down-regulated 
at 1dpi and up-regulated at 6dpi. 
Common microRNA induction profiles between different bacterial infections
To further analyze the common response to different bacterial infections, we per-
formed a two-dimensional hierarchical cluster analysis. To limit the complexity of 
Figure 3. Hierarchical cluster analysis of differentially expressed miRNA probes in adult and 
embryonic infection experiments. A) The set of significantly up- and down-regulated known 
miRNAs, C1, and C2 category probes were analyzed together by one-dimensional hierarchical 
cluster analysis using MultiExperiment Viewer with settings for average linkage method with 
Euclidean distance. Induced genes are indicated by increasingly brighter shades of yellow, and 
down-regulated genes are indicated by increasingly brighter shades of blue. Eight clusters were 
defined in this set of probes named 1-8. Clusters containing less than 3 miRNAs were excluded. B) 
Cluster analysis of significantly up- and down-regulated C3 category probes.
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Figure 4. Venn diagrams showing the overlap between differentially expressed miRNA 
probes in adult and embryonic infection experiments. Orange - total number of overlapping 
probes; yellow - overlapping probes showing up-regulation in both groups; blue - overlapping 
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the cluster analysis we included only those probes that were differentially expressed 
in two or more infection experiments. We divided the probes into two main groups 
for which we performed separate cluster analysis (Fig. 3A,B). In the first set we com-
bined the probes for known miRNAs and probes for miRNAs in the small C1 and C2 
categories that include candidate miRNAs supported by experimental evidence. In 
the second set only C3 category probes that are less likely to represent miRNAs were 
evaluated. The cluster analysis of the C3 probes showed that in adult infection with 
the M. marinum E11 and Mma20 strains at 1 dpi a largely overlapping set of probes 
was up-regulated (Fig. 3B). In addition, the large numbers of down-regulated C3 
probes observed with both strains at 6 dpi was also largely overlapping. For further 
analysis we concentrated on the set with known miRNAs and C1 and C2 predicted 
miRNAs. The clustering pattern of this probe set was notably different from that 
of the C3 probe set, with much less overlap between the M. marinum adult infec-
tion samples. We could distinguish eight major clusters of probes showing different 
trends in expression over the embryonal and adult infection experiments (Fig. 3A). 
MiRNAs in cluster 1 exhibited significant changes in several adult infection samples 
but not in embryonal infections. In contrast, miRNAs in clusters 2 and 3 were com-
monly induced in several samples of both adult and embryonal infections. Cluster 
4 includes a non-specifically regulated group of miRNAs that was down-regulated 
in embryonic yolk injections with M. marinum but also by the PVP carrier used for 
these infections. In cluster 5, miRNAs are commonly down-regulated in M. mari-
num Mma20 infection of adults (1 dpi) and in M. marinum E11 embryonal yolk in-
fection. Cluster 6 miRNAs were up-regulated at 6 dpi in adult M. marinum infection 
(Mma20 or E11 strains or both), but not in the embryonal M. marinum E11 infection. 
In cluster 7 miRNAs were commonly decreased in adult (1 dpi) and embryonal M. 
marinum infections, while cluster 8 miRNAs were commonly down-regulated in 
adult M. marinum infections at 6 dpi but not in embryonal infection. 
In addition to the cluster analysis, we used Venn diagrams to show the common 
responsive miRNAs in different infection experiments. As shown in Fig.4A, in the 
M. marinum adult infections several tens of regulated miRNAs were overlapping 
probes showing down-regulation in both groups; green - overlapping probes showing regulation 
in opposite directions. Only the probes in the category of known miRNAs are denominated in the 
colored boxes below the Venn diagrams. Probes correspond to the left (l) or right (r) arms of the 
pre-miRNA hairpin structure. A) Comparison of differentially expressed known miRNAs, C1, and C2 
category probes in adult infections with the Mma20 and E11 strains. The Venn diagrams show the 
overlap in responsive miRNAs between the strains and at the two time points of analysis (1 and 6 
dpi). B) Comparison of known miRNA, C1, and C2 category probe expression patterns in adult (1dpi 
and 6 dpi combined) and embryonal M. marinum E11 infection experiments. Numbers in yellow/
blue/green boxes do not add up to 46 due to the fact that miRNAs can be changed in different 
directions at the 1dpi and 6 dpi time points. C) Comparison of known miRNAs, C1, and C2 category 
probes in embryonal infections with M. marinum E11, S. typhimurium and L. casei Shirota.
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between the E11 and Mma20 strains and between the 1dpi and 6dpi time points. 
However, regulation of other miRNAs appeared to be strain or time point dependent. 
For example, miR-15a and miR-363 were up-regulated by E11 at 1 dpi and down-regu-
lated by E11 at 6dpi, but were not regulated by Mma20 at both time-points. Similarly, 
miR-203b and miR-29a were not regulated by Mma20, but down-regulated by E11 at 
1dpi and up-regulated at 6 dpi. On the other hand, miR-146b* (146b-1-r), miR-20b, 
miR-21 (miR-21-2-r), miR-217, miR-29b, miR-365, miR-489, miR-727, miR-728, and 
miR-730 were regulated by Mma20 at both time points but not by E11 at both time 
points. We also found miRNAs that changed in the opposite direction at 1 and 6 dpi 
time points in infections with both the E11 and Mma20 strains, such as miR-181c 
(down at 1 dpi, up at 6 dpi) and miR-461 (up at 1 dpi, down at 6 dpi). In addition, we 
identified that 46 known or C1/C2 category miRNAs were commonly regulated in 
adult and embryonal M. marinum E11 infections, of which 2 were up-regulated in the 
same direction, and 27 down-regulated in the same direction (Fig.4B). Comparison 
of all embryonal infection experiments showed that miR-21, miR-146a, and miR-
146b were commonly up-regulated by the pathogenic M. marinum and S. typhimu-
rium bacteria as well as by the non-pathogenic L. casei Shirota bacteria (Fig.4C). In 
conclusion, we observed common aspects in the response of miRNAs to different 
bacterial infections as well as differences related to the bacterial species or strains, 
the time points of analysis, and the adult or embryonal stage of the zebrafish host.
Functions and disease associations of commonly infection responsive 
miRNAs 
To further narrow down the list of miRNAs that are commonly responsive to 
bacterial infections in zebrafish we took those miRNAs that occurred in more than 
four infection experiments. These miRNAs include miR-20b, miR-21, miR-128, miR-
146a, miR-146b, miR-152, miR-181a, miR-181c, miR-461, miR-728, miR-730 and two 
predicted miRNAs in the C1 category (Table 1). We searched the literature for data on 
the function of the known miRNAs and their association to diseases in human and 
in mammalian animal models (Table 1). Reviewing the literature revealed that these 
miRNAs are involved in several processes related to the immune response, such as 
immune cell development, regulation of innate immunity, cytokine regulation, and 
inflammation. The miR-146 family, whose members miR-146a and miR-146b we find 
commonly up-regulated in infections of zebrafish, has previously been shown to af-
fect the TLR signaling pathway that is involved in the innate immune response to 
bacterial infection (Taganov et al., 2006; Williams et al., 2008). Down-regulation 
of miR-181 family members, which we observed in four infection experiments, has 
been shown to contribute to an aggressive leukemia phenotype through mechanisms 
associated with the activation of innate immunity pathways mediated by TLRs and 
interleukin-1beta. The involvement of miR-181 in T-cell development has also been 
demonstrated (Chen et al., 2004; Larson, 2009). The interleukin-12 p35 subunit gene 
is a demonstrated target of the miR-21 family (Lu et al., 2009), whose members were 
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Figure 5. Members of the miR-146 family in human and zebrafish and their target sites in 
zebrafish TLR and IL-1R pathway genes. A) Sequence alignment of the members of the human 
(hsa) and zebrafish (dre) miR-146 family. Nucleotide differences with the dre-miR-146b/b* sequenc-
es are indicated in red. B) Confirmation of the presence of miR-146a/b target sites in the 3’UTR of 
the zebrafish irak1 gene. A target site for miR-146a and miR-146b is located in the Zv8 genomic 
sequence between nucleotides 255-276 downstream of the stop codon of the irak1 transcript. To 
check if this target site is included the 3’UTR of the irak1 transcript RT-PCR was performed on RNA 
from S. typhimurium-infected embryos. RT-PCR reactions were performed with (+RT) and without 
(-RT) the reverse transcription step to verify that genomic DNA contamination was removed. With 
inclusion of the RT step a 316 bp fragment was amplified that includes the miR-146a/b target site. 
C) Alignments of predicted target sites of zebrafish miR-146a and b in TLR and IL-1R pathway genes, 
traf6 (NM_199821), myd88 (NM_212814) and irak1 (Zv8 genome). We compared target sites of myd88 
transcript NM_212814 from the RefSeq database and the myd88 transcript from the Ensembl da-
tabase (ENSDART00000011143) where we detected a SNP (G > A polymorphism, indicated in red) 
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up-regulated in four zebrafish infections and down-regulated in one. MiR-152 has 
also been implicated in the immune system (Hiroki et al., 2009; Kannan et al., 2009; 
Lehmann et al., 2008). Furthermore, in previous studies most of the commonly in-
fection responsive miRNAs (miR-20b, miR-21, miR-128, miR-146b, miR-152, miR-
181a, miR-181c) have been implicated in various processes related to the development 
of cancer, such as apoptosis, proliferation, invasion, metastasis, and cell motility. 
Aberrant expression of these miRNAs has been detected in different types of cancer, 
including breast, liver, lung, and colon cancer, and leukemia (Table 1). Considering 
the common expression characteristics in adult and embryonal zebrafish infection 
experiments and the clear link with the immune response in human and other ani-
mal models, we focused our further analyses on family members of miR-146.
Targeting of the TLR and IL-1R pathways by the miR-146 family in human and 
zebrafish
MiR-146 was one of the most consistently induced miRNAs in our infection stud-
ies in zebrafish and has previously been linked to innate immune response in mam-
malian systems (Hou et al., 2009; Perry et al., 2009; Taganov et al., 2006). In human, 
the miR-146 family members are derived from two genes, MIR146A and MIR146B, 
located on chromosomes 5 and 10, respectively. The miRNAs processed from the left 
arm of the stem loop precursor miRNAs, miR-146a and miR-146b-5p, differ in their 
mature sequence only by two nucleotides at the 3’ end (Taganov et al., 2007). In addi-
tion, mature miRNAs, miR-146a* and miR-146b-3p, are also processed from the right 
arm of the precursor miRNAs. Recently, it has been reported that there is a rapid 
increase in miR-146a and miR-146b expression in immune cells following activation 
of members of the TLR and IL-1 receptor families, activated by microbial ligands and 
pro-inflammatory cytokines, respectively. The induction of most TLR pathways and 
IL-1 signaling is initiated by the recruitment of adaptor protein MyD88 to the recep-
tor. MyD88 transmits the signal to IL-1 receptor associated kinase 1 (IRAK1) that then 
recruits TNF receptor-associated factor 6 (TRAF6) into the complex. This activates 
IKB kinase and JNK and, in turn, the downstream NF-κB and AP-1 transcription 
factors and results in up-regulation of several hundreds of immune-responsive genes. 
IRAK1 and TRAF6 have been shown to represent potential targets of the miR-146 
family, and overexpression of miR-146a and b resulted in down-regulation of IRAK1 
and/or TRAF6 (Taganov et al., 2006). It has also been shown that miR-146a expres-
sion is regulated via NF-KB and JNK-1/2, whilst miR-146b expression was mediated 
via MEK-1/2 and JNK-1/2 (Perry et al., 2009). Together, these data suggest a role for 
the miR-146 family in negative feed back regulation of the innate immune response. 
According to the data in miRBase (www.miRbase.org/) the zebrafish miR-146 fam-
that increases the complementarity with the miR-146a/b sequences. In all alignments the miR 
sequences are shown on top in the 3’ to 5’ direction. Free minimum energy values (FME) for the 
interactions are indicated next to the alignments.
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ily consists of two members, dre-miR-146a and dre-miR-146b, derived from genes 
located on chromosomes 13 and 21, respectively. Experimental evidence is indicat-
ed in miRBase only for mature miRNAs derived from the left stem loop precursor 
arms. However, in our microarray analysis we also detected differential expression 
of probes for miRNAs derived from the right stem loop precursor arms, which we 
named dre-miR-146a* and dre-miR-146b*. The alignment of mature sequences of 
human and zebrafish miR-146 family members is shown in Fig. 5A. 
To determine if the specificity of miR-146 members for the irak1 and traf6 genes 
in the TLR/IL-1R pathways might be conserved in zebrafish we used different target 
prediction programs. MiRanda prediction identified traf6 as a putative target of both 
miR-146a and b from zebrafish, however irak1 was not identified. We checked irak1 
mRNAs/ESTs in the database, but only few sequences were present, of which only 
two ESTs contained a very short 3’UTR. Upon inspection of the irak1 genomic se-
quence we identified two perfect miR-146 target sites present at nucleotide locations 
293-316 and 903-924 downstream of the irak1 stop codon. By reverse transcriptase 
PCR on RNA from S. typhimurium-infected zebrafish embryos we confirmed that 
the irak1 transcript contains a longer 3’UTR containing at least the first target site 
(Fig. 5B). MiRanda analysis predicted myd88 as a third gene in the TLR pathway that 
could be a potential target of zebrafish miR-146 a and b. However, it was not pre-
dicted for human miR-146. Interestingly, zebrafish myd88 is polymorphic for the pre-
Figure 6. Conservation of predicted targets of the miR-146 family. Target genes of miR-146 
family members in zebrafish (dre), human (hsa), mouse (mmu), rat (rno) and chicken (gga) were 
predicted using MicroCosm Targets. The predicted targets from zebrafish, mouse, rat, and chick-
en, were converted to human Ensembl Gene ID homologues and were compared across differ-
ent species. If the predicted targets had the same human homologues, then these targets were 
considered to be potentially conserved across these species. The numbers of overlapping targets 
between species are indicated in the table. B) Comparison of miR-146a and miR-146b predicted 
targets. The Venn diagram shows the overlap between the targets of miR-146a and miR-146b that 
were commonly predicted for human and zebrafish.




dicted target site, which contains a SNP (single nucleotide polymorphism) in the 5’ 
seed region that is most important for the miRNA interaction (Fig. 5C). Alignments 
of miR-146 a and b with their predicted target sites in all three TLR pathway genes, 
traf6, irak1, and myd88 are shown in Fig. 5C. 
To further investigate the conservation of miR-146 target sites in the myd88, irak1 
and traf6 genes we employed two target site prediction methods, RNAhybrid and 
TargetScan, in addition to miRanda, and also used an integration algorithm to rank 
these predictions (Table 2). This showed that miR-146 target sites in traf6 are in the 
top 2 raking for miR-146a and b from both human and zebrafish. MiR-146a and b 
target sites in zebrafish irak1 (containing the longer 3’UTR from genomic prediction) 
ranked in the top 2 and for human IRAK1 ranked on 8th and 23rd position using the 
integration algorithm. MiR-146 target sites in zebrafish myd88 were in the top 20, 
but for human MYD88 were predicted only by the RNAhybrid method and with low 
ranking. Target sites in the TLR pathway genes are also predicted for the miR-146 
star/3p sequences but with lower ranking.
Other predicted targets of the human and zebrafish miR-146 family
To predict further conserved targets we downloaded miRanda-predicted target 
gene lists of zebrafish (dre-miR-146a, -146b), human (hsa-miR-146a, -146a*,-146b-5p, 
-146b-3p), mouse (mmu-miR-146a, -146b, -146b*), rat (rno-miR-146a) and chicken 
(gga-miR-146a, -146b, -146b*) miR-146 family members from MicroCosm Targets 
(formerly known as miRBase Targets). To compare targets across different species, 
we converted the predicted targets from zebrafish, mouse, rat and chicken to the ho-
mologous human Ensembl Gene IDs and HGNC gene symbol (Fig. 6A). Among 701 
predicted target genes for miR-146a in zebrafish, we found 38 overlapping between 
zebrafish and human, of which 7 were also conserved in at least one other species 
(Fig. 6 and Table 3). For miR-146b, 27 out of 681 predicted target genes in zebrafish 
were overlapping with human, with 6 conserved in at least one other species (Fig. 
6 and Table 3). Next, we compared the results for miR-146a and b showing that 19 
genes were predicted to be commonly targeted by miR-146a and b in both human 
and zebrafish, 19 genes only targeted by miR-146a, and 10 genes only targeted by 
miR-146b (Fig. 6B). To this list of 48 genes we added those predicted targets that 
overlapped between zebrafish and at least two other species but not human (Table 3). 
This list of in total 64 genes was used for functional annotation and analysis of bio-
logical pathways (Table 3). These analyses revealed that most of the predicted targets 
in the list have immune related functions and were previously shown to be associated 
with immunological diseases or cancer. Genes were mostly classified into signaling 
in the immune system (ARHGAP17, COMMD7, HSPA1A, IRAK1, IRF5, LCK, PIAS2, 
TRAF6, TRPC1), haemostasis (FGB, MMP11), apoptosis (ARD1, ARSG, CTSB, DAXX, 
FAS), cell cycle signaling (CHEK1, PPP2R4, ASPM), gene expression (ARID3B, BCOR, 
FBXO8, IARS, POLR2A, PUM2, SMYD1, SNRPC, TGIF, YEATS4, ZNF143, ZNF326), 
and metabolic processes (AMARC, B3ALT2, GNE, NUDT4, PHKA1, POLQ, PTGES2, 
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TUBB2A), all pathways previously linked to immune functions. 
Comparison between miRNA expression and the expression of the predicted 
target genes 
Next we compared miR-146 expression with expression of predicted target genes 
from Table 3 under infection conditions. For comparison we took previously pub-
lished data from van der Sar et al. 2009, where the zebrafish host transcriptome 
response to M. marinum Mma20 and E11 was determined using the same samp-
les as for miRNA analysis in the present study. In addition, we used data from 
Stockhammer et al. 2009, where a time-course transcriptome profiling of the ze-
brafish embryonic innate immune response to salmonella infection was performed. 
We found that approximately half (35) of the predicted target genes in Table 3 showed 
significant (P<10-4) expression changes (up- or down-regulation) in either of these 
infection studies (Table 4). It is possible that the number of infection-responsive 
genes might still be higher since not all predicted target genes (13) were present on 
the microarray platform used in the expression studies. Responsiveness to both M. 
marinum and S. typhimurium infection was observed for 10 predicted target genes, 
17 were responsive only to M. marinum infection, 8 only to S. typhimurium infection, 
and 13 predicted target genes represented on the microarray were not responsive 
to both infections. Irak1, one of the genes of the TLR and IL-1R pathways that are 
experimentally validated targets in human, was not present on the microarray. Traf6 
the other experimentally validated target in TLR and IL-1R signaling pathways was 
up-regulated at the end stage of S. typhimurium infection in embryos (24hpi). The 
interferon-responsive factor 5 (IRF5) gene is another key immune response gene that 
has been experimentally validated in mammalians and for which a miR-146 a and 
b target sites are also predicted in zebrafish. Expression of irf5 was up-regulated in 
all samples of the M. marinum infection study. In conclusion, many of the predicted 
miR-146 target genes that are conserved between human and zebrafish can be linked 
to bacterial infection processes by expression changes.
Discussion
To increase knowledge of miRNAs involved in the vertebrate host response to 
bacterial infections we have analyzed miRNA expression profiles of zebrafish in-
fected with two model pathogens, S. typhimurium and M. marinum (Stockhammer 
et al., 2009; van der Sar et al., 2009). While adult zebrafish have complex innate and 
adaptive immunity similar to the human immune system, zebrafish embryos rely 
solely on the function of their innate immune response. Therefore, by using both 
embryos and adult zebrafish as hosts for bacterial infection, we could link miRNA 
expression profiles to the innate and adaptive components of the immune response. 
We identified a set of commonly responsive miRNAs in embryonic and adult infec-
tion experiments that includes highly conserved miRNAs with strong associations to 
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the immune system and development of cancer in human and mammalian models. 
We also determined that predicted target genes of the strongly infection-inducible 
miR-146 family are conserved between human and zebrafish, including key signaling 
intermediates of the TLR pathway that is pivotal for the innate immune response to 
bacterial infections (Hou et al., 2009; Perry et al., 2009; Taganov et al., 2006).
The set of commonly infection-responsive miRNAs included the highly con-
served miRNAs, miR-20b, miR-21, miR-128, miR-146a/b, miR-152, and miR-181a/c. 
The mammalian counterparts of these miRNAs are differentially expressed in many 
types of cancer and have been implicated in tumor growth, invasion and metastasis 
(Debernardi et al., 2007; Evangelisti et al., 2009; Hiroki et al., 2009; Lei et al., 2009; 
Perry et al., 2009; Shi et al., 2008; Zhu et al., 2008). The mammalian counterparts 
of miR-21, miR-146 and miR-181 have also been linked to the immune system. Our 
study is the first that connects these miRNAs with mycobacterium and salmonella 
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infections. It is well known that the signaling pathways involved in the immune re-
sponse and inflammation are strongly overlapping with those involved in the devel-
opment of cancer, and it has previously been suggested that changes in expression of 
miRNAs might link these processes (Williams et al., 2008). In agreement, deregu-
lated expression of miRNAs, for example miR-146a, has been observed in several 
inflammatory diseases, such as psoriasis, rheumatoid arthritis and osteoarthritis, as 
well as in different types of cancer such as papillary thyroid carcinoma, cervical can-
cer, ovarian cancer, breast cancer, pancreatic cancer and prostate cancer (Nakasa et 
al., 2008; Perry et al., 2009; Xia et al., 2009). The infection data reported here further 
support the notion that many miRNAs implicated in cancer processes are also con-
nected to regulation of the immune response. 
In connection to the immune response, the miR-146 family is one of the most 
interesting. We found that expression of miR-146a and b was commonly induced 
by infection in adult zebrafish as well as in embryos, indicating that the context of 
innate immunity is sufficient for the induction of the miR-146 miRNAs. This is con-
sistent with results in human an animal models that have implicated the miR-146 
family in regulation of innate immunity signaling pathways (Hou et al., 2009; Perry 
et al., 2009; Taganov et al., 2006). Induction of miR-146a and b was observed in 
human immune cells stimulated with microbial components (LPS) and proinflam-
matory mediators IL-1β, TNFα (Taganov et al., 2006). Furthermore, viral infections 
and Helicobacter pylori infections also increased expression of miR-146 (Belair et al., 
2009; Hou et al., 2009; Motsch et al., 2007). NF-κB, the central transcription factor 
of the immune response, was shown to control miR-146 transcription (Taganov et al., 
2006). Furthermore, two key intermediates of the common TLR and IL-1R signaling 
pathway, TRAF6 and IRAK1, were shown to be potential molecular targets of the 
miR-146 family members (Taganov et al., 2006). Based on these results, the miR-
146 miRNAs were proposed to fine-tune the innate immune response by negative 
feedback regulation of the TLR and IL-1R signaling pathways (Taganov et al., 2006). 
Consistent with this hypothesis, miR-146a expression directly or indirectly down-
regulated the IL-1β-induced release of chemokines, IL-8 and RANTES (Williams 
et al., 2008) and the LPS-induced production of IFN-γ and nitric oxide (Dai et al., 
2008). In addition to a role in fine-tuning TLR and IL-1R signaling, miR-146a was 
also proposed as a negative regulator of the RIG-I-dependent antiviral pathway by 
targeting TRAF6, IRAK1, and IRAK2 (Hou et al., 2009). In contrast to these data, 
miR-146b was found to be down-regulated in an in vivo model of acute inflamma-
tion triggered by LPS infusion of healthy human volunteers, indicating that this 
miRNA might respond differently in leukocytes in vivo than in in vitro studies or 
that miR-146b levels might be oscillating during inflammation owing to a possible 
sensing mechanism (Schmidt et al., 2009). In our in vivo infection studies, miR-146a 
and b were consistently induced, but during early stages of mycobacterium infection 
in adult zebrafish we observed down-regulation of the miR-146 star sequences that 
currently have unknown function. Thus, it will be of interest to study the dynamic 
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pattern of miR-146 family members in greater detail using in vivo models. Besides its 
role in innate immunity, miR-146a was recently suggested to also modulate adaptive 
immunity (Schmidt et al., 2009). The zebrafish model, in which innate and adaptive 
immunity can be studied in separation, can therefore contribute to dissecting the 
diverse functions of the miR-146 family.
Similar as for the miR-146 family, we also observed increased expression of miR-
21 primary miRNAs and star sequences during several conditions of infection in 
zebrafish embryos and adults. MiR-21 was also found to be up-regulated in cultured 
human gastric epithelial cells upon H. pylori infection, which is a major risk factor 
for gastric cancer (Zhang et al., 2008). Significantly increased levels of miR-21 were 
observed in several human gastric cancer tissues and cell lines as well, and the over-
expression of miR-21 was shown to promote cell proliferation and migration and in-
hibit apoptosis in a gastric cancer cell line (Zhang et al., 2008). The up-regulation of 
miR-21 expression during H. pylori infection was found to be mediated by AP-1 and 
STAT3, which in turn are activated by NF-κB activation and IL-6 secretion in the 
gastric mucosa (Belair et al., 2009; Loffler et al., 2007). In addition, the miR-21 gene 
was found to be transactivated by the NF-κB p65 subunit following infection with 
Cryptosporidium parvum, a protozoan parasite that elicits strong innate immune re-
sponses of the gastrointestinal epithelium (Zhou et al., 2009). MiR-21 also showed 
elevated expression during Epstein-Barr virus infection (Cameron et al., 2008) and 
was shown to regulate interleukin-12 p35 expression during allergic airway inflam-
mation. Thus, like for miR-146, the infection-responsiveness of miR-21 in zebrafish 
indicates an evolutionary conserved role for this miRNA family in the vertebrate 
immune response.
Another interesting miRNA family that we found to be regulated in zebrafish 
infection experiments is the miR-181 family that has an important role in normal 
haematopoiesis, B-cell differentiation and T-cell development in mammals and has 
been associated with aggressive leukemia (Chen and Lodish, 2005; Li et al., 2007; 
Pekarsky et al., 2006). Little is known of the role of miR-181 in bacterial infections, 
but LPS stimulation of macrophages positively regulated miRNA-181c expression in 
a protein kinase Akt1-dependent manner (Androulidaki et al., 2009). Like miR-146-
a/b, the miR-181 family may function in negative regulation of the innate immune re-
sponse, as expression levels of its members were inversely correlated with expression 
levels of predicted targets in TLR and IL-1R signaling (Marcucci et al., 2008). In our 
experiments miR-181a and c family members were down-regulated during bacterial 
infections of zebrafish, but showed opposite patterns of regulation in adult zebrafish. 
While miR-181a miRNAs were down-regulated at early stages and up-regulated at lat-
er stages of mycobacterium infection with two different strains, miR-181c expression 
showed the exact inverse pattern. In further studies the zebrafish-mycobacterium 
model may prove useful to dissect the functions of these members of the miR-181 
family in the immune response.
Besides several hundreds of known miRNAs or predicted miRNAs with experi-
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ment support (C1/C2 categories), our custom microarray used in the zebrafish infec-
tion studies contained probes for several thousands of additional hairpin sequences 
identified in the zebrafish genome sequence (C3 category). Many of these probes 
were infection responsive. Interestingly, there was a striking common regulation of 
C3 probes during mycobacterium infections of adult fish with the M. marinum E11 
and Mma20 strains. We examined the response to these stains at 1 and 6 days after 
infection and observed a strongly overlapping pattern at both stages, despite the 
fact that there is a major difference in disease phenotypes elicited by the two strains. 
While E11-infected fish develop a chronic infection and show no symptoms of dis-
ease, Mma20-infected fish develop acute infection and are close to the end point of 
the disease at 6 dpi. The common regulation of C3 probes is in sharp contrast with 
what we have seen for gene expression where in a 2D cluster analysis of the data set 
the strains rather than the time points clustered together (van der Sar et al., 2009). 
In addition, the clustering pattern for the C3 category (Fig.3B) was very different 
from the clustering pattern of the known and C1/C2 category miRNAs (Fig. 3A) that 
showed much less overlap between the strains and time points. These observations 
warrant further study, as it is currently unknown if the C3 probes represent miRNAs 
or might correspond to other types of non-coding or coding RNAs.
The knowledge of target genes is crucial for the understanding of miRNA func-
tion. We focused on the infection-inducible miR-146 family to investigate possible 
conservation of target genes between zebrafish and mammals. As discussed above, 
mammalian miR-146a and b are thought to fine-tune TLR and IL-1R signaling by 
targeting IRAK1 and TRAF6. Here we show the presence of conserved miR-146 tar-
get sites in the 3’UTRs of zebrafish irak1 and traf6. Additionally, we found a miR-146-
a/b target site in the 3’UTR of MyD88, which functions upstream of irak1 and traf6 
as the common adaptor of several TLRs and IL-1R. However, targeting of MyD88 
by miR-146 in zebrafish awaits experimental confirmation and appears not to be 
conserved in human or rodents. We have previously shown that several TLR path-
way genes and downstream effector genes are induced during infections in zebrafish 
(Stockhammer et al., 2009; van der Sar et al., 2009). In addition, we observed that 
many negative regulatory genes of the TLR pathway, for example irak3, are induced 
during salmonella infection (Stockhammer et al., 2009). The induction of miR-146, 
as a putative negative regulator of several genes in TLR pathway, is in line with these 
findings. Together these gene expression and miRNA expression data suggest the 
importance of feed back mechanisms to properly control the inflammatory response 
that might in some cases be more damaging than the infection itself. 
We attempted to predict other targets than the TLR pathway genes for miR-146. 
The available target prediction programs generate lists of hundreds to thousands of 
candidate target genes probably containing many false positive hits. We reasoned that 
predicted targets common between multiple species or distant species like human 
and zebrafish could be the most likely candidates for being true in vivo targets. We 
found 64 targets that appeared conserved between zebrafish and human, of which 27 
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were conserved also in mouse, rat and/or chicken. The majority of these genes were 
previously linked to immune response processes with gene ontology or pathway an-
notations related to apoptosis, regulation of NF-κB transcription factor activity, hae-
mostasis, infections, T-cell development and function, and TLR signaling (Table 3). 
In addition, many of these genes are linked to tumor progression, consistent with 
the previously proposed link between miR-146 function in cancer and the immune 
response (Williams et al., 2008). One of the predicted targets conserved between hu-
man and zebrafish is interferon response factor 5 (IRF5), which is a critical transcrip-
tion factor in the immune response downstream of TLR signaling and also has been 
linked to tumor suppression (Balkhi et al.; Hu and Barnes, 2009; Pandey et al., 2009; 
Yang et al., 2009). Targeting of human IRF5 by miR-146 is supported by experimental 
data (Tang et al., 2009), consistent with the possibility that other predicted targets 
conserved between zebrafish and human may also be bona fide target genes. We also 
examined how the expression of the predicted miR-146 target genes responded to 
infection in zebrafish. In general, it cannot be predicted if and how the induction of 
miR-146 might affect transcript levels of its target genes. MiR-146 induction might 
affect only translation of its targets, or it might down-regulate their transcription or 
dampen their induction. However, it was notable that many of the predicted targets 
could be linked by expression changes to the infection process. This, together with 
the fact that most of the predicted targets have functional annotations linked to im-
munity, suggests that our list of conserved predicted targets may be a good starting 
point for experimental validation studies.
In conclusion, we have shown here that infection-responsive miRNAs are highly 
conserved between human and zebrafish. It is likely, as we have shown for the miR-
146 family, that there is also considerable overlap in miRNA target genes, indicat-
ing that the zebrafish can be a useful model to dissect functions of miRNAs in the 
vertebrate immune system. Several miRNAs are not only responsive to infection in 
zebrafish adults, but also in embryos prior to the onset of adaptive immunity. In the 
embryo model, miRNAs can be easily over-expressed by micro-injection of synthetic 
miRNA duplexes, or knocked down using morpholinos (Schier and Giraldez, 2006). 
In addition, target protecting morpholinos can be used to experimentally validate 
predicted target genes in vivo (Choi et al., 2007). In future studies these strategies 
will be applied to analyze the function of infection-responsive miRNAs in the ze-
brafish embryo model.
Materials and methods
Bacterial strains and growth conditions
M. marinum strains E11 and Mma20 have been described before (van der Sar 
et al., 2004). Bacteria were grown at 30 °C in Middlebrook 7H9 medium supple-
mented with Middlebrook oleic acid-albumin-dextrose-catalase (BD Biosciences) 
and 0.05% Tween-80. S. typhimurium wild type strain SL1027 bacteria containing 
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DsRed expression vector pGMDs3 were used for the infection of zebrafish embryos 
(Stockhammer et al., 2009; van der Sar et al., 2003). Bacteria were freshly grown at 37 
°C overnight on Luria-Bertani agar plates supplemented with 100 µg/ml carbenicillin. 
M. marinum and S. typhimurium bacterial numbers were determined by measuring 
the optical density at 600 nm and by plating and CFU determination. L. casei Shirota 
bacteria were taken from Yakult fermented milk drink (Yakult Europe B.V., Almere) 
specified to contain 108 bacteria/ml. Bacteria were collected by centrifugation and 
washed extensively with PBS. 
Zebrafish husbandry and infection experiments
Zebrafish (Danio rerio) were handled in compliance with the local animal wel-
fare regulations and maintained according to standard protocols (http://ZFIN.org). 
The infection experiment of adult male zebrafish with M. marinum E11 and Mma20 
strains has been previously described (van der Sar et al., 2009). The analysis of miR-
NA expression profiles was done using powdered tissue from the same fish as used 
for mRNA expression analysis in the previous study (van der Sar et al., 2009). As 
before, three fish per strain and time point (1 and 6 days post infection) were used 
and PBS-injected fish were used as a control. Infection experiments at the embryonic 
stage were performed using mixed egg clutches from different pairs of wild type ze-
brafish. Embryos were grown at 28.5–30°C in egg water (60µg/ml Instant Ocean sea 
salts) and staged by morphological criteria (Kimmel et al., 1995). For the duration 
of bacterial injections embryos were kept under anaesthesia in egg water contain-
ing 0.02% buffered 3-aminobenzoic acid ethyl ester (tricaine; Sigma-Aldrich). For 
infection with M. marinum E11 embryos were staged at 48 h post fertilization (hpf). 
Bacteria were resuspended at desired concentrations in a 2% suspension of polyvi-
nylpyrrolidone (PVP, average mol wt 40000, Calbiochem, San Diego) in PBS and 
approximately 1 nl of this mixture was injected into the yolk sac of 48 hpf embryos. 
PVP was chosen as the vehicle for yolk injections as it is commonly used in clini-
cal medicine and experimental animals. The amount of injected M. marinum per 
embryo totalled 2,000 or 20,000 CFU. As we observed only a minor concentration 
effect on miRNA expression, these samples were treated as biological duplicates in 
the microarray analysis. L. casei Shirota was used as a non-pathogenic bacterium for 
comparison and injected in PVP suspension at similar concentrations as used for M. 
marinum. PVP-injected and uninjected embryos were employed as controls. Pools 
of 10–30 embryos from each group were taken at 72 h post infection (hpi). For the S. 
typhimurium infection study embryos were staged at 27 hpf and approximately 250 
CFU of S. typhimurium bacteria in PBS were injected into the caudal vein close to 
the urogenital opening. As a control an equal volume of PBS was likewise injected. 
Triplicate pools of 20–40 embryos were collected at 8hpi. In all infection experiments, 
bacterial injections were controlled using a Leica MZ Fluo 3 stereomicroscope with 
epifluorescence attachment, a Femtojet microinjector (Eppendorf) and a microma-
nipulator with pulled microcapillary pipettes.
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RT-PCR analysis of irak1
RNA from S. typhimurium-infected 1-day-old embryos at 24 hpi (Stockhammer 
et al. 2009) was used to amplify the 3’ UTR of irak1. Traces of genomic DNA were 
removed by incubation with DNA-free solution (Ambion). RT-PCR analysis was 
performed using the SuperScript III One-Step RT-PCR System with Platinum Taq 
DNA Polymerase (Invitrogen) using forward (5’AGAAAGAAACGCACAACAGATA
TGTTG3’) and reverse (5’GTGCTGTTTAACAAGGCCGTAATC3’) primers, locat-
ed respectively at nucleotides 1-27 and 293-316 downstream of the irak1 stop codon. 
To confirm the identity of the amplified sequence, the PCR product was cloned in 
pCRII-TOPO vector (Invitrogen) and sequenced using the sequencing service of 
ServiceXS (Leiden, The Netherlands).
Microarray design
Custom-designed 8x15k microarray slides were ordered from Agilent Technologies. 
The 15k custom design was obtained from Edwin Cuppen and Eugene Berezikov, 
Hubrecht Institute, Utrecht, The Netherlands and will be submitted into the Gene 
Expression Omnibus database. The 15k design contained a duplicate of 7604 probes 
of 60-oligonucleotide length. The probes consisted of 2x22 nucleotide sequences an-
tisense to mature miRNAs separated by a spacer of 8 nucleotides (CGATCTTT) and 
with a second spacer with the same sequence at the end. From 7604 probes 546 were 
designed for left (5’) and right (3’) arms of the hairpins of zebrafish miRNAs that 
are currently known in miRBase. The remainder 7058 probes were classified into 3 
categories: 62 probes into C1 category (novel confident miRNAs for which there is 
compelling experimental evidence), 54 probes into C2 category (candidate miRNAs 
with clear hairpin structure but less experimental evidence), and 6942 into C3 cat-
egory (additional hairpins identified in the zebrafish genome sequence that are less 
likely to be miRNAs).
RNA isolation, labeling and hybridization
Adult fish and embryos for RNA isolation were snap frozen in liquid nitrogen 
and subsequently stored at −80 °C. Adult fish were homogenized in liquid nitrogen 
as described (van der Sar et al., 2009) and portions of 50–100 µg of powdered tis-
sue were used for RNA extraction. Total RNA from adult or embryo sample was 
isolated using the miRNeasy Mini kit to preserve small RNA species. RNA labe-
ling was carried out with miRCURY™ LNA microRNA, Hy3™/Hy5™ Power Labeling 
kit (Exiqon) using 1 µg of total RNA according to the manufacturer’s instructions. 
RNA samples from mycobacterium-infected adult fish were labeled with Hy3 and 
hybridized against Hy5-labeled RNA samples from PBS-injected controls. For the 
yolk infection study of 2-day-old embryos, the RNA samples from mycobacterium-
injected, L. casei Shirota injected, and PVP-injected embryos were labeled with Hy3 
and hybridized against Hy5-labeled samples from uninjected controls. RNA samples 
from salmonella-infected 1-day-old embryos were labeled with Hy3 and hybridized 
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against Hy5-labeled RNA samples from PBS-injected controls. The dual colour hy-
bridization of the microarray chips was performed according to Agilent protocol 
GE2-v5_95_Feb07 and GE2_105_Jan09 (www.Agilent.com) for two-color microar-
ray-based gene expression analysis except that hybridization and washing was per-
formed at 37 °C. 
Data analysis
Microarray data were processed from raw data image files with Feature Extraction 
Software 10.1.1 and 10.5.1 (Agilent Technologies). Processed data were subsequently 
imported into Rosetta Resolver 7.2 (Rosetta Biosoftware) and subjected to default 
ratio error modeling. Ratio results from control vs. infected replicates were com-
bined using the default ratio experiment builder. Significance cut-offs for the ratios 
of infected versus control were set at 1.5-fold change at P≤10−4. Two-dimensional 
hierarchical cluster analyses were performed with MultiExperiment Viewer version 
4.4.1 (TM4 Software Development Team) settings for average linkage method with 
Euclidean distance.
Target prediction
To predict miR-146 family member target sites in TLR pathway genes traf6, 
irak1 and myd88 and rank these predictions we employed three different miRNA 
target site prediction methods: miRanda (www.microrna.org/) (John et al., 2004), 
RNAhybrid (bibiserv.techfak.uni-bielefeld.de/rnahybrid/) (Rehmsmeier et al., 2004), 
and TargetScan (www.targetscan.org/) (Lewis et al., 2003), and an integration algo-
rithm for these three methods developed by Yanju Zhang and Fons Verbeek, Leiden 
Insititute for Advanced Computer Science. To predict further conserved targets 
of miR-146 family members in zebrafish, human, mouse, rat and chicken we used 
MicroCosm Targets (formerly known as miRBase Targets) (http://www.ebi.ac.uk/
enright-srv/microcosm/htdocs/targets/v5/). The predicted targets from zebrafish, 
mouse, rat and chicken were converted to human Ensembl Gene ID homologues 
using the Biomart program of the Ensembl database. Targets which appeared across 
zebrafish and human or multiple other species were selected to study their involve-
ment in biological pathways using the Reactome pathway database (www.reactome.
org/), GeneALaCart (www.genecards.org) and AmiGO pathways (amigo.geneontol-
ogy.org/cgi-bin/amigo/go.cgi). 
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The use of zebrafish models for liver cancer has been supported by a strong con-
servation of gene expression signatures between zebrafish and human liver tumors. 
The expression levels of genes involved in many cellular processes are modulated by 
the activity of microRNAs. Aberrant expression of these small non-coding RNAs has 
been associated with many diseases, including cancer. In this study we compared the 
miRNA transcriptomes of zebrafish liver tumors and human hepatocellular carcino-
ma (HCC). Microarray analysis of five individual zebrafish with carcinogen-induced 
liver tumors indicated a consistent tumor-specific expression signature for a large set 
of known and predicted miRNAs. The most notable similarities between zebrafish 
and human liver cancer were the common up-regulation of miR-21, miR-23a, miR-
146a/b, miR-221 and miR-222, and the common down-regulation of miR-1 and miR-
122. In addition, several miRNAs not previously linked to HCC but linked to several 
other types of human cancer showed differential expression in zebrafish liver tumors. 
A subset of the liver tumor-related miRNAs, including members of the miR-21 and 
miR-146 families, was also responsive to Mycobacterium marinum infection in ze-
brafish, suggesting a common role in cancer and the immune response. Finally, we 
investigated the possible conservation of miRNA target genes and found that sev-
eral putative target genes of the miR-1, miR-146 and miR-221/miR-222 families are 
conserved between human and zebrafish. The conserved expression signatures of 
these tumor-related miRNAs and the involvement of their predicted target genes in 
cancer-related processes and signal transduction pathways corroborate the similarity 
between zebrafish and human liver cancer.
Introduction
Zebrafish is increasingly used as a model organism for cancer research (Amatruda 
et al., 2002; Berghmans et al., 2005; Feitsma and Cuppen, 2008; Lam and Gong, 2006). 
Several types of cancers have been studied in zebrafish as they can spontaneously de-
velop almost any type of tumors with notable similarities to human and mammalian 
tumors. The ease of performing tumor transplantations and visualization of tumor 
invasiveness stimulated the development of zebrafish cancer models using forward 
and reverse genetic screens and transgenesis methods.
Recently, zebrafish has been used as a model species to study liver cancer. It has 
been shown that zebrafish and human liver tumors share molecular, biochemical 
and cellular similarities (Chu and Sadler, 2009; Lam and Gong, 2006; Lam et al., 
2006; Ung et al., 2009). They have largely overlapping expression profiles of genes 
involved in cell cycle/proliferation, apoptosis, DNA replication and repair, metasta-
sis and cell adhesion, cytoskeletal organization and cell motility, and RNA processing 
and protein synthesis. Differential expression of genes in these processes is consist-
ent with the characteristics of human liver cancer such as defective apoptosis, uncon-
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trolled proliferation, limitless replication and loss of tissue-specific functions (Chu 
and Sadler, 2009; Lam and Gong, 2006; Lam et al., 2006).
MicroRNAs (miRNA) are highly conserved small non-coding RNAs that con-
trol gene expression by regulating mRNA stability and translation. They play crucial 
roles in essential physiological functions including cell cycle, differentiation, devel-
opment, and metabolism (Schmidt et al., 2009; Sonkoly and Pivarcsi, 2009). A large 
number of recent studies support that miRNAs are important regulators of the im-
mune system and that specific alterations of their expression contribute to pathogen-
esis of cancer and other diseases (Calin et al., 2002; Garofalo et al., 2008; Garzon et 
al., 2009; Lu et al., 2005; Lu and Liston, 2009; Medina and Slack, 2008). More than 
50% of miRNA genes were found to reside in cancer-associated genomic regions 
(Calin et al., 2004). 
Differentially expressed miRNAs in cancer can act either as direct causatives 
of tumorigenesis (oncogenic and tumor suppressor oncomirs) or can be indirectly 
involved in genomic, epigenomic or physiological changes associated with cancer 
(Esquela-Kerscher and Slack, 2006). Recently, a significant group of miRNAs have 
been found to be expressed in the liver and to modulate several liver functions 
(Chen, 2009). Their deregulation may play a crucial role in liver diseases including 
hepatocellular carcinoma (HCC). HCC is the most common malignancy in the liver 
and one of the most common causes of death from cancer triggered either by viral 
(hepatitis B and C) or nonviral (alcohol and aflatoxin B1) agents. Revealing altera-
tions in miRNA expression and uncovering their mRNA targets is important to our 
understanding of carcinogenesis and could lead to novel therapeutic strategies based 
on the modulation of miRNA activity. Using a murine liver cancer model, it was 
recently shown that systemic administration of miR-26a, a miRNA showing reduced 
expression in HCC cells, could suppress tumorigenesis (Kota et al., 2009). In addi-
tion to this miRNA replacement strategy, the application of synthetic inhibitors (an-
tagomirs) of miRNAs up-regulated in HCC may prove to be a promising approach to 
liver cancer treatment (Krutzfeldt et al., 2005; Pineau et al.; Tsai et al., 2009). 
While numerous studies have uncovered miRNA profiles of different cancer types, 
their exact functions are not well understood. MiRNAs that have been linked to the 
progression of HCC and metastasis among others include miR-10, miR-15a, miR-21, 
miR-26a, miR-29a, miR-34a, miR-101, miR-122, miR-146, miR-199, miR-221/222, and 
miR-224 (Budhu et al., 2008; Chen, 2009; Huang et al., 2008; Ladeiro et al., 2008; 
Murakami et al., 2006; Su et al., 2009; Varnholt et al., 2008). Several miRNAs that 
are differentially expressed in HCC show similar alterations in other cancers, sug-
gesting that there are common miRNAs regulating basic processes of carcinogenesis. 
Each miRNA is predicted to regulate several hundreds of target mRNAs. The iden-
tification of true in vivo targets is crucial for understanding of miRNA function. A 
number of targets of deregulated miRNAs in HCC and other types of cancer have 
now been experimentally validated, including several oncogenes and tumor sup-
pressor genes, inhibitors of apoptosis, cell cycle regulators and genes involved in cell 
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proliferation, migration and invasion (Bueno et al., 2008; Mann et al., 2007; Medina 
and Slack, 2008; Mott, 2009; Qin and Tang, 2002).
Here, we analyzed the miRNA transcriptome of zebrafish liver tumors and 
compared our data set with miRNAs previously detected in human liver cancer. 
Furthermore, we determined the overlap between the liver cancer-related miRNAs 
and miRNAs identified in previous infection studies of zebrafish (chapter 4). Finally, 
we compiled experimentally validated targets of differentially expressed tumor-relat-
ed miRNAs to shed more light on their role in cancer mechanisms. With these stud-
ies we have defined tumor and immune-related miRNA marker sets and predicted 
targets conserved between human and zebrafish.
Results
Differentially expressed miRNAs in liver tumor samples from zebrafish
Previously, it has been shown that gene expression profiles between zebrafish and 
human liver tumors are strongly overlapping (Lam and Gong, 2006). In order to 
determine if miRNA expression is also conserved between zebrafish and human liver 
tumors, we obtained samples from these previous studies and analyzed them using 
a custom-designed Agilent 8x15k microarray for relative quantification of miRNA 
expression. We compared liver tissues from 5 fish with liver tumors induced by car-
cinogen (DMBA) treatment with normal liver tissues from 5 healthy control fish. In 
the five biological replicates the numbers of differentially expressed probes showing 
more than 1.5-fold induction or repression (P < 1.00E−5) ranged between 385 and 
888 (Fig. 1). The percentage of up-regulated probes (45%-60%) was similar to that 
of down-regulated probes in all replicates (Fig.1). The custom-designed zebrafish 
microarray platform contained probes for both known and predicted miRNAs, the 
latter classified into three categories: C1 - novel confident miRNAs for which there is 
compelling experimental evidence, C2 - candidate miRNAs with clear hairpin struc-
ture but less experimental evidence, and C3 - additional hairpins identified in the ze-
brafish genome sequence that are less likely to be miRNAs. Approximately one third 
of the differentially expressed probes corresponded to known miRNAs, even though 
these represent less than one tenth of the total number of probes on the microarray 
(546 out of 7604 probes). The largest group of probes on the microarray belongs to 
the C3 category (6942 probes) and between 4-9% of these probes showed differen-
tial expression in the microarray analysis. In the smaller C1 (62 probes) and C2 (54 
probes) categories only a few probes showed altered expression in the replicate liver 
tumor samples (C1: 4 to 8; C2: 1 to 5). Next, we determined the overlap of differen-
tially expressed probes between the biological replicates (Fig. 2). Taking together the 
known miRNA probes and the C1/C2 probes for experimentally supported miRNA 
candidates, we found that 72 probes were consistently changed in at least 4 out of 5 
biological replicates, of which 26 probes showed differential expression in all 5 repli-
cates. A good overlap was also observed for the probes in the C3 category of putative 
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miRNAs without experimental support, where 140 probes were changed in at least 4 
out of 5 biological replicates. In conclusion, our microarray analysis of five individual 
fish with carcinogen-induced liver tumors indicated a consistent tumor-specific ex-
pression signature for a large set of known and predicted miRNAs.
Comparison of miRNA regulation between zebrafish and human 
To study the miRNA transcriptome similarities between zebrafish and human liv-
er tumors we compiled in Table 1 those miRNAs that were differentially expressed in 
at least 4 replicates of the zebrafish liver tumor study and investigated which of these 
miRNAs have previously been related to human hepatocellular carcinoma (HCC) or 
to other types of human cancer. Furthermore, we also included in Table 1 all other 
human miRNAs that were previously linked to HCC in the literature and indicated 
the number of zebrafish liver tumor replicates in which these miRNAs were differen-
tially expressed. The results of the comparative analysis in Table 1 are summarized in 
Figure 3, showing that several miRNAs were commonly regulated in zebrafish and 
human liver cancer. MiRNAs previously reported to show increased expression in 
HCC and that we also found up-regulated in zebrafish liver tumors included miR-
Figure 1. Differentially expressed miRNA probes in zebrafish liver tumor samples. (A) Total 
number of up-regulated and down-regulated probes in five biological replicates of healthy liver 
versus liver tumor. (B) Number of up-regulated and down-regulated probes in four annotation cat-
egories: known miRNAs, and predicted miRNAs, C1, C2, and C3, with decreasing level of confidence 
as further detailed in the text. The total number of probes on the array per category is: 546 probes 
in known, 62 probes in C1, 54 probes in C2 and 6942 probes in C3 category.
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21, miR-23a, miR-146a, miR-146b, miR-221 and miR-222, which were consistently 
changed in at least 4 replicates of our microarray study. Furthermore, miR-1 and 
miR-122, for which decreased expression was reported in HCC, were consistently 
down-regulated in zebrafish tumors. Other miRNAs increased (miR-10a/b, miR-18c, 
miR-93, miR-125b and miR-181a/b, miR-338) or decreased (let-7a, miR-101b, miR-148 
and miR-199) in HCC, were also changed in the same direction in zebrafish liver 
tumors, but only in 2 or 3 out of the 5 replicates. We also found miRNAs (including 
miR-9, miR-15a, miR-29a/b and miR-34 changed in 4-5 replicates, and miR-125a and 
miR-223 changed in 2-3 replicates) for which the observed direction of change in 
zebrafish liver tumors was opposite to changes reported for HCC (Figure 3). In addi-
tion, several miRNAs not previously linked to HCC showed differential expression 
in at least 4 replicates of the zebrafish liver tumor study, including miR-15b, miR-16-
a/b, miR-27a/b, miR-132, miR-153a/b/c, miR-193a/b, miR-210, miR-212, miR-217, miR-
Figure 2. Overlap of differentially expressed miRNA probes between biological replicates of 
healthy liver versus liver tumor. (A) Overlap of probes in the combined categories of known miR-
NAs and C1 and C2 miRNAs that include candidate miRNAs supported by experimental evidence. 
(B) Overlap of probes in the C3 category of putative miRNAs not supported by experimental evi-
dence. Probes were sorted according to the number of replicates in which they were differentially 
expressed. 






























































































































































































































































































































































































































































































































































































































































































































































































































































365 and miR-455. These miRNAs have been linked to other types of cancer in human 
and like those linked to HCC, these miRNAs have also been suggested to play roles 
in tumorigenicity, tumor suppression, apoptosis, cell proliferation, invasion, and me-
tastasis (Table 1, Figure 3). 
Expression of miRNA star sequences
Besides regulation of the described mature miRNAs, in several cases we also de-
tected differential expression of probes matching miRNA star sequences (Table 1). 
Star sequences (miRNA*) are derived from the other arm of the pre-miRNA hair-
pin structure during miRNA biogenesis, but are not loaded into the RISC complex 
and are degraded. However, sometimes miRNA* can have similar 5’ end stability as 
the mature miRNA strands and similar incorporation efficiency into the RISC com-
plex, and therefore can also be functional (Soares AR et al 2009). For several miR-
NAs (miR-21, miR-125b, miR-126, miR-146a, miR-148, miR-199, miR-222, miR-223, 
miR-455) we found both the primary miRNA and the miRNA* to be differentially 
expressed in liver tumors, while in other cases (miR-7a*, miR-24*, miR-128*, miR-
Figure 3. Common regulation of miRNA expression in zebrafish liver tumors and human can-
cer. Differential expression of miRNAs in zebrafish liver tumors is compared with literature data 
on the expression of the homologous human miRNAs in human liver cancer (hepatocellular carci-
noma) and in other types of cancer as further detailed in Table 1. Yellow indicates miRNAs up-reg-
ulated in zebrafish liver tumor tissue compared to normal liver and blue indicates down-regulated 
miRNAs in zebrafish liver tumors. MiRNAs showing differential expression in 4 out of 5 or 5 out of 5 
biological replicates are in bold and miRNAs differentially expressed in 2 or 3 biological replicates 
are in normal script. MiRNAs for which both up- and down-regulation has been reported in human 
cancer are indicated with asterisks. MiRNAs for which both up- and down-regulation was observed 
in zebrafish liver tumors are indicated with diamonds.




489*) altered expression of only the miRNA* was detected. Most of the zebrafish 
miRNA* that we found to be differentially expressed in liver tumors have not been 
previously reported in miRBase. However, miRBase provides evidence for expres-
sion of several of these miRNA* in human, such as miR-7-1/2*, miR-21*, miR-24*, 
miR-125b*, miR-126*, miR-143*, miR-146a*, miR-148a*/b*, miR-222*, and miR-223*. 
Our microarray data support that these miRNAs* are also expressed in zebrafish and 
suggest that they play a role in liver cancer similar as the primary miRNAs. 
Comparison of miRNA expression in liver cancer and tuberculosis infection 
 Besides being involved in the pathogenesis of cancer, miRNAs are also known 
to play important regulatory roles in the development and function of the immune 
system (Lu and Liston, 2009). Previously we used the same microarray platform 
to investigate miRNA expression during the immune response of adult zebrafish 
to infection with Mycobacterium marinum, the causative agent of fish tuberculosis 
(chapter 4). Here we compared the data from this infection study with the liver can-
cer study in order to define common tumor and immune-related miRNAs (Table 2).
In our infection study we used Mycobacterium marinum strains Mma20 and 
E11, which respectively cause acute disease or chronic granulomatous tuberculosis 
in adult zebrafish (van der Sar et al., 2004; van der Sar et al., 2009), and determined 
miRNA profiles at 1 and 6 days post infection (dpi). Comparing the datasets of liver 
tumor-related miRNAs to M. marinum infection-related miRNAs we found that 8 
miRNAs, miR-15c, miR-16a, miR-21, miR-21*, miR-34, miR-146a, miR-146a* and 
miR-146b, were commonly up-regulated in liver tumors and at either the 1 or 6 dpi 
time point of infection with the Mma20 or E11 strains (Table 2). Two of these miR-
NAs (miR-21* and miR-34) were up-regulated by only one of the M. marinum strains, 
but down-regulated by the other. Expression of miR-217 was down-regulated in liver 
tumors and at different time points of M. marinum infection with both strains. Five 
miRNAs (miR-128*, miR-132, miR-212, miR-455, miR-455*) were up-regulated in 
liver tumors, but down-regulated at one or more time points of infection with the 
M. marinum strains. Other miRNAs that were up-regulated in liver tumors (miR-
15a, miR-15b, miR-16b, miR-23a, miR-24*, miR-27a/b/c/d, miR-29a/b, miR-153a/b/c, 
miR-193a/b, miR-210, miR-221, miR-222, miR-222*, miR-365, miR-457a/b and miR-
735) or down-regulated in liver tumors (miR-1, miR-7a*, miR-9, miR-122) were not 
differentially expressed in the samples of the M. marinum infection study. Among 
the miRNAs commonly regulated in the liver cancer and tuberculosis studies, in 
particular the members of the miR-21 and miR-146 family can be strongly linked to 
the immune response, as they were also found to be induced by different bacterial 
infections in zebrafish embryos (chapter 4).
Experimentally validated targets of liver tumor-related miRNAs
To shed further light on the role of differentially expressed liver tumor-related 
miRNAs in the mechanism of cancer we searched the TarBase database for putative 
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target genes that have been experimentally validated targets in human cell-based as-
says (Table 3). Gene Ontology analysis using DAVID tools linked these target genes 
to biological processes such as apoptosis signaling, cell proliferation, cell cycle, cell 
motility, cell adhesion, cytoskeleton organization and biogenesis, and immune sys-
tem process, as well as to signaling pathways, including the I-kappaB kinase/NF-
kappaB cascade, small GTPase mediated signal transduction, ErbB signaling, MAPK 
signaling, VEGF signaling, p53 signaling, and several KEGG cancer pathways (Table 
3). These processes and pathways are often deregulated in HCC suggesting that these 
miRNAs can be part of signaling pathways that significantly contribute to cancer 
(Chen et al., 2002; Kim et al., 2004; Neo et al., 2004; Okabe et al., 2001; Xu et al., 
2001). Next we used different miRNA target prediction programs to investigate if the 
homologous zebrafish genes might contain miRNA target sites for the same miR-
NAs as those involved in HCC. This analysis showed that several target genes of 
the miR-146 and the miR-221/miR-222 families, which we found to be commonly 
up-regulated in zebrafish liver tumors and in HCC, might be conserved between 
zebrafish and human (Table 3, Figure 4). For the miR-146 family these included two 
pivotal signaling intermediates, IRAK1 and TRAF6, of the NF-kappaB pathway and 
the IRF5 transcription factor gene that is a target of this pathway. Predicted common 
targets of the human and zebrafish miR-221/miR-222 family included cyclin-depend-
ent kinase inhibitor genes (CDKN1B and CDKN1C), linked with epidermal growth 
factor receptor (ErbB) signaling, and the proto-oncogene tyrosine-protein kinase 
Figure 4. Common predicted tar-
get genes of liver tumor-related 
miRNAs in zebrafish and human. 
Up-regulation (yellow) of members 
of the miR-146 and miR-221/miR-222 
families and down-regulation (blue) 
of miR-1 was observed in at least 4 
out of 5 biological replicates of ze-
brafish liver tumor tissue compared 
to normal liver and changes in the 
same direction have been reported 
in the literature on human liver can-
cer (hepatocellular carcinoma) as 
detailed in Table 1. Members of the 
miR-146, miR-221/miR-222 and miR-1 
families are predicted to target sev-
eral genes whose human homologs have been reported as experimentally validated target genes 
in the TarBase database. The figure shows the common predicted target genes and the biologi-




KIT. Furthermore, we could predict 7 conserved target genes for miR-1, which we 
identified as a commonly down-regulated miRNA in zebrafish liver tumors and in 
reports on HCC. One of these was a member of the connexin family (GJA1, gap 
junction protein, alpha 1, 43kDa) related to cell-cell signaling and positive regulation 
of the NF-kappaB pathway. Another predicted conserved miR-1 target was the pro-
grammed cell death 4 (PDC4) gene, also known as neoplastic transformation inhibi-
tor, which has a still unknown function in apoptosis regulation. Three other genes 
encoded cytoskeleton-related proteins, including the stress-responsive, actin-bind-
ing tropomyosin 4 (TPM4) protein, the actin-binding protein LASP1 (LIM and SH3 
protein 1), which has been shown to play an essential role in tumor cell growth and 
migration and was reported as p53 transcriptional target involved in HCC (Wang et 
al., 2009a), and the actin-sequestering protein TMSB4X (thymosin beta 4, X-linked), 
which has been reported to positively regulate the expression of hepatocyte growth 
factor (Barnaeva et al., 2007) and has been implicated in cell proliferation, migra-
tion, and differentiation as well as tumor metastasis and angiogenesis (Wang et al., 
2004; Zhang et al., 2008a). Finally, two members of the RAS oncogene family-like 2 
(RABL2A and RABL2B) were also predicted to be conserved targets of miR-1 in hu-
man and zebrafish. Taken together, our results show that several miRNAs are com-
monly regulated in human and zebrafish liver cancer and predict conservation of a 
number of target genes strongly linked to cancer-related biological processes and 
signaling pathways.
Discussion
Recently, it has been shown that there are remarkable molecular similarities be-
tween zebrafish and human liver cancer not only with respect to general molecular 
hallmarks (Lam et al., 2006) but also at the level of biological modules related to tu-
morigenesis and transcription factor target modules (Ung et al., 2009). In this study 
we show that there is conservation at the level of miRNA expression as well. Using a 
custom microarray platform we observed highly reproducible induction and repres-
sion of miRNAs in zebrafish liver tumors, many of which were previously linked to 
human hepatocellular carcinoma (HCC) or to other types of human cancer. We also 
show that a subset of these liver tumor-related miRNAs overlap with miRNAs re-
sponsive to Mycobacterium marinum infection, suggesting a common role in cancer 
and the immune response. Finally, based on target predictions for zebrafish miRNAs 
and experimental target validation data reported for human miRNAs, we suggest 
that several target genes of the miR-1, miR-146 and miR-221/miR-222 families, which 
are commonly deregulated in liver tumors, are conserved between human and ze-
brafish.
To compare miRNA expression signatures between human and zebrafish liver 
tumors we took two approaches. First, using a custom Agilent microarray platform 
we analyzed differential expression in carcinogen-induced zebrafish liver tumors as 
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compared to healthy liver tissue. Second, by PubMed abstract searching we compiled 
human miRNAs previously reported to show altered expression in HCC or associ-
ated to HCC by polymorphisms. Together this resulted in the identification of 83 
liver tumor-related miRNAs, including 70 primary miRNAs reported in miRBase 
and 13 miRNA star sequences. The majority of the miRNAs previously linked to 
HCC showed altered expression in zebrafish liver tumors. The most notable similari-
ties were the common up-regulation of miR-21, miR-23a, miR-146a/b, miR-221 and 
miR-222, and the common down-regulation of miR-1 and miR-122. These miRNAs 
showed consistent up- or down-regulation in four or five out of five biological rep-
licates of zebrafish liver tumors and have been reported to show the same direction 
of expression changes in HCC. A similar number of HCC-linked miRNAs was also 
changed in the same direction in zebrafish liver tumors, but in less than four rep-
licates. Some other miRNAs, most notably miR-9, miR-15a, miR-29a/b and miR-34, 
showed opposite changes in zebrafish liver tumors compared to literature reports 
on HCC. Approximately half of the zebrafish miRNAs with consistent differential 
expression in liver tumors were not previously linked to HCC. Some of these miR-
NAs lacked human counterparts, but in most cases the human counterparts of these 
miRNAs were already associated with various other types of cancer and therefore it 
is conceivable that associations with human liver cancer may also be found in future 
studies. Most of the miRNAs associated with HCC or other human tumors, includ-
ing those commonly regulated in zebrafish liver tumors, have been found to play 
roles in different mechanisms of cancer such as tumorigenicity, tumor suppression, 
apoptosis, cell proliferation, differentiation, invasion, and metastasis. These data fur-
ther support that zebrafish liver tumors are appropriate for modeling human liver tu-
mors and that the molecular similarities between the species extend from conserved 
tumor-associated gene expression signatures to shared expression alterations of a set 
of tumor-associated miRNAs.
The custom microarray platform used in this study not only contained probes 
for almost all known miRNAs reported in miRBase but also for the putative star se-
quences of all primary miRNAs and for predicted hairpin structures with or without 
experimental support for miRNA identity. Our microarray data support the expres-
sion of several miRNA star sequences that were not yet reported in miRBase and 
show that in most cases altered expression of these miRNA star sequences in liver tu-
mors occurs concomitantly with expression of the corresponding primary miRNAs. 
We also noted that 86 probes for predicted hairpin structures without experimental 
support for miRNA identity were differentially expressed in all five biological repli-
cates of the liver tumor study. Similarly, we previously observed differential expres-
sion of many probes in this category during bacterial infection of zebrafish (chapter 
4). The possibility that these probes represent an additional group of non-coding 
small RNAs with putative regulatory functions during cancer and infection is of 
great interest for further investigation.
Differential expression of miRNAs has been implicated not only in different 
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mechanisms of many types of cancer but also in the immune response. In agreement, 
our previous work suggests that many miRNAs implicated in cancer processes are 
also connected to regulation of the immune response in zebrafish (chapter 4). In the 
previous study we used the same microarray platform to analyze miRNAs induced 
by Mycobacterium marinum infection in zebrafish (chapter 4). M. marinum is closely 
related to Mycobacterium tuberculosis and the pathology of M. marinum infection in 
zebrafish strongly resembles that of human tuberculosis. In particular, the formation 
of granulomas, a hallmark of tuberculosis, is well conserved between zebrafish and 
human. Granuloma formation involves the aggregation of infected and non-infected 
macrophages and other immune cells into tight structures. In this respect granu-
loma formation shares interesting similarities with tumor formation, which gener-
ally is also associated with the attraction of macrophages and other immune cells. 
Therefore, it was of interest to determine the miRNAs commonly regulated in liver 
tumors and in response to M. marinum infection. We identified several miRNAs 
that were commonly up-regulated in liver tumors and at one or more stages of infec-
tion with two M. marinum strains, including miRNAs of the miR-15, miR-16, miR-21, 
miR-34, and miR-146 families. Three of the most interesting commonly regulated 
miRNAs (miR-146a, miR-146a* and miR-146b) are members of the miR-146 family, 
which has previously been implicated in regulation of innate immunity signaling 
pathways and recently suggested also to modulate adaptive immunity (Hou et al., 
2009; Perry et al., 2009; Schmidt et al., 2009; Taganov et al., 2006; Williams et al., 
2008). Altered expression of human miR-146 miRNAs was observed in viral and 
bacterial infections, under inflammatory conditions as well as in different types of 
cancer, including HCC, leukemia and breast cancer (Bellon et al., 2009; Nakasa et 
al., 2008; Perry et al., 2009; Shen et al., 2008; Williams et al., 2008; Xia et al., 2009; 
Xu et al., 2008). Similarly, elevated expressed members of the human miR-21 family, 
which were also commonly up-regulated in zebrafish liver tumors and mycobacte-
rium infection, was previously reported in studies of infection, allergic inflammation 
and cancer, including HCC, gastric cancer, glioma, colon cancer and breast cancer 
(Cameron et al., 2008; Connolly et al., 2008; Gramantieri et al., 2007; Lu et al., 2009; 
Wang et al., 2009b; Zhang et al., 2008b; Zhou et al., 2009). ). It has been suggested 
that the connection between processes of cancer and the immune response might 
be due to changes in expression of miRNAs regulating shared signaling pathways 
(Williams et al., 2008). The common and conserved regulation of several miRNAs 
in tumors and during infection that we observed in this study further supports this 
connection.
Finally, we investigated the possible conservation of miRNA target genes. 
Although there are numerous predicted miRNA targets detected by bioinformatics 
approaches only a few have been validated. In this study we compiled experimentally 
validated targets of human liver tumor-related miRNAs. Functional classification 
of these targets by gene ontology analysis revealed their involvement in signaling 
pathways and biological processes that formerly have been identified as common 
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molecular hallmarks of zebrafish and human liver cancers (Lam and Gong, 2006; 
Lam et al., 2006; Ung et al., 2009). Next we checked the 3’UTR regions of the ho-
mologous zebrafish genes for the presence of target sites for the same miRNAs. For 
several miRNAs no conserved targets were predicted by MiRanda, TargetScan and 
RNA-hybrid algorithms; however, we cannot exclude the possible presence of target 
sites in introns or the presence of target sites not recognized due to limitations of 
the target prediction algorithms or incomplete annotation of the 3’UTR regions in 
the Ensembl database. Interestingly, target predictions indicated several conserved 
target genes for miRNAs of three families, including the miR-146 and miR-221/miR-
222 families that were commonly up-regulated in human and zebrafish liver tumors, 
and miR-1, a commonly down-regulated miRNA family in human and zebrafish 
liver tumors. Shared target genes of the miR-146 family encoded signaling interme-
diates (IRAK1, TRAF6) and a transcription factor (IRF5) involved in the immune 
response. As discussed above, the miR-146 family is also induced by infection in 
human and zebrafish; therefore, the predicted conservation of these target genes fur-
ther supports that this miRNA family functions at the crossroads of cancer and the 
immune response. Proteins encoded by the predicted conserved target genes of the 
miR-221/222 family (CDKN1B, CDKN1C, KIT) and the miR-1 family (GJA1, PDCD4, 
TPM4, LASP1, TMSB4X, RABL2A, RABL2B) are involved in several cancer-related 
biological processes such as proliferation, cell cycle regulation, apoptosis, and cy-
toskeletal organization and motility. Furthermore, these genes have been implicated 
in cancer-related signaling pathways, including ErbB, NF-κB and p53 signaling, and 
small GTPase-mediated signal transduction. The ErbB signaling pathway has been 
implicated in the development and malignancy of numerous types of human cancers, 
including liver cancer (Altimari et al., 2003; Ito et al., 2001; Olayioye et al., 2000). 
NF-κB signaling is involved in the immune response, cell adhesion, differentiation, 
proliferation, angiogenesis and apoptosis and imbalanced regulation of this path-
way has been associated with development of multiple types of tumors (Steele and 
Lane, 2005; Sun and Zhang, 2007), similar as for deregulation of the p53 tumor-
suppression pathway (Steele and Lane, 2005). Finally, predicted target genes involved 
in small GTPase-mediated signal transduction are potential markers for tissue inva-
siveness of liver tumor cells (Lam and Gong, 2006). The predicted conservation of 
target genes in these pathways and processes further supports the similarity between 
zebrafish and human liver cancer and that miRNAs might play a pivotal role in regu-
lating these cancer-related mechanisms in both species.
Taken together, our data suggest that there is high conservation between zebrafish 
and human liver tumors not only at the level of gene expression signatures and tran-
scriptional targets, but also at the level of the regulation by miRNAs. These results 
further support the usefulness of zebrafish as a useful model for studying liver cancer 




Generation of zebrafish liver tumors
Liver tumor samples were obtained from the group of Zhiyuan Gong (National 
University of Singapore) and generated by carcinogen treatment as described in Lam 
et al., 2006. In brief, three-week-old juvenile zebrafish were treated with 0.75 ppm 
7,12-dimethylbenz[α]anthracene (DMBA) or dimethyl sulfoxide (DMSO, vehicle) for 
24 h and the treatment was repeated once at five weeks of age for another 24 hours 
with 1.25 ppm DMBA or DMSO. Treated fish were rinsed three times in fresh wa-
ter and transferred into new tanks for maintenance. Fish were sampled during 6-10 
months after the onset of DMBA exposure. Tumor samples used for the microarray 
study were all bigger than 3 mm in diameter. Partial liver tumors were used for RNA 
extraction and the rest of the tissues were used for histopathological diagnosis. The 
normal livers were also sampled at 6 months to 10 months after the control treatment 
(DMSO, vehicle). Zebrafish husbandry was as described (Lam et al., 2006).
Microarray design
Custom-designed 8x15k microarray slides were ordered from Agilent Technologies. 
The 15k custom design was obtained from Edwin Cuppen and Eugene Berezikov, 
Hubrecht Institute, Utrecht, The Netherlands and will be submitted into the Gene 
Expression Omnibus database. The 15k design contained a duplicate of 7604 probes 
of 60-oligonucleotide length. The probes consisted of 2x22 nucleotide sequences an-
tisense to mature miRNAs separated by a spacer of 8 nucleotides (CGATCTTT) and 
with a second spacer with the same sequence at the end. From 7604 probes 546 were 
designed for left (5’) and right (3’) arms of the hairpins of zebrafish miRNAs that 
are currently known in miRBase. The remainder 7058 probes were classified into 3 
categories: 62 probes into C1 category (novel confident miRNAs for which there is 
compelling experimental evidence), 54 probes into C2 category (candidate miRNAs 
with clear hairpin structure but less experimental evidence), and 6942 into C3 cat-
egory (additional hairpins identified in the zebrafish genome sequence that are less 
likely to be miRNAs).
RNA isolation, labeling and hybridization
Total RNA from five liver tumors and five normal livers was isolated using the 
miRNeasy Mini kit to preserve small RNA species. Three of the liver tumor samples 
were from male zebrafish and two from female zebrafish and each was compared 
with normal liver samples from fish with the same sex. RNA labeling was carried 
out with miRCURY™ LNA microRNA, Hy3™/Hy5™ Power Labeling kit (Exiqon) us-
ing 1 µg of total RNA according to the manufacturer’s instructions. RNA samples 
from liver tumors were labeled with Hy3 and hybridized against Hy5-labeled RNA 
samples from normal livers. The dual colour hybridization of the microarray chips 
was performed according to Agilent protocol GE2-v5_95_Feb07 and GE2_105_Jan09 
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(www.Agilent.com) for two-color microarray-based gene expression analysis except 
that hybridization and washing was performed at 37 °C. 
Data analysis
Microarray data were processed from raw data image files with Feature Extraction 
Software 10.5.1 (Agilent Technologies). Processed data were subsequently imported 
into Rosetta Resolver 7.2 (Rosetta Biosoftware) and subjected to default ratio er-
ror modeling. Significance cut-offs for the ratios of infected versus control were 
set at 1.5-fold change at P≤10−5. Experimentally validated target genes of human 
miRNAs were obtained from TarBase V.5 (http://diana.cslab.ece.ntua.gr/tarbase/) 
(Papadopoulos et al., 2009). Gene ontology and pathway analysis was carried out us-
ing Database for Annotation, Visualization and Integrated Discovery (DAVID) soft-
ware tools (http://david.abcc.ncifcrf.gov/) (Huang da et al., 2009). MiRNA target site 
predictions for the homologous zebrafish genes were derived from the MicroCosm 
database and were performed by locally running miRanda, TargetScan and RNA-
hybrid prediction algorithms using the 3’UTR regions derived from the Ensembl 
Zv8 zebrafish database. For the zebrafish homolog of IRAK1 the 3’UTR region expe-
rimentally determined in chapter 4 was included in the predictions.
Supplementary data 
Supplementary data associated with this chapter can be found at http://apo.
szbk.u-szeged.hu/transfer/A_ORDAS/.
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Recently, new developments in transcriptome profiling technologies have sig-
nificantly advanced genomic research. The use of these technologies to analyze the 
expressed transcripts in several prokaryotic and eukaryotic genomes has revealed 
the high complexity of transcriptomes. Furthermore, quantification of expressed 
transcripts using these technologies has facilitated our understanding of the mo-
lecular background of specific developmental processes and pathological conditions. 
Several high-throughput methods for transcriptome profiling have been developed 
with two basic approaches, microarray-based and sequencing-based methods, both 
offering great opportunities for large-scale analysis. Microarray analysis is a widely 
used technique able to simultaneously interrogate thousands of transcripts and has 
led to crucial advances in a variety of biological problems. However, microarrays 
have several limitations inherent to hybridization-based analysis and are biased by 
a predefined array content. The discovery of next generation sequencing methods 
allows the detection of millions of transcripts simultaneously and overcomes the 
limitations of microarray technology. The two approaches can be considered as com-
plementary techniques to scrutinize the genome, producing not only overlapping 
results but also disclosing technology-dependent findings. Transcriptome analysis is 
invaluable to reveal the regulation of gene expression. Gene expression is regulated 
on different levels, from transcription to post-translational modification of the pro-
tein. Recently, it has become evident that small non-coding RNAs such as miRNAs 
are important components of this regulation. MiRNAs negatively regulate mRNA 
translation or stability and have been implicated in a variety of biological processes, 
for instance the development and function of the immune system. Aberrant expres-
sion of miRNAs has been associated with different disorders such as infectious dis-
eases and cancer. Revealing groups of differentially expressed miRNAs under disease 
conditions and demonstrating their biological functions is therefore important to 
our understanding of pathogenesis. To study mRNA and miRNA profiles affected 
by disease processes, both in vitro and in vivo models are applied. Zebrafish is a 
commonly applied vertebrate model organism used for developmental biology, em-
bryogenesis and more recently for immunological research due to the remarkable 
similarities of its immune system to that of human. In the recent years zebrafish 
models for several infectious diseases and types of cancer have proved useful addi-
tions to mammalian models.
Taking advantage of the novel technological opportunities for transcriptome 
analysis and the possibilities of applying zebrafish as a model organism, this thesis 
focuses on the analysis of transcriptome complexity during infectious disease and 
cancer and aims to gain insight into regulatory functions of microRNAs.
In Chapter 2 we report for the first time on profiling of the transcriptional re-
sponse to infectious disease using Solexa/Illumina’s digital gene expression (DGE or 
Tag-Seq) technology, a tag-based transcriptome sequencing method. In this study 
we investigated the zebrafish host response to Mycobacterium marinum infection 
modeling human tuberculosis. We generated two Tag-Seq libraries of control fish 
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and two Tag-Seq libraries of mycobacterium-infected fish and confirmed the techni-
cal reproducibility of the method. With this approach we detected 5-8 million tags 
per library and mapping analysis showed that the libraries contained tag sequences 
for over 70% of all genes represented in transcript databases. The tag sequences that 
were significantly changed upon mycobacterium infection mapped to approximately 
2% of the database transcripts. In addition to quantitative information on gene ex-
pression, Tag-Seq analysis also provided information on the directionality of the 
transcripts. There is increasing evidence for the occurrence of antisense transcrip-
tion; however, its biological relevance is still unclear. In our study, approximately 40% 
of the mapping events were detected on the antisense strand of database transcripts 
consistently with other recent deep sequencing studies. However, when taking only 
the significantly changed tag entities into account we found that the transcriptional 
regulation in the mycobacterium-induced immune response acts most strongly on 
the sense strand. Thus, our work focused on the regulation of the sense strand tran-
scripts, although the regulation of antisense expression is of great interest and war-
rants further research. 
To validate our results we compared our Tag-Seq data to a previously compiled 
Figure 1. Complementary use of different transcriptome profiling techniques.  Microarray, 
Tag-Seq and RNA-Seq methods as used in this thesis to study the response to bacterial infections 
in zebrafish can be considered as complementary techniques to analyze the transcriptome. The 
specific advantages of the different methods are summarized in the figure.
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reference set of mycobacterium-regulated genes in zebrafish generated by multiplat-
form microarray analysis. This comparison revealed strong correlation between the 
two methods. Furthermore, we performed microarray analysis using a new custom-
designed Agilent platform, also demonstrating a considerable overlap with the Tag-
Seq data. Moreover, gene ontology analysis showed that both profiling methods de-
tected similar functional groups of genes, further supporting comparability of the 
two approaches. On the other hand, comparisons uncovered some differences due 
to limitations of microarray (limited sensitivity, cross-hybridization problems and 
inadequate probe design) and Tag-Seq (unable to identify some transcripts that lack 
a unique tag sequence or cutting site for the DGE anchoring enzyme). Therefore, 
microarray analysis and Tag-Seq can be considered complementary to each other 
(Fig. 1). In addition to the comparison with microarray analysis, we verified a sub-
set of differentially expressed tag sequences by qPCR analysis, which supported 
the Tag-Seq results even in the cases of conflicting results between Tag-Seq and 
microarray. Subsequently, we demonstrated with several examples how additional 
valuable information can be obtained from Tag-Seq transcriptome profiling. Overall, 
we showed that Tag-Seq data can be used to investigate genomic clustering of co-
regulated transcripts, to verify predicted gene models, to detect transcript isoform 
switching induced by infection, and to detect and map novel mycobacterium-regu-
lated transcripts missing from EST databases. Taken together, with these results we 
proved here that Solexa/Illumina’s digital gene expression system is a remarkably 
useful technology for transcriptome quantification and revealing the complexity of 
the transcriptome.
In Chapter 3 we used tag-based (Tag-Seq) and full transcript sequencing (RNA-
Seq) to extend our knowledge on the transcriptome of zebrafish embryos during 
the innate host response to Salmonella enterica serovar Typhimurium (S. typhimu-
rium) infection. We analyzed S. typhimurium infected 1-day-old zebrafish embry-
os at 8 hours post infection (hpi) based on the strong induction of inflammatory 
genes detected previously by microarray. We determined a set of 165 transcripts that 
were commonly responsive in Tag-Seq and microarray analysis. The comparison 
of Tag-Seq with RNA-Seq revealed an overlap of 241 transcripts differentially ex-
pressed, thus we showed, for the first time, the comparable performance of both 
methods in quantifying the transcriptome response to infection (Fig. 1). Combining 
the sequencing-based and microarray-based transcriptome data we presented an 
annotated reference set of infection-responsive genes in zebrafish embryos, encod-
ing transcription factors, signal transduction proteins, cytokines and chemokines, 
complement factors, proteins involved in apoptosis and proteolysis, proteins with 
anti-microbial activities, as well as many known or novel proteins not previously 
linked to the immune response. Furthermore, we compared our Tag-Seq data of 
S. typhimurium infection performed in zebrafish embryos to the Tag-Seq data of 
M. marinum infection in adult zebrafish reported in Chapter 2. The end stage of M. 
marinum infection in adult fish is associated with a strong inflammatory response, 
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similar to what we observed during S. typhimurium infection of zebrafish embryos. 
The comparison revealed a common set of 206 up-regulated infection-responsive 
genes, including transcription factors and signaling components involved in the in-
nate host defense, as well as genes not previously linked to the immune response. 
With this transcriptome analysis we provided a valuable reference for further studies 
of host-pathogen interactions using zebrafish infection models.
In Chapter 4 we aimed to reveal miRNA functions in the vertebrate immune sys-
tem during infectious diseases. As in the previous chapters, we used adult zebrafish 
and zebrafish larvae infected with the bacterial pathogens M. marinum and S. typh-
imurium as disease models. By using embryonic and adult zebrafish in our experi-
ments we could determine miRNA expression distinctive to the innate and adaptive 
immune response, due to the fact that in embryos only the innate immune system 
is developed. Using a custom-designed Agilent microarray platform we identified a 
set of common infection-responsive zebrafish miRNAs, including members of the 
miR-21, miR-146 and miR-181 families. These results were consistent with previous 
studies showing that these highly conserved miRNAs are strongly associated to the 
immune system and also to development of cancer in human and mammalian mod-
els. However, our study is the first that links these miRNAs with mycobacterium 
and salmonella infections. Moreover, our results support previous suggestions that 
common miRNAs might participate in the regulation of the immune response and 
processes of cancer. 
The miR-146 family has previously been implicated in the regulation of innate 
immunity signaling pathways in human and animal models. Our zebrafish data are 
consistent with these findings, as miR-146a/b were commonly induced by infection 
in adult zebrafish and in embryos that rely solely on innate defense mechanisms. 
The role of miR-146a/b in innate immunity is believed to be a fine-tuning function 
of the TLR and IL1R signaling involved in pathogen recognition and activation of 
the innate immune response. To investigate if the function of miR-146 might be 
conserved in zebrafish, we subsequently identified predicted target genes of this fam-
ily. We showed that irak1 and traf6, two genes involved in TLR and IL1R signaling 
and targeted by mammalian miR-146a/b, also contain target sites for these miRNAs 
in zebrafish. Additionally, we found that the transcript encoding MyD88, the com-
mon adaptor in TLR and IL1R signaling pathways, contained putative target sites 
for zebrafish miR-146a/b. The induction of miR-146 by bacterial pathogens is in line 
with the mRNA expression data in chapters 2 and 3, showing that several TLR path-
way genes as well as downstream effector genes and negative regulatory genes of the 
TLR pathway are induced during infections in zebrafish. Thus, our data support that 
miRNA regulation plays an important role as a feed back mechanism to properly 
control the immune response. We also used target prediction software to identify 
other possible targets of the miR-146 family. Most of the predicted miR-146 target 
genes conserved between human and zebrafish were previously linked to immune 
response processes related to apoptosis, regulation of NF-κB transcription factor 
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activity, haemostasis, infections, T-cell development and function, TLR signalling, 
and also tumor progression. Thus, these target predictions further support the im-
portance of miR-146 in the regulation of the immune response. With this study we 
demonstrated that the zebrafish is a useful model to scrutinize miRNA functions in 
the vertebrate immune system based on the highly conserved infection-responsive 
miRNAs that we detected during bacterial infections and the considerable overlap in 
predicted miRNA target genes between human and zebrafish.
In Chapter 5 we assessed miRNA expression patterns in zebrafish liver tumors in 
order to increase understanding of the contribution of miRNAs to the mechanisms 
of cancer. Zebrafish has been demonstrated to be a valuable disease model for liver 
cancer due to remarkable molecular similarities to human hepatocellular carcinoma 
(HCC), including conserved expression signatures and transcriptional regulation 
of several cancer-related gene groups. To determine if there is also conservation at 
the level of miRNA expression in zebrafish and human liver tumors, we performed 
miRNA transcriptome profiling of carcinogen-induced zebrafish liver tumor sam-
ples. We compared the significantly differentially expressed miRNAs in zebrafish 
liver tumors with the miRNAs that had previously been associated with human HCC 
and identified a set of miRNAs that were commonly deregulated in liver tumors of 
both organisms. The most notable similarities were the common up-regulation of 
miR-21, miR-23a, miR-146a/b, miR-221 and miR-222, and the common down-reg-
ulation of miR-1 and miR-122. Furthermore, we identified another set of miRNAs 
in zebrafish liver tumors that have not been previously linked to human HCC but 
have been connected to other types of human cancer with roles in tumorigenicity, 
tumor suppression, apoptosis, cell proliferation, differentiation, invasion, and metas-
tasis. Besides the deregulation of primary miRNAs, in several cases we also detected 
deregulation of putative star sequences of the miRNAs. Furthermore, we observed 
differential expression of a large group of probe sequences corresponding to hairpin 
structures in the zebrafish genome that might represent additional miRNAs or other 
types of non-coding RNAs that remain to be further studied. Our results therefore 
further support that zebrafish liver tumors are suitable models of human liver tu-
mors, as they share high molecular similarities, and demonstrate that custom Agilent 
microarray technology is useful to detect expression of novel predicted transcripts 
representing putative miRNAs. 
Subsequently, we compared the liver tumor-related miRNA set to the miRNA 
set induced by Mycobacterium infection that we established in chapter 4. The com-
parison revealed a common group of tumor and immune-related miRNAs including 
members of the miR-15, miR-16, miR-21, miR-34, and miR-146 families, supporting 
the view that many miRNAs implicated in regulation of the immune response are 
also connected to cancer processes. 
Finally, we investigated the possible conservation of target genes of cancer-re-
lated miRNAs. Functional annotation of experimentally validated targets of human 
liver tumor-related miRNAs revealed that they are involved in various cancer-relat-
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ed processes and pathways. Prediction of miRNA recognition sites in the homolo-
gous zebrafish genes showed that several target genes of the miR-146 family (IRAK1, 
TRAF6, IRF5), the miR-221/miR222 families (CDKN1B, CDKN1C, KIT), and the 
miR-1 family (GJA1, PDCD4, TPM4, LASP1, TMSB4X, RABL2A, RABL2B) may be 
conserved between human and zebrafish. These genes are involved in the immune 
system as well as in cancer-related processes, such as cell cycle regulation, prolifera-
tion, apoptosis, cell adhesion, cell motility, and cytoskeletal organization, and they 
function in cancer- and immune-related pathways, such as MAPK signaling, NF-κB 
signaling, p53 signaling, small GTPase-mediated signal transduction, and the ErbB 
signaling pathway. These results further support the similarity between zebrafish 
and human liver cancer and the hypothesis that miRNAs might play an important 
role in regulating these cancer-related mechanisms in both species. Therefore, our 
miRNA results present a new level of conservation between zebrafish and human 
liver tumors in addition to the high conservation at the level of gene expression and 
transcriptional regulation by transcription factors. Hence, zebrafish as a liver cancer 
model can offer further valuable information of miRNA functions in cancer and 
contribute to studying the interaction between cancer and the immune system.
In conclusion, the studies described in this thesis further support that zebrafish is 
a valuable model system for infectious diseases and cancer as well as for scrutinizing 
the regulatory functions of miRNAs in the vertebrate immune system and disease. 
Using next-generation sequencing methods to analyze zebrafish mycobacterium and 
salmonella infection models, we have demonstrated for the first time that Solexa/
Illumina’s digital gene expression (DGE or Tag-Seq) system is a useful technology 
for transcriptome analysis of the vertebrate host response to infection. Our results 
demonstrated that this technology provides valuable complementary information to 
array-based methods, such as insight into infection-induced expression of alterna-
tive transcript isoforms. Furthermore, we have shown that another deep-sequencing 
technology, RNA-Seq, is also useful for quantification of the transcriptome response 
to infection. Since RNA-Seq is even more powerful than Tag-seq for studying tran-
scriptional landscapes, future in depth analysis of RNA-Seq data can be expected 
to provide further insights into alternative isoform expression during infection. By 
combining sequencing-based and microarray-based transcriptome data we have 
provided a valuable reference set of infection-responsive genes in zebrafish infection 
models. These infection-responsive genes include not only well-known vertebrate 
immune response genes but also genes not previously linked to infectious disease 
and that are of great interest for functional analysis of their possible role in host-
pathogen interactions. In addition, we have evaluated a set of infection-responsive 
and liver cancer-related miRNAs conserved between human and zebrafish, support-
ing that common miRNAs might play regulatory roles in the immune response and 
processes underlying the development of cancer. Our combined mRNA and miRNA 
transcriptome data provide a strong basis for future applications of zebrafish as an 
infection and cancer model.

Samenvatting
In het wetenschappelijk onderzoek naar de werking van alle genen (genomica) is 
de laatste jaren een enorme vooruitgang geboekt door nieuwe technologische ont-
wikkelingen waarmee de expressie van genen (het transcriptoom) op grote schaal 
in kaart gebracht kan worden. De toepassing van deze nieuwe technologieën heeft 
duidelijk gemaakt dat de transcriptomen van zowel prokaryote als eukaryote orga-
nismen veel complexer zijn dan voorheen werd gedacht. Bovendien heeft het gebruik 
van deze technologieën voor transcriptoomanalyse nieuwe inzichten verschaft in de 
moleculaire basis van ontwikkelings- en ziekteprocessen. De technologieën voor 
grootschalige transcriptoomanalyse berusten op twee benaderingen, microarrayana-
lyse en sequentieanalyse. Microarrayanalyse is een veelgebruikte techniek waarmee 
de expressieniveaus van duizenden transcripten gelijktijdig bepaald kunnen worden. 
Deze techniek heeft bijgedragen aan de oplossing van een groot aantal biologische 
vraagstellingen. Echter, microarrayanalyse heeft verschillende beperkingen die in-
herent zijn aan alle analysemethoden die gebaseerd zijn op hybridisatie van DNA 
of RNA. Bovendien is onderzoek waarbij microarrays gebruikt worden bevooroor-
deeld in die zin dat de samenstelling van de genen op de array voorafgaand aan 
het experiment is bepaald. Met de opkomst van de nieuwe generatie van technolo-
gieën voor sequentieanalyse is het mogelijk geworden om miljoenen transcripten 
tegelijk te detecteren en zijn de beperkingen van microarrayanalyse overwonnen. 
Transcriptoomanalyse is onmisbaar om de regulering van genexpressie aan het licht 
te brengen. Genexpressie wordt gereguleerd op verschillende niveaus, van transcrip-
tie tot post-translationele modificatie van het gecodeerde eiwit. Recentelijk is het 
duidelijk geworden dat kleine, niet-coderende RNA-moleculen, zoals microRNA’s 
(miRNA’s) belangrijke componenten van het reguleringsmechanisme van genexpres-
sie zijn. MiRNA’s werken als negatieve regulatoren van mRNA-translatie of mRNA-
stabiliteit en spelen een rol bij een groot aantal biologische processen, bijvoorbeeld 
de ontwikkeling en de functie van het immuunsysteem. Afwijkende expressie van 
miRNA’s is waargenomen bij verschillende ziekten, waaronder infectieziekten en 
kanker. Het in kaart brengen van de verschillen in miRNA-expressie tijdens ziekte-
processen en het ontrafelen van de biologische functies van miRNA’s is daarom van 
groot belang voor het begrip van de moleculaire mechanismen van ziekten. Om te 
onderzoeken hoe ziekteprocessen de expressiepatronen van mRNA’s en miRNA’s be-
invloeden, worden zowel in vitro-systemen (celculturen) als in vivo-systemen (proef-
diermodellen) toegepast. De zebravis is een veelgebruikt modelorganisme voor ont-
wikkelingsbiologie en recentelijk ook voor immunologisch onderzoek, vanwege de 
opvallende overeenkomsten tussen het immuunsysteem van de zebravis en dat van 
de mens. In de laatste jaren hebben zebravismodellen voor verschillende infectie-
ziekten en vormen van kanker zich bewezen als nuttige aanvullingen op zoogdier-
modellen. 
Het doel van het in dit proefschrift beschreven onderzoek was om inzicht te krij-
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gen in de complexiteit van het transcriptoom tijdens infectieziekten en kanker en 
in de regulerende functies van miRNA’s bij deze ziekteprocessen, door gebruik te 
maken van de nieuwe technologische mogelijkheden voor transcriptoomanalyse en 
de mogelijkheden van de zebravis als modelorganisme.
In Hoofdstuk 2 rapporteren wij voor het allereerst over de toepassing van groot-
schalige sequentieanalyse voor onderzoek naar de reactie van het transcriptoom van 
een gastheerorganisme op een bacteriële infectieziekte. Hierbij hebben wij gebruik 
gemaakt van het Solexa/Illumina-systeem voor digitale genexpressie (DGE of Tag-
Seq), een methode die is gebaseerd op het detecteren van korte transcript-specifieke 
sequenties (“tags”). In deze studie onderzochten wij de gastheerreactie van de zebra-
vis op een infectie met Mycobacterium marinum, een model voor humane tuberculo-
se. Door twee Tag-Seq-banken te maken van controlevissen en twee Taq-seq-banken 
van mycobacterium-geïnfecteerde vissen konden wij de technische reproduceerbaar-
heid van de methode bevestigen. Met deze benadering konden wij 5-8 miljoen se-
quenties per bank detecteren en de kartering daarvan toonde aan deze representatief 
waren voor meer dan 70% van alle genen die aanwezig zijn in de publieke transcript-
databanken. De Tag-Seq-sequenties die een significant verschillende expressie ver-
toonden na mycobacterium-infectie omvatten ongeveer 2% van de transcripten in de 
databases. Behalve kwantitatieve informatie over genexpressie, kon uit de Tag-Seq-
analyse ook worden afgeleid of de transcriptsequenties van de coderende (“sense”) 
of van de niet-coderende (“antisense”) streng van het DNA afkomstig waren. Er is 
toenemend bewijs voor het bestaan van antisense-transcripten, hoewel de biologi-
sche relevantie hiervan nog veel vragen oproept. In onze studie vonden wij ongeveer 
40% antisense-sequenties, in overeenstemming met andere recente grootschalige 
sequentiestudies in de muis en in menselijke cellen. Echter, het grootste deel van 
de sequenties die significant verschillend waren tussen geïnfecteerde vissen en de 
controles betrof sense-transcripten. Dit geeft aan dat de transcriptionele regulering 
van de door mycobacterium-geïnduceerde immuunreactie vooral op het niveau van 
de sense-transcripten plaatsvindt. Daarom hebben wij onze verdere studie gericht op 
de analyse van de sense-transcripten, hoewel de regulering van antisense-expressie 
ook zeer interessant is en verder onderzoek behoeft. 
Om onze resultaten te valideren hebben wij onze Tag-Seq-data vergeleken met 
een eerder samengestelde referentieset van mycobacterium-gereguleerde genen van 
de zebravis, die bepaald was door middel van een multiplatform-microarrayanalyse. 
Deze vergelijking liet een sterke correlatie tussen de twee methoden zien. Daarnaast 
hebben wij een nieuwe microarrayanalyse uitgevoerd met een zelfontworpen 
Agilent-platform, waaruit ook een aanzienlijke overlap met de Tag-Seq-data bleek. 
Het feit dat met Agilent-microarrayanalyse en met Tag-Seq-analyse dezelfde functi-
onele groepen van genen gedetecteerd werden, toonde aan dat deze twee benaderin-
gen voor transcriptoomanalyse goed vergelijkbaar zijn. Aan de andere kant bracht de 
vergelijking ook verschillen aan het licht die verklaard kunnen worden door de be-
perkingen van microarrayanalyse (zoals beperkte gevoeligheid, hybridisatie-artefac-
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ten en onvolkomenheden in het array-ontwerp) of van de Tag-Seq-methode (waarbij 
sommige transcripten gemist worden omdat ze geen unieke sequentie bevatten of 
een knipplaats voor het enzym dat gebruikt wordt voor de vervaardiging van Tag-
Seq-banken). Daarom kunnen microarrayanalyse en Tag-Seq-analyse beschouwd 
worden als complementaire technieken. Naast de vergelijking met microarrayana-
lyse, hebben wij ook enkele van de differentieel tot expressie komende transcriptse-
quenties geverifieerd met behulp van kwantitatieve PCR-analyse. Dit ondersteunde 
de Tag-Seq-resultaten zelfs in gevallen waar er een discrepantie was tussen de Taq-
Seq- en microarray-resultaten. Vervolgens hebben wij aan de hand van verschillende 
voorbeelden laten zien hoe transcriptoomanalyse met behulp van Tag-Seq additio-
nele waardevolle informatie over genexpressie kan opleveren. Op basis van de Taq-
Seq-data konden wij concluderen dat er groepen zijn van gecoördineerd-gereguleer-
de genen op bepaalde chromosomen. De Tag-Seq-data waren tevens bruikbaar om 
voorspellingen van genmodellen (intron-exon-structuren) te verifiëren. Bovendien 
toonden de Tag-Seq-data aan dat infectie kan leiden tot expressie van andere trans-
cript-isovormen en konden wij nieuwe mycobacterium-gereguleerde transcripten in 
kaart brengen die ontbraken in de beschikbare transcript-databanken. Bij elkaar ge-
nomen hebben wij met deze resultaten aangetoond dat het Solexa/Illumina-systeem 
voor digitale genexpressie een uiterst waardevolle technologie is om expressie te 
kwantificeren en om de complexiteit van het transcriptoom te ontrafelen. 
In Hoofdstuk 3 hebben wij sequentieanalyse gebruikt om meer kennis te verga-
ren over het transcriptoom van zebravisembryo’s tijdens de reactie van het aange-
boren (“innate”) immuunsysteem op een infectie met Salmonella enterica serovar 
Typhimurium (S. typhimurium). Hierbij hebben wij twee sequentiemethoden toege-
past, de Tag-Seq-methode, die is gebaseerd op het bepalen van korte transcript-spe-
cifieke sequenties verkregen door enzymatische digestie, en de RNA-Seq-methode, 
waarbij de gehele transcripten worden gefragmenteerd en de sequentie bepaald. Wij 
analyseerden 1 dag oude zebravisembryo’s op 8 uur na infectie met S. typhimurium, 
welk tijdspunt was gebaseerd op eerder microarraydata waarbij een sterke inflam-
matoire reactie was waargenomen. Onze analyse resulteerde in een set van 165 trans-
cripten die een overeenkomstige reactie vertoonden in zowel de Tag-Seq-analyse als 
in de microarrayanalyse. Bij de vergelijking van Tag-Seq met RNA-Seq vonden wij 
een overlap van 241 transcripten die differentieel tot expressie kwamen, waarmee 
wij hebben laten zien dat deze twee sequentiebepalingsmethoden een vergelijkbare 
prestatie leveren bij het kwantificeren van de transcriptoomreactie op infectie. De 
gecombineerde transcriptoomdata van de sequentie- en microarrayanalyses heb-
ben wij vervolgens gebruikt om een geannoteerde referentieset samen te stellen van 
infectie-responsieve genen in zebravisembryo’s. De genen in deze referentieset code-
ren voor transcriptiefactoren, signaaltransductie-eiwtten, cytokinen en chemokinen, 
complementfactoren, eiwitten betrokken bij apoptose en proteolyse alsmede eiwit-
ten met anti-microbiële activiteiten. Daarnaast omvatte de referentieset genen voor 
zowel bekende als nieuwe eiwitten die niet eerder met de immuunreactie in verband 
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waren gebracht. Wij hebben de Tag-Seq-data van de S. typhimurium-infectie van ze-
bravisembryo’s ook vergeleken met de Tag-Seq-data van M. marinum-infectie in vol-
wassen zebravissen uit Hoofdstuk 2. Het eindstadium van de M. marinum-infectie 
in volwassen vissen gaat gepaard met een sterke inflammatoire reactie, vergelijkbaar 
met de reactie van zebravisembryo’s op S. typhimurium-infectie. De vergelijking re-
sulteerde in een gemeenschappelijke set van 206 genen die een verhoogd expressie-
niveau vertoonden in beide infectiemodellen. Deze set omvatte transcriptiefactor-
genen en signaaltransductiegenen betrokken bij de aangeboren immuunreactie, 
evenals genen waarvoor een rol bij de immuunreactie niet eerder bekend was. Deze 
transcriptoomdata vormen een waardevolle referentie voor toekomstig onderzoek 
naar gastheer-pathogeen-interacties met gebruik van zebravis-infectiemodellen.
Het onderzoek beschreven in Hoofdstuk 4 was gericht op functies van miRNA’s 
bij het immuunsysteem van gewervelde dieren (vertebraten) tijdens infectieziekten. 
Net als in de voorgaande hoofdstukken, gebruikten wij als ziektemodellen zowel 
volwassen zebravissen als zebravisembryo’s die geïnjecteerd waren met de bacteri-
ele pathogenen M. marinum and S. typhimurium. Door embryonale en volwassen 
zebravissen in onze experimenten te gebruiken konden wij onderscheid maken in 
miRNA-expressiepatronen die kenmerkend waren voor het aangeboren (“innate”) 
immuunsysteem en voor het verworven (“adaptive”) immuunsysteem, aangezien in 
embryo’s alleen nog het aangeboren systeem is ontwikkeld. Door gebruik te maken 
van een nieuw Agilent-microarrayplatform voor miRNA-detectie konden we een 
set van miRNA’s identificeren die algemeen reageren op verschillende typen infec-
ties, waaronder leden van de miR-21-, miR-146- en miR-181-families. De resultaten 
waren in overeenstemming met eerdere studies die een verband hadden aangetoond 
van deze miRNA’s met het immuunsysteem en met kanker in humane patiënten-
materialen en celcultuursystemen en in proefdiermodellen van zoogdieren. Echter, 
onze studie is de eerste die deze miRNA’s in verband brengt met mycobacterium- en 
salmonella-infecties. Bovendien ondersteunen onze resultaten eerdere hypothesen 
dat regulering van de immuunreactie en kankerprocessen afhankelijk is van gemeen-
schappelijke miRNA’s.
De miR-146-familie is eerder in verband gebracht met de regulering van signaal-
routes van het aangeboren immuunsysteem in de mens en in diermodellen. Onze 
data zijn hiermee in overeenstemming, aangezien miR-146a en miR-146b niet alleen 
geïnduceerd werden in volwassen zebravissen, maar ook in embryo’s die volledig af-
hankelijk zijn van het aangeboren immuunsysteem. Er wordt gedacht dat miR-146a 
en -b een rol spelen bij de fijnafstelling van de Toll-receptor- en interleukine-1-recep-
tor-signaalroutes (TLR- en IL1R-signaalroutes) die een sleutelrol spelen bij de her-
kenning van pathogenen en bij de activering van de aangeboren immuunreactie. Om 
te onderzoeken of de functie van miR-146 geconserveerd is in de zebravis hebben wij 
een voorspelling gemaakt van de genen die door deze miRNA’s gereguleerd zouden 
kunnen worden (doelwitgenen of “target genes”). Wij vonden herkenningsplaatsen 
voor miR-146-a en -b van de zebravis in irak1 en traf6, twee genen die een rol spelen 
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in de TLR- en IL1R-signaalroutes en die beide herkend ook worden door de miR-146
-familie van zoogdieren. Daarnaast vonden wij dat het transcript dat codeert voor 
MyD88, een essentieel adaptereiwit in de TLR- en IL1R-signaalroutes, ook mogelijke 
herkenningsplaatsen voor miR-146a en -b van de zebravis bevat. De inductie van 
miR-146 door bacteriële pathogenen is in overeenstemming met de genexpressiedata 
uit hoofdstukken 2 en 3, die laten zien dat tijdens infecties in de zebravis er verschil-
lende genen van de TLR-signaalroute geïnduceerd worden, evenals doelwitgenen en 
negatieve regulatoren van deze route. Daarom ondersteunen onze data de hypothese 
dat miRNA-regulering een belangrijke rol speelt als een negatief terugkoppelings-
mechanisme om de immuunreactie op de juiste manier onder controle te houden. 
Om andere mogelijke doelwitgenen van de miR-146-familie te identificeren hebben 
wij gebruik gemaakt van softwareprogramma’s waarmee herkenningsplaatsen voor 
miRNA’s voorspeld kunnen worden. De meeste van de voorspelde doelwitgenen van 
miR-146 die geconserveerd waren tussen de zebravis en de mens, waren genen die 
eerder in verband gebracht waren met infecties, tumorprogressie en processen die 
onderdeel uitmaken van de immuunreactie, zoals TLR-signaaltransductie, regule-
ring van de activiteit van de centrale transcriptiefactor NF-κB, apoptose, hemostase 
en T-cell-ontwikkeling en -functie. Onze voorspelling van geconserveerde miR-
146-doelwitgenen ondersteunt daarom de veronderstelde functie van miR-146 bij 
de regulering van de immuunreactie. Met deze studie hebben wij laten zien dat de 
zebravis een bruikbaar model is om miRNA-functies bij het immuunsysteem van 
vertebraten te onderzoeken, aangezien de miRNA’s die tijdens bacteriële infecties 
tot expressie komen sterk geconserveerd zijn en er een aanzienlijk overlap is in de 
voorspelde doelwitgenen van miRNA’s in de mens en in de zebravis.
Om meer inzicht te krijgen in de rol van miRNA’s in mechanismen van kanker 
hebben wij in Hoofdstuk 5 miRNA-expressiepatronen in levertumoren van de ze-
bravis onderzocht. Eerder was aangetoond dat de zebravis een waardevol ziektemo-
del is voor leverkanker, aangezien er opvallende moleculaire overeenkomsten zijn 
met humane hepatocellulaire carcinoma (HCC), zoals geconserveerde patronen van 
genexpressie en transcriptionele regulering van verschillende bij kanker betrokken 
gengroepen. Op te bepalen of er ook conservering is op het niveau van miRNA-
expressie tussen levertumoren van de zebravis en van de mens, hebben wij een miR-
NA-transcriptoomanalyse uitgevoerd van carcinogeen-geïnduceerde levertumoren 
van zebravissen. Wij hebben miRNA’s die een significant verschillende expressie ver-
toonden tussen levertumoren en gezonde lever van de zebravis vergeleken met de 
miRNA’s die eerder in verband waren gebracht met humane HCC. Deze vergelijking 
resulteerde in een set van miRNA’s waarvan de expressie ontregeld was in levertumo-
ren van zowel de zebravis als de mens. De meest opvallende overeenkomsten waren 
de inductie van miR-21, miR-23a, miR-146a/b, miR-221 en miR-222, en de repressie 
van miR-1 en miR-122. Bovendien konden wij diverse andere miRNA’s aantonen in 
levertumoren van de zebravis die niet eerder in verband gebracht waren met humane 
HCC, maar die wel eerder geassocieerd waren met verschillende andere typen van 
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kanker. Voor deze miRNA’s zijn functies gepostuleerd bij het ontstaan van tumoren, 
bij de suppressie van tumoren, bij apoptose, proliferatie, differentiatie, invasiviteit en 
metastase. Naast de ontregeling van primaire miRNA’s, vonden wij in verschillende 
gevallen ook ontregeling van de zogenoemde ster-sequenties. Dit zijn miRNA’s die 
afkomstig zijn van de tegenovergestelde arm van de haarspeldstructuur van precur-
sor-miRNA’s. Bovendien konden wij een differentiële expressie waarnemen van een 
grote groep van sequenties die overeenkomen met voorspelde haarspeldstructuren 
in het zebravisgenoom. Van deze structuren is het nog niet bekend of het mogelijk 
ook miRNA-genen zijn of dat er andere typen niet-coderende RNA’s van worden af-
geschreven, die nog verdere studie behoeven. Samen met de eerder gepubliceerde ge-
nexpressiestudies tonen onze miRNA-expressiedata aan dat zebravis-levertumoren 
een geschikt model zijn voor het bestuderen van humane levertumoren, gezien de 
aanzienlijke moleculaire overeenkomsten. Tevens tonen onze resultaten aan dat de 
Agilent-microarraytechnology zeer bruikbaar is om nieuw voorspelde miRNA’s of 
andere niet-coderende, regulerende RNA-moleculen te detecteren.
Vervolgens hebben wij de set van levertumor-gerelateerde miRNA’s vergeleken 
met de set van miRNA’s die geïnduceerd waren door mycobacterium-infectie, zo-
als bepaald in hoofdstuk 4. Deze vergelijking resulteerde in een gemeenschappe-
lijke groep van tumor- en immuun-gerelateerde miRNA’s, waaronder leden van de 
miR-15-, miR-16-, miR-21-, miR-34- en miR-146-families. Dit ondersteunt de op-
vatting dat veel miRNA’s die betrokken zijn bij regulering van de immuunreactie, 
ook een rol spelen bij processen van kanker.Tenslotte hebben wij onderzocht of de 
doelwitgenen van kanker-gerelateerde miRNA’s mogelijk ook geconserveerd zijn. 
Functionele annotatie van experimenteel-gevalideerde doelwitgenen van miRNA’s 
die betrokken zijn bij humane leverkanker, toont aan dat deze genen een rol spelen 
in diverse kanker-gerelateerde processen en signaalroutes. Voorspelling van de miR-
NA-herkenningsplaatsen in de overeenkomstige genen van de zebravis liet zien dat 
verschillende doelwitgenen van de miR-146-familie (IRAK1, TRAF6, IRF5), de miR-
221/miR222-familie (CDKN1B, CDKN1C, KIT) en de miR-1-familie (GJA1, PDCD4, 
TPM4, LASP1, TMSB4X, RABL2A, RABL2B) mogelijk geconserveerd zijn tussen 
de mens en de zebravis. Deze genen zijn betrokken bij het immuunsysteem zowel 
als bij kanker-gerelateerde processen, zoals regulering van de celcyclus, prolifera-
tie, apoptose, celadhesie, celmotiliteit en organisatie van het cytoskelet. Bovendien 
functioneren deze genen in kanker- en immuun-gerelateerde signaalroutes, zoals 
MAPK-, NF-κB-, p53- en ErbB-signaaltransductie, alsmede signaaltransductie door 
kleine G-eiwitten.  Door deze resultaten wordt de overeenkomst tussen leverkan-
ker van de zebravis en de mens verder versterkt, evenals de hypothese dat miRNA’s 
een belangrijke rol spelen bij deze kanker-gerelateerde processen in beide soorten. 
Onze miRNA-resultaten hebben een nieuw niveau van conservering tussen levertu-
moren van de zebravis en de mens aan het licht gebracht naast de al aangetoonde 
sterke conservering van genexpressiepatronen en regulering door transcriptiefacto-
ren. Daarom kan de zebravis als leverkankermodel bijdragen om miRNA-functies 
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bij kanker te ontrafelen en om de interactie tussen kanker en het immuunsysteem 
verder te onderzoeken.
Concluderend heeft het in dit proefschrift beschreven onderzoek ondersteunend 
bewijs geleverd dat de zebravis een waardevol modelsysteem is voor infectieziekten 
en kanker, evenals voor het bestuderen van de regulerende functies van miRNA’s bij 
het immuunsysteem en ziekten van vertebraten. Met het gebruik van de nieuwe ge-
neratie van technologieën voor sequentieanalyse voor de studie van mycobacterium- 
and salmonella-infectiemodellen van de zebravis, hebben wij voor het eerst aange-
toond dat het Solexa/Illumina-systeem voor digitale genexpressie (DGE of Tag-Seq) 
een zeer bruikbare technologie is voor transcriptoomanalyse van de gastheerreactie 
op een infectie. Onze resultaten hebben aangetoond dat deze technologie waardevol-
le additionele informatie oplevert ten opzichte van microarrayanalyse, zoals inzicht 
in infectie-geïnduceerde expressie van alternatieve transcript-isovormen. Bovendien 
hebben wij laten zien dat een andere grootschalige sequentietechnologie, RNA-Seq, 
evenzeer geschikt is voor het kwantificeren van de transcriptoomreactie op infectie. 
Aangezien RNA-Seq een nog krachtiger techniek is dan Tag-Seq om transcriptionele 
landschappen in kaart te brengen, is het te verwachten dat een toekomstige diepte-
studie van RNA-Seq-data verdere inzichten zal opleveren in de expressie van alterna-
tieve isovormen tijdens infectie. Door combinatie van de transcriptoomdata van de 
sequentie- en microarrayanalyses hebben wij een waardevolle referentieset samen-
gesteld van infectie-responsieve genen in zebravis-infectiemodellen. Deze infectie-
responsieve genen omvatten niet alleen welbekende immuunreactiegenen van verte-
braten, maar ook genen die niet eerder met infectieziekten in verband zijn gebracht 
en die daarom zeer interessant zijn voor functioneel onderzoek naar hun mogelijke 
rol bij gastheer-pathogeen-interacties. Daarnaast hebben wij een set van infectie-res-
ponsieve en leverkanker-gerelateerde miRNA’s in kaart gebracht die geconserveerd 
zijn tussen de mens en de zebravis en hiermee ondersteunend bewijs geleverd dat 
gemeenschappelijke miRNA’s een regulerende rol spelen bij de immuunreactie en 
bij processen die ten grondslag liggen aan de ontwikkeling van kanker. Onze gecom-
bineerde mRNA- en miRNA-transcriptoomdata vormen een sterke basis voor de 
toepassing van de zebravis als infectie- en kankermodel in toekomstig onderzoek.

Összefoglalás
Az utóbbi években a transzkriptómikai vizsgálatokban alkalmazott technológiák 
fejlődésének köszönhetően a genom kutatás területén jelentős előrehaladás figyelhető 
meg. A disszertáció első fejezete ezen technológiákról, a génexpresszió szabályo-
zásáról, és a szabályozás vizsgálatához használt modellekről ad átfogó képet. A transz-
kriptómikában alkalmazott technológiák fényt derítettek néhány prokarióta és euka-
rióta szervezet transzkriptómájának komplexitására, továbbá bizonyos fejlődési és 
patológiás folyamatok molekuláris hátterére. Számos high-throughput technikát fej-
lesztettek már ki a transzkritómikában, melyek alapvetően két csoportba sorolhatóak: 
a mikrochip alapú és a szekvenálás alapú eljárások, melyek mindegyike lehetőséget 
biztosít az átfogó vizsgálatokra. A mikrochip analízis széles körben használt tech-
nológia, mely több ezer transzkript egyidejű vizsgálatára képes. Bár a mikrochipek 
sok biológiai probléma megoldásában hasznosnak bizonyultak, a hibridizáció és a 
chipre felvitt, előre meghatározott szekvenciájú próbák hátrányt jelentenek a transz-
kriptómikai vizsgálatok során. Az új-generációs szekvenálási technikák kifejlesz-
tésével ezen hátrányokat legyőzve több millió transzkript szimultán detektálására van 
lehetőség. A két technika egymást kiegészítő eljárásként használható a genom vizs-
gálatára, melyek nem csak átfedő, de az egyes módszerek tulajdonságából következő 
specifikus eredményeket is hoznak. Transzkriptómikai elemzések elengedhetetlenül 
fontosak a génexpresszió szabályozásának vizsgálatánál. A génexpresszió több szin-
ten szabályzott, egészen a transzkripciótól a fehérjék poszt-transzlációs módosításáig. 
Az utóbbi években fény derült arra, hogy ebben a szabályozásban nagy szerepet ját-
szanak a kisméretű nem-kódoló RNS-ek, mint például a mikroRNS-ek (miRNS). A 
miRNS-ek negatívan szabályozzák a mRNS transzlációját vagy stabilitását. Számos 
biológia folyamatban bizonyították már szerepüket, így például a fejlődés valamint az 
immunrendszer működése során. A miRNS-ek megváltozott expresszióját mutatták 
ki különböző betegségek, mint például a fertőző betegségek és a rák esetében. Annak 
érdekében, hogy jobban megismerjük ezen megbetegedések patogenezisét, fontos 
tudnunk, mely miRNS-ek expressziója változott meg az egyes esetekben. Az egyes 
betegségek következtében megváltozott mRNS és miRNS expressziós vizsgálatokhoz 
in vitro, és in vivo modelleket is használnak. A zebrahal egy gyakran alkalmazott 
gerinces modellszervezet, melyet fejlődésbiológiai, embriogenenezist érintő, vala-
mint újabban immunológiai kísérletekben használnak köszönhetően annak, hogy 
immunrendszere jelentős hasonlóságot mutat a humánéval. Az utóbbi években a 
zebrahal, az emlős állatmodellek mellett, egy kiváló modellszervezetnek bizonyult 
számos fertőző betegség és a tumoros megbetegedés vizsgálatában. 
Kihasználva a transzkriptómikában megjelenő újfajta technológiai lehetőségeket, 
valamint alkalmazva a zebrahalat, mint modellszervezetet ez a doktori disszertáció a 
fertőző betegségek és tumoros megbetegedések során bekövetkező transzkriptómi-
kai változások vizsgálatát és annak eredményeit foglalja össze, valamint betekintést 
nyújt a miRNS-ek szabályzó funkciójába. 
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A második fejezetben elsőként mutatjuk be a fertőző megbetegedések során 
bekövetkező transzkriptómikai változásokat, melyet a Solexa/Illumina rendszer 
úgynevezett digitális génexpresszió (DGE vagy Tag-Seq) technológiájával vizsgál-
tunk, mely egy szekvencia mintavételezésen alapuló, ún. tag-alapú transzkriptóm 
szekvenálási technika. Ebben a tanulmányban a humán tuberkulózist modellező 
Mycobacterium marinum fertőzés során fellépő változásokat vizsgáltuk zebrahalban. 
Kontrol és fertőzött halak esetében is két-két könyvtárat hoztunk létre, melyek bi-
zonyították a technikai reprodukálhatóságot. Az eljárással könyvtáranként 5-8 millió 
tag-et detektáltunk, melyek lefedték a transzkript adatbázisokban található összes 
gén több mint 70%-át. A szignifikánsan megváltozott tag szekvenciák az adatbázis 
transzkriptjeinek 2%-ára térképeződtek. A Tag-Seq analízis nem csak kvantitatív in-
formációt nyújt a génexpresszióról, hanem a transzkriptek irányultságáról is tájékoz-
tat. Vizsgálatunk során a tag-ek közel 40%-a térképeződött az antiszensz szálra, mely 
megegyezik más tanulmányokkal. Azonban, mivel a szignifikánsan megváltozott 
tag-ek nagy része a szensz szálra térképeződött, és bár az antiszensz jelenségre egyre 
több bizonyíték létezik, de biológiai jelentősége még nehezen értelmezhető, a továb-
biakban csak a szensz transzkripteket tanulmányoztuk.
Annak érdekében, hogy bizonyítsuk a Tag-Seq technológiával nyert ered-
ményeink helyességét, egy korábban, különböző típusú mikrochip kísérletek során 
felállított, mikobaktérium által regulált gének referencialistájával hasonlítottuk össze 
Tag-Seq eredményünket. Az összevetés erős korrelációt mutatott alátámasztva a két-
féle metódus összehasonlíthatóságát, másrészről azonban felfedte az egyes eljárások 
hátrányait is. Ezért a két technika egymást kiegészítő eljárásnak tekinthető. A mikro-
chip mellett qPCR segítségével is ellenőriztünk egyes megváltozott tag szekvenciák 
expresszióját. Ezek a Tag-Seq eredményeket igazolták olyan esetekben is, ahol el-
lentétes expressziót mutatott a Tag-Seq és mikrochip technika. Ezenkivül bemutat-
tuk, hogy a Tag-Seq technológia milyen más értékes információt nyújthat a kutató 
számára. Használható együttesen szabályzott transzkriptek vizsgálatára, prediktált 
génmodellek megerősítésére, fertőzés által indukált izoforma-változás vizsgálatához, 
újabb, mikobaktérium által regulált transzkriptek detektálására és térképezésére. 
Összefoglalva tehát bemutattuk, hogy a Solexa/Illumina digitális génexpressziós 
rendszere egy igen alkalmas technológia a transzkriptómikai analízisek során, kvan-
tifikációs és komplexitási vizsgálatokhoz egyaránt. 
A harmadik fejezetben tag-alapú szekvenálást (Tag-Seq) és teljes transzkript 
szekvenálást (RNA-Seq) alkalmazva végeztünk transzkriptómikai analízist olyan 1 na-
pos zebrahal embriók esetében, amelyeket Salmonella enterica serovar Typhimurium-
mal (S. typhimurium) fertőztünk 8 órával a vizsgálat előtt. Egy korábbi mikrochip 
kísérletben a S. typhimurium-mal fertőzött embriók transzkriptómikai vizsgálata-
kor számos gyulladást okozó gén indukcióját mutattuk ki. A Tag-Seq és a mikro-
chip kísérletek eredményeit összehasonlítva 165 olyan transzkriptet találtunk, mely 
mindkét esetben változást mutatott. A Tag-Seq és a RNA-Seq összehasonlításával 
241 mindkét esetben egyaránt megváltozott expressziójú transzkriptet azonosí-
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tottunk, így elsőként demonstráltuk a két módszer hasonló teljesítményét fertőzés 
során fellépő transzkriptómikai változások vizsgálatakor. Egyesítve a szekvenálás 
alapú és a mikrochip alapú transzkriptóm vizsgálatok eredményeit összeállítottunk 
egy annotált referencia génlistát, mely zebrahal embriókban fertőzés következtében 
megváltozik. Ide tartoznak a transzkripciós faktorokat, szignál transzdukciós fehér-
jéket, citokineket és kemokineket, komplement faktorokat, apoptózisban és prote-
olízisben részt vevő fehérjéket, anti-mikrobiális aktivitással bíró fehérjéket kódoló 
gének, valamint számos olyan ismert és nem ismert gén, amelyet eddig nem hoztak 
összefüggésbe az immunválasszal. Ezenkívül összehasonlítottuk a S. typhimurium-
mal fertőzött zebrahal embriókkal végzett kísérlet Tag-Seq adatait a második feje-
zetben leírt M. marinum-mal fertőzött kifejlett zebrahalakkal végzett kísérlet Tag-
Seq adataival, mivel mindkét esetben erős gyulladásos immunválaszt figyeltünk 
meg. Összesen 206 fertőzés következtében megnövekedett expressziójú gént azon-
osítottunk, melyek a természetes immunválaszban részvevő transzkripciós faktorok 
és jelátviteli komponensek, valamint olyan gének, melyeket eddig nem kötöttek az 
immunválasz folyamatához. Ezzel a transzkriptómikai analízissel egy értékes refe-
rencialistát állítottunk össze, mely a további, zebrahal és patogén kapcsolatát tanul-
mányozó vizsgálatban hasznos lehet.
A negyedik fejezetben célul tűztük ki, hogy megismerjük a miRNS-ek fertőzéses 
megbetegedések esetén betöltött szerepét a gerincesek immunrendszerében. M. 
marinum és S. typhimurium bakteriális patogénekkel fertőzött kifejlett zebrahalakat, 
valamint embriókat alkalmaztunk, hogy modellezzük az egyes humán betegségeket. 
Azzal, hogy mind embrionális, mind pedig kifejlett egyedeket használtunk, meg-
határozhattuk, hogy az egyes miRNS-ek a természetes vagy a szerzett immunválasz-
ban játszhatnak szerepet, hiszen az embriókban csak a természetes immunitás van 
kifejlődve. Egyedi tervezésű mikrochipet alkalmazva számos közös, fertőzésre re-
agáló miRNS-t sikerült azonosítanunk zebrahalban, beleértve a miR-21, miR-146 és 
a miR-181 családot. Ezek konzerváltságát, immunrendszerben való közreműködését, 
illetve tumorok kifejlődésében való szerepét humánban és más emlősben több egyéb 
kísérlet is jól bizonyítja. Azonban ez a tanulmány hozza kapcsolatba elsőként ezen 
miRNS-eket mikobaktérium és szalmonella fertőzésekkel. Továbbá eredményeink 
azt a korábbi feltevést is igazolják, miszerint azonos miRNS-ek vehetnek részt az im-
munrendszer és a tumoros folyamatok szabályozásában.
A miR-146 család természetes immunitásban betöltött szerepét már korábban bi-
zonyították emberben és állat modellekben. Eredményeink megegyeznek ezekkel az 
adatokkal, hiszen a miR-146 a/b expresszió növekedést mutatott fertőzés következ-
tében a kifejlett halakban és az embriókban egyaránt, melyeknél csak a természetes 
immunrendszer van kifejlődve. Feltételezések szerint a miR-146 a/b természetes im-
munválaszban betöltött szerepe a TLR és az IL1R szignalizáció szabályozásában le-
het, amely a patogének felismerésében és a természetes immunválasz aktiválásában 
jelentős. Annak érdekében, hogy megtudjuk, hogy a miR-146 funkciója konzervált-e 
zebrahalban, azonosítottuk a család prediktált célgénjeit. Ezek között találtuk a TLR 
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és IL1R szignalizációs útvonalakban részt vevő irak1 és traf6 gént, mely emlősökben 
is a miR-146 a/b célgénje. Ezenkívül találtunk vélt miR-146 a/b kötődési pontokat a 
zebrahal MyD88 génjén, mely a két szignalizációs útvonal közös adaptere. A miR-146 
bakteriális fertőzés hatására bekövetkező indukciója összhangban áll a második és 
harmadik fejezetben leírt mRNS expressziós adatokkal, ezzel demonstrálva néhány 
TLR szignalizációs gén, effektor gén és azok szabályzó génjeinek indukálódását 
fertőzés hatására zebrahalban. Tehát eredményeink alátámasztják azt a feltevést, hogy 
a miRNS-ek fontos feed-back mechanizmusként szerepet játszanak az immunválasz 
pontos szabályozásában. Ezenkívül bioinformatikai szoftverek segítségével azonosí-
tottunk további prediktált miR-146 célgént. A legtöbb gén, mely konzervált a humán 
és a zebrahal között, közreműködik az immunrendszer egyes folyamataiban, így 
például az apoptózisban, az NF-KB transzkripciós faktor aktivitását szabályozásában, 
hemosztázisban, fertőzés során, T-sejtek fejlődésében és funkciójában, TLR szig-
nalizációban, valamint tumor fejlődésében. Összességében tehát ez a tanulmány 
megerősítést ad arról, hogy a zebrahal egy megfelelő modellszervezet a gerincesek 
immunrendszerében részt vevő miRNS-ek funkciójának vizsgálatára, hiszen számos 
bakteriális fertőzésben résztvevő konzervált miRNS-t, valamint számos konzervált 
miRNS célgént azonosítottunk. 
Az ötödik fejezetben célunk az volt, hogy megtudjuk, hogy a miRNS-ek milyen 
szerepet töltenek be a rák mechanizmusában, ezért azonosítottuk azokat a miRNS-
eket, amelyek szerepet játszhatnak a májtumor kialakulásában zebrahalak esetében. 
A zebrahal ígéretes modellnek bizonyult a májtumor modellezésében, hiszen mole-
kulárisan nagyon hasonlít a humán hepatocelluláris karcinómára (HCC). Annak 
érdekében, hogy kiderítsük, hogy ez a hasonlóság, konzerváltság megtalálható-e a 
miRNS expresszió szintjén is, miRNS transzkriptómikai analízist végeztünk zeb-
rahalból nyert, karcinogénnel indukált májtumor mintákkal. Összehasonlítottuk a 
zebrahalban általunk azonosított és a humán HCC-vel korábban kapcsolatba hozott 
szignifikánsan megváltozott expressziójú miRNS-eket, és összeállítottunk azoknak 
a listáját, melyek mindkét szervezetben deregulációt mutattak. Ide sorolható a meg-
növekedett expressziójú miR-21, miR-23a, miR-146a/b, miR-221 és miR-222, valamint 
a csökkent expressziójú miR-1 és miR-122. Ezeken felül kimutattunk olyan miRNS-
eket is, amelyeket eddig még csak másfajta humán tumoros megbetegedéssel kap-
csolatban publikáltak, és amelyek részt vesznek a tumor képződésében, tumor szup-
presszióban, apoptózisban, sejtosztódásban, differenciációban, invázióban és meta-
sztázisban. Az érett miRNS-ek mellett bizonyos esetekben megváltozott expressziót 
figyeltünk meg a miRNS hajtű-struktúra másik karjánál is, illetve olyan szekven-
ciák esetében is, amelyek újabb miRNS-eket vagy másfajta nem-kódoló RNS struk-
túrákat reprezentálhatnak. Eredményeink tehát igazolják, hogy a zebrahal májtumor 
megfelelően modellezi a humán májtumort, valamint hogy az Agilent mikrochip 
technológiával lehetőség van újabb, vélt miRNS-eket expressziójának kimutatására. 
Ezt követően összehasonlítottuk a májtumorral összefüggésbe hozott miRNS-ek 
listáját azon miRNS-ekkel, melyek mikobaktérium fertőzés hatására indukálódtak (4. 
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fejezet). A közösen megjelenő miRNS-ek, a miR-15, miR-16, miR-21, miR-34, és miR-
146 család, megerősítik azt a nézetet, miszerint sok miRNS, amely szerepet játszik az 
immunválaszban, annak szerepe van a tumoros folyamatokban is.
Végül, vizsgáltuk a tumorban résztvevő miRNS-ek célgénjeinek lehetséges kon-
zerváltságát. Elvégeztük a humán májtumorban közreműködő miRNS-ek kísérle-
tesen is bizonyított célgénjeinek funkcionális annotációját, amely azt mutatta, hogy 
ezek a gének részt vesznek különböző tumorral kapcsolatos folyamatokban, szig-
nalizációs útvonalakban. A homológ zebrahal géneknél végzett miRNS kötő hely 
prediktáció azt mutatta, hogy néhány miR-146 család célgén (IRAK1, TRAF6, IRF5), 
miR-221/222 család célgén (CDKN1B, CDKN1C, KIT) és miR-1 család célgén (GJA1, 
PDCD4, TPM4, LASP1, TMSB4X, RABL2A, RABL2B) konzervált lehet humán és 
zebrahal között. Ezek a gének mind az immunrendszerben, mind pedig a tumoros 
folyamatokban szerepet játszanak, így például a sejtciklus szabályozásban, sejtosz-
tódásban, apoptózisban, sejtadhezióban, sejtmozgásban, citoszkeletális organizáció-
ban, valamint immunválasszal és tumorral kapcsolatos szignalizációs útvonalakban, 
a MAPK, NF-κB, p53, ErbB szignalizációban, és a kis GTPáz-hoz kapcsolt szignál 
transzdukciós útvonalakban. Ezek az eredmények alátámasztják a zebrahal és humán 
májtumor hasonlóságát, valamint azt a hipotézist, miszerint a miRNS-ek fontos sze-
repet játszhatnak mindkét organizmusban a tumorral kapcsolatos mechanizmusok 
szabályzásában. MiRNS tanulmányunk tehát a zebrahal és humán májtumor közti 
hasonlóság újabb szintjét mutatja be a génexpresszió és a transzkripciós faktorok 
általi transzkripciós szabályzáson túl. 
Összefoglalva, a tézisben leírt tanulmányaink alátámasztják azt, hogy a zebrahal 
alkalmas a fertőző és a tumoros megbetegedések modellezésére, valamint alkalma-
sak a miRNS-eknek a gerincesek immunrendszerében és egyes megbetegedésekben 
betöltött szabályzó funkciójának vizsgálatára. Bemutattuk, hogy az újgenerációs 
szekvenálási eljárás, a Solexa/Illumina digitális génexpressziós rendszere (DGE 
vagy Tag-Seq) jól alkalmazható a gerincesek fertőzésre adott immunválaszának 
transzkriptómikai vizsgálatára, és mint egy kiegészítő technológiaként használható 
a mikrochip alapú eljárások mellett. Továbbá bemutattuk, hogy egy másik újgene-
rációs szekvenálási technika, az RNA-Seq ugyancsak megfelelő a fertőzésekre adott 
transzkriptómikai változások elemzésére. A szekvenálás alapú és a mikrochip alapú 
transzkriptómikai adatok egyesítésével egy értékes referencialistát állítottunk össze 
azokból a génekből, melyek expressziója a fertőzés következtében változott meg zeb-
rahalban. Ez a génlista nemcsak jól ismert, a gerinces immunválaszban részvevő gé-
neket tartalmaz, hanem olyanokat is, amelyeket eddig még nem figyeltek meg fertőző 
betegségeknél, viszont értékes információkat rejthetnek a gazda-patogén kölcsönha-
tásban betöltött szerepüket illetően. Ezenkivül összeállítottuk azon miRNS listáját, 
amelyek fertőzésekben és a májtumor folyamatában egyaránt közreműködnek, és 
konzerváltságot mutatnak humán és zebrahal közt, mindezzel megerősítve azt, hogy 
közös miRNS-ek vehetnek részt az immunválasz és a tumor kialakulásának szabály-
zásában. Tanulmányainkban végzett mRNS és miRNS transzkriptómikai adatok ala-
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pul szolgálhatnak a jövőben olyan vizsgálatokhoz, melyek a zebrahalat a fertőző és 
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